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I. Zusammenfassung 
Toxoplasma gondii ist ein weit verbreiteter, obligat-intrazellulärer, einzelliger Parasit, der die 
lebensbedrohliche Krankheit Toxoplasmose in Menschen und Tieren hervorrufen kann.  
Der schnell replizierende Parasit benötigt erhebliche Mengen an Phospholipiden zur Biogenese intra- 
und extrazellulärer Membranen. Phosphatidylethanolamin (PtdEtn) ist ein wichtiges und ubiquitäres 
Phospholipid in Pro- und Eukaryoten und das zweithäufigste Lipid in T. gondii. Dieses kann de novo 
über den CDP-Ethanolamin Stoffwechselweg oder durch Decarboxylierung von Phosphatidylserin 
synthetisiert werden. Aufgrund seiner konischen Struktur, scheint PtdEtn vor allem eine wichtige 
Funktion bei der Krümmung, Fusion und Abschnürung von Membranen, sowie der Stabilisierung von 
Membranproteinen einzunehmen. Zudem ist PtdEtn essentiell für die Integrität und Funktion von 
Mitochondrien in Eukaryoten. 
Im Rahmen dieser Arbeit konnte die Expression von zwei distinkten Phosphatidylserin 
Decarboxylasen (PSDs) in T. gondii nachgewiesen werden: TgPSD1pv ist partiell löslich und wird über 
Dichte Granula in die Parasitophore Vakuole sekretiert, während sich TgPSD1mt im Mitochondrium 
von Tachyzoiten befindet. 
TgPSD1mt ist in der Lage einen Ethanolamin-auxotrophen S. cerevisiae Stamm zu komplementieren, 
wohingegen TgPSD1pv in Hefe nicht funktionell ist. Ein Knock-down von TgPSD1mt verursacht eine 
verlangsamte Parasitenreplikation, welche zu einem verminderten in vitro Wachstum führt. Der 
PtdEtn-Gehalt in der Mutante bleibt unverändert, was auf eine stringente Homöostase des zellulären 
PtdEtn Reservoirs durch alternative Lipidbiogenesewege hindeutet. Tatsächlich verfügt T. gondii 
zusätzlich über einen aktiven CDP-Ethanolamin Stoffwechselweg im Endoplasmatischen Retikulum, 
welchen die Δtgpsd1mt-Mutante für einen erhöhten Einbau von 14C-Ethanolamin in PtdEtn nutzt. 
Dies deutet darauf hin, dass der Parasit versucht den Verlust von TgPSD1mt über eine 
Hochregulierung des de novo PtdEtn Stoffwechselweges auszugleichen. Das zweite und Coccidia-
spezifische TgPSD1pv-Enzym hingegen scheint zwar für das Parasitenwachstum in vitro entbehrlich zu 
sein, verfügt jedoch über einzigartige enzymatische Eigenschaften, die sich nicht in anderen PSD 
Enzymen finden. 
Infektionsversuche mit [14C]-Ethanolamin markierten Wirtszellen zeigten zudem eine Aufnahme von 
PtdEtn oder PtdEtn-Derivaten in T. gondii als weiteren Mechanismus der PtdEtn-Homöostase in 
intrazellulär replizierenden Tachyzoiten. 
Diese Ergebnisse demonstrieren eine außergewöhnliche Kompartmentalisierung und Plastizität der 
PtdEtn-Synthese in T. gondii, welche dem Parasiten sehr wahrscheinlich eine flexible 
Membranbiogenese bei unterschiedlichem Nährstoffangebot ermöglicht.  
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II. Abstract 
Toxoplasma gondii is a remarkably successful and widespread obligate intracellular protozoan 
parasite, which can cause the potentially life-threatening disease Toxoplasmosis in humans and 
animals.  
This fast proliferating parasite requires a significant amount of phospholipids for biogenesis of 
organelles and enclosing vacuolar membranes. Phosphatidylethanolamine (PtdEtn) is one of the most 
ubiquitous phospholipids and the second most abundant lipid in T. gondii. It can be produced de novo 
by the CDP-ethanolamine pathway or by decarboxylation of phosphatidylserine. Due to its conical 
structure, the lipid plays important roles in membrane curvature as well as fusion and fission events. 
Furthermore, PtdEtn is critical for the mitochondrial function and integrity in eukaryotes. 
This work revealed the expression of two distinct PtdSer decarboxylase (PSD) enzymes in T. gondii: 
One of which is Coccidia-specific and partially soluble and secreted into the parasitophorous vacuole 
via dense granules (TgPSD1pv), and a second enzyme that localizes in the mitochondrion (TgPSD1mt) 
of tachyzoites. 
The mitochondrial PSD can complement a S. cerevisiae mutant auxotrophic for ethanolamine, 
whereas TgPSD1pv is not functional in yeast. A conditional knockdown of the TgPSD1mt gene impairs 
the parasite growth in vitro. Surprisingly, the mutant displayed an unaltered total PtdEtn content, 
which suggests a stringent homeostasis of the cellular PtdEtn pool by alternative routes of lipid 
biogenesis. Consistently, the parasite encodes an active CDP-ethanolamine pathway in the 
endoplasmic reticulum. Metabolic labeling of the TgPSD1mt mutant displayed an increased utilization 
of ethanolamine into PtdEtn, indicating an upregulation of the de novo CDP-ethanolamine pathway. 
Likewise, exogenous ethanolamine partially restored the growth phenotype of the mutant. In 
contrast, the TgPSD1pv enzyme is dispensable for the parasite growth. However, the enzyme displays 
unique enzymatic characteristics, not shared with other PSD enzymes. Host cell labeling with [14C]-
ethanolamine prior to infection indicated a potential uptake of host-derived PtdEtn or PtdEtn-
derivates, which could ensure PtdEtn homeostasis in intracellular parasites. 
Taken together, these results demonstrate an exceptional compartmentalization and plasticity of the 
PtdEtn synthesis in T. gondii, which likely ensures a flexible membrane biogenesis in dissimilar 
nutritional milieus. 
 
III. ACKNOWLEDGEMENTS 
3 
 
III. Acknowledgements 
First of all, I would like to thank my supervisor Dr. Nishith Gupta for his guidance and encouragement 
during the course of my thesis and his constant interest and enthusiasm for my projects. 
Particularly, I would like to thank Prof. Dr. Richard Lucius for his support and the opportunity to work 
in an excellent research environment in his department. 
I would also like to thank Prof. Dr. Kai Matuschewski and Prof. Dr. Thomas Günther-Pomorski for their 
effort of reviewing this dissertation as well as the other members of my thesis committee for their 
courtesy. 
My special thanks go to Grit Meusel who constantly keeps the lab running whilst creating a warm and 
familiar atmosphere. I would like to thank all of my coworkers at the department of Molecular 
Parasitology for creating a pleasant and productive atmosphere in the laboratory, especially those 
who also became valuable friends outside the lab. 
Furthermore, I want to thank all the collaboration partners who shared reagents and knowledge for 
promoting my projects, especially Prof. Dr. Maik Lehmann and Gabriele Drescher for their excellent 
work on the electron microscope, Prof. Dr. Emanuel Heitlinger for his guidance with phylogenetic 
analysis, Dr. Matthew Hepworth for introducing me into FACS analysis as well as Prof. Dr. Peter 
Hegemann and Dr. Manuela Stierl for their support in entering the field of Optogenetics. Thanks also 
to Vera Sampels and René Lang for their preliminary work on the PSD project and Maria Hellmund for 
her excellent work during her Bachelor´s thesis and her research assistance. 
A very warm thank you goes to Prof. Dennis Voelker for hosting me in his lab and Dr. Jae Yeon Choi 
and Prof. Dr. Wayne Riekhof for sharing their expertise on PSD enzymes during my time at National 
Jewish Health in Denver. 
Furthermore, I want to appreciate the Caroline von Humboldt stipend program and the DFG for their 
financial support as well as the DAAD, the German Society for Parasitology and the GRC organization 
team for awarding me with travel stipends. 
I also want to thank Richard, Manja and Sabine for their effort of proofreading the manuscript. 
I am very grateful to my family for their constant love and invaluable support during my whole 
biology studies. 
Last but not least, I would like to express my sincere thanks to my friends, especially Sabine, Fleur and 
Andre for their motivation and unconditioned support. 
 
IV. TABLE OF CONTENTS 
4 
 
IV. Table of contents 
I. Zusammenfassung ........................................................................................................................... 1 
II. Abstract ........................................................................................................................................... 2 
III. Acknowledgements ......................................................................................................................... 3 
IV. Table of contents ............................................................................................................................. 4 
V. List of abbreviations ........................................................................................................................ 7 
VI. List of figures ................................................................................................................................... 8 
VII. List of tables ................................................................................................................................... 10 
1. Introduction .................................................................................................................... 11 
1.1. Apicomplexa ...................................................................................................................... 11 
1.2. Toxoplasma gondii ............................................................................................................. 12 
1.2.1. Toxoplasmosis in humans ....................................................................................................... 12 
1.2.2. The life cycle of T. gondii ......................................................................................................... 13 
1.2.3. Morphology and lytic cycle of T. gondii .................................................................................. 15 
1.2.4. Genetic manipulation of T. gondii ........................................................................................... 17 
1.3. Lipids and membrane biology ........................................................................................... 18 
1.3.1. Membrane composition of eukaryotes .................................................................................. 20 
1.3.2. De novo phospholipid synthesis in the mammalian (host) cell .............................................. 21 
1.3.3. Membrane synthesis in T. gondii ............................................................................................ 22 
1.3.4. Phospholipid biogenesis in T. gondii ....................................................................................... 23 
1.4. Objective of this study ....................................................................................................... 25 
2. Materials and methods .................................................................................................... 26 
2.1. Materials ............................................................................................................................ 26 
2.1.1. Biological resources ................................................................................................................ 26 
2.1.2. Chemical reagents .................................................................................................................. 26 
2.1.3. Materials for radioactive work ............................................................................................... 27 
2.1.4. Vectors .................................................................................................................................... 28 
2.1.5. Antibodies and working dilutions ........................................................................................... 28 
2.1.6. Enzymes .................................................................................................................................. 29 
2.1.7. Instruments ............................................................................................................................ 29 
2.1.8. Plasticware and other disposables ......................................................................................... 30 
2.1.9. Commercial kits ...................................................................................................................... 31 
2.1.10. Reagent preparations ............................................................................................................. 31 
2.1.11. Oligonucleotide primers ......................................................................................................... 34 
2.1.12. Software ................................................................................................................................. 38 
2.2. Methods – Molecular Cloning and Protein analysis .......................................................... 38 
2.2.1. PCR reactions .......................................................................................................................... 38 
2.2.2. DNA restriction and ligation ................................................................................................... 38 
2.2.3. Transformation of E. coli ......................................................................................................... 39 
2.2.4. Nucleic acid preparation ......................................................................................................... 39 
2.2.5. Expression of recombinant proteins in E. coli ......................................................................... 40 
2.2.6. Protein extraction, preparation and Immuno-blot analysis.................................................... 40 
2.3. Methods – Cell culture and transfection ........................................................................... 41 
IV. TABLE OF CONTENTS 
5 
 
2.3.1. Host cell cultivation ................................................................................................................ 41 
2.3.2. T. gondii cultivation and genetic manipulation ....................................................................... 41 
2.3.3. Cultivation and transfection of COS-7 cells............................................................................. 42 
2.3.4. S. cerevisiae cultivation and transformation .......................................................................... 42 
2.4. Methods – Biological and Biochemical Assays .................................................................. 43 
2.4.1. Indirect immuno fluorescence assay ...................................................................................... 43 
2.4.2. Transmission electron microscopy .......................................................................................... 43 
2.4.3. Correlative microscopy ........................................................................................................... 44 
2.4.4. T. gondii plaque assay ............................................................................................................. 44 
2.4.5. T. gondii replication assay ....................................................................................................... 45 
2.4.6. Annexin binding on Jurkat T-cells ........................................................................................... 45 
2.4.7. Subcellular fractionation of S. cerevisiae ................................................................................ 45 
2.4.8. Radioactive phosphatidylserine decarboxylation assay ......................................................... 46 
2.4.9. Metabolic labelling of T. gondii and host cells ........................................................................ 46 
2.4.10. Lipid extraction, separation and analysis ................................................................................ 47 
2.4.11. Preparation of T. gondii secretome and NBD-PSD assay ........................................................ 48 
2.5. Bioinformatics and data analyses ...................................................................................... 49 
3. Results ............................................................................................................................ 50 
3.1. T. gondii encodes multiple pathways to synthesize phosphatidylethanolamine .............. 50 
3.1.1. Predicted subcellular localizations of PtdEtn-synthesis proteins............................................ 51 
3.1.2. Phylogenetic origin of phosphatidylserine decarboxylases in T. gondii .................................. 53 
3.2. Phosphatidylserine decarboxylases localize to distinct organelles ................................... 55 
3.2.1. TgPSD1mt is localized in the mitochondrion of T. gondii tachyzoites ..................................... 55 
3.2.2. TgPSD1pv is secreted into the parasitophorous vacuole via dense granules ......................... 57 
3.3. Expression and subcellular localization of TgPSD enzymes in COS-7 cells ........................ 60 
3.4. TgPSD1mt can functionally complement a S. cerevisiae PSD mutant ............................... 61 
3.4.1. TgPSD1mt is expressed in its active form in yeast mitochondria ........................................... 62 
3.4.2. TgPSD1mt is active in yeast irrespective of its mitochondrial localization ............................. 64 
3.4.3. TgPSD1pv is not able to complement for PSD function in S. cerevisiae.................................. 64 
3.5. Overexpression of TgPSD1pv in T. gondii ........................................................................... 65 
3.5.1. The TgPSD1pv overexpression strain displays a many-fold higher PSD activity ..................... 66 
3.5.2. TgPSD1pv can perform interfacial catalysis at mammalian plasma membranes .................... 68 
3.5.3. Overexpression of TgPSD1pv does not affect tachyzoite growth ........................................... 69 
3.6. Overexpression of TgPSD1pv variants in E. coli ................................................................. 70 
3.7. Conditional and direct knockout of TgPSD1mt .................................................................. 72 
3.7.1. TgPSD1mt is dispensable for the parasite survival ................................................................. 72 
3.7.2. TgPSD1mt is necessary for an optimal parasite growth and replication ................................ 74 
3.7.3. Direct knockout of TgPSD1mt and phenotyping ..................................................................... 75 
3.8. The TgPSD1mt mutant upregulates its CDP-ethanolamine pathway ................................ 75 
3.9. The TgPSD1mt mutant can tolerate a depletion of ethanolamine .................................... 78 
3.10. TgPSD1mt depletion does not influence mitochondrial morphology ............................... 79 
3.11. Targeted gene disruption of TgPSD1pv .............................................................................. 80 
3.11.1. The TgPSD1pv mutant does not secrete PSD activity ............................................................. 81 
3.11.2. TgPSD1pv is not essential for the lytic cycle of T. gondii in vitro ............................................ 82 
IV. TABLE OF CONTENTS 
6 
 
4. Discussion ....................................................................................................................... 84 
4.1. Phosphatidylethanolamine biogenesis in T. gondii tachyzoites ........................................ 84 
4.2. Evolutionary context and characteristics of TgPSD enzymes ............................................ 86 
4.3. TgPSD1pv – a common dense granule protein? ................................................................ 88 
4.4. Other putative functions of TgPSD1pv .............................................................................. 91 
4.5. Cooperativity of PtdEtn routes ensures membrane integrity of T. gondii ......................... 92 
4.6. Future perspective of PtdEtn research in T. gondii ............................................................ 95 
VIII. References ..................................................................................................................................... 96 
IX. Appendix ...................................................................................................................................... 109 
X. List of publications and presentations ......................................................................................... 125 
XI. Selbständigkeitserklärung ........................................................................................................... 126 
 
 
V. LIST OF ABBREVIATIONS 
7 
 
V. List of abbreviations 
 
ATc   Anhydrotetracycline 
ATP  Adenosine triphosphate 
bp   base pairs 
CAT  Chloramphenicol acetyltransferase 
CD  catalytic domain 
CDP  Cytidine diphosphate 
cDNA  complementary DNA 
CL  Cardiolipin 
CMV  Cytomegaolovirus 
DAPI  4’,6-diamidino-2-phenylindole 
DEPC  Diethylpyrocarbonate 
DER1  Degradation in the endoplasmatic 
reticulum protein 1 
DHFR-TS   Dihydrofolate reductase thymidylate 
synthase 
DIC  Differential interference contrast 
DMEM  Dulbeccos’s modified Eagle medium 
DNA  Deoxyribonucleic acid 
ECT  CTP:phosphoethanolamine 
cytidylyltransferase 
EDTA  Ethylendiamine tetraacetate 
EK  Ethanolamine kinase 
ECT  Ethanolaminephosphate 
cytidyltransferase 
EPT  CDP-ethanolamine:diacylglycerol 
ethanolamine-phosphotransferase 
ER  Endoplasmatic reticulum 
EtOH  Ethanol 
F(wd)  forward 
F1B  ATPase subunit F1-β 
FACS  Fluorescence-associated cell sorting 
FASI/II  Fatty acid synthase type I/II 
FCS  Fetal calf serum 
F-dUMP   5´-Fluorodeoxyuridine 
monophosphate 
FUDR   5´-Fluorodeoxyuridine 
GAL  Galactose 
gDNA  genomic deoxyribonucleic acid 
Gap45  gliding-associated protein (45 kDa) 
GFP   Green fluorescent protein 
GRA  dense granule protein 
GSH  Glutathione 
h(r)  hour 
HA  Hemagglutinin 
HEPES  4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
HFF  Human foreskin fibroblast 
Hsp90  Heat-shock protein (90 kDa) 
HXGPRT  Hypoxanthine-xanthine-guanine 
phosphoribosyltransferase 
ICM  Intracellular-type medium 
IFA  Indirect immunofluorescence assay 
IPTG  Isopropyl-ß-D-1-
thiogalactopyranoside 
IT  Insertional tagging 
IVN  Intravacuolar network 
kb   kilo bases 
KO   Knockout 
KOV   Knockout verification 
ME  Mammalian expression 
MEM  Modified Eagle´s medium 
MeOH  Methanol 
MOI  Multiplicity of infection 
MOPS  3-(N-morpholino) 
propanesulfonic acid 
MPA  Mycophenolic acid 
mt  mitochondrion/mitochondrial 
mTP  mitochondrial targeting peptide 
NBD  7-nitrobenz-2-oxa-1,3-diazol-4-yl 
dNTP  desoxyribo nucleotide triphosphates 
ORF   Open reading frame 
PAGE  Polyacrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
PCR  Polymerase chain reaction 
PEG  Polyethylene glycol 
PEMT  Phosphatidylethanolamine 
methyltransferase 
PEtn-Cer  Phosphoethanolamine ceramide 
PMSF  Phenylmethylsulfonyl fluoride 
PIC  Protease inhibitor cocktail 
PSD   Phosphatidylserine decarboxylase 
PSR  Phosphatidylserine receptor 
PtdCho   Phosphatidylcholine 
PtdEtn   Phosphatidylethanolamine 
PtdGro  Phosphatidylglycerol 
PtdIns  Phosphatidylinositol 
PtdSer   Phosphatidylserine 
PV  Parasitophorous vacuole 
PVM  Parasitophorous vacuole membrane 
PYR   Pyrimethamine 
R(ev)  reverse 
RNA  ribonucleic acid 
rpm  rotations per minute 
RT  room temperature 
s(ec)  second 
Sag1  Surface antigen 1 
Sc  Saccharomyces cerevisiae 
SDS  Sodium dodecyl sulphate 
SP  Signal peptide 
TaTi  Trans-activator trap identified 
Tet   Tetracycline 
TEM  Transmission electron microscopy 
Tg   Toxoplasma gondii 
TGD  Targeted gene disruption 
TLC  thin-layer chromatography 
OD  Optical density 
U  Unit(s) 
UMP   Uridine-5´-monophosphate 
UPRT   Uracilphosphoribosyltransferase 
UTR   Untranslated region 
 
VI. LIST OF FIGURES 
8 
 
VI. List of figures 
Figure 1: Developmental stages of Apicomplexa .................................................................................................. 12 
Figure 2: Life cycle of T. gondii .............................................................................................................................. 14 
Figure 3: Ultrastructure of T. gondii tachyzoites ................................................................................................... 15 
Figure 4: Lytic cycle of T. gondii ............................................................................................................................. 16 
Figure 5: Structure and classification of neutral and polar lipids .......................................................................... 18 
Figure 6: Structure and remodelling of major phospholipids ............................................................................... 19 
Figure 7: Major phospholipid synthesis pathways in the mammalian cell ........................................................... 21 
Figure 8: Model of phospholipid synthesis pathways in T. gondii ......................................................................... 24 
Figure 9: TgPSD1mt and TgPSD1pv are of different phylogenetic origin. ............................................................. 53 
Figure 10: TgPSD1mt shares sequence homologies with type I PSDs. .................................................................. 54 
Figure 11: Ectopic expression of TgPSD1mt-HA in intracellular and extracellular tachyzoites. ............................ 55 
Figure 12: 3´-insertional-tagging of TgPSD1mt confirms its mitochondrial localization. ...................................... 56 
Figure 13: The mTP-deletion variants of TgPSD1mt-HA fail to localize in the mitochondrion. ............................. 57 
Figure 14: TgPSD1pv is stored in the dense granules and secreted into the PV. ................................................... 58 
Figure 15: Localization of TgPSD1pv in the parasitophorous vacuole under its endogenous promotor element. 59 
Figure 16: Localization of TgPSD1pv-HA in the parasitophorous vacuole by correlative imaging. ....................... 60 
Figure 17: TgPSD1mt localizes to the mitochondria and nucleus and TgPSD1pv to the endomembrane system in 
monkey kidney fibroblasts. ................................................................................................................................... 61 
Figure 18: Schematic overview of the phospholipid synthesis in S. cerevisiae ..................................................... 62 
Figure 19: TgPSD1mt can rescue the growth of a S. cerevisiae mutant lacking its endogenous PSD activity. ...... 63 
Figure 20: Loss of TgPSD1mt results in a phenotypic reversion of the Δpsd1Δpsd2 S. cerevisiae mutant............ 63 
Figure 21: The mitochondrial targeting peptide in TgPSD1mt is required for an efficient localization but not for 
enzyme activity in S. cerevisiae. ............................................................................................................................ 64 
Figure 22: TgPSD1pv fails to rescue Δpsd1Δpsd2 yeast mutants. ......................................................................... 65 
Figure 23: The pNTP3-TgPSD1pv-HA strain shows increased decarboxylation of NBD-PtdSer ............................. 66 
Figure 24: Overexpression of TgPSD1pv causes a 10-fold higher PSD activity in T. gondii. ................................... 67 
Figure 25: Overexpression of TgPSD1pv leads to an increased secretion of soluble PSD activity. ........................ 68 
Figure 26: Secreted TgPSD1pv can decarboxylate PtdSer on the surface of Jurkat T-cells. .................................. 69 
VI. LIST OF FIGURES 
9 
 
Figure 27: Overexpression of TgPSD1pv does not affect tachyzoite growth. ........................................................ 70 
Figure 28: Expression of functional TgPSD1pv-6xHis isoforms in E. coli. .............................................................. 71 
Figure 29: Conditional mutagenesis allows a tetracycline-regulated knockdown of TgPSD1mt in T. gondii. ....... 73 
Figure 30: The Δtgpsd1mt/TgPSD1mt-HAr mutant displays a growth defect due to an impaired replication. ..... 74 
Figure 31: TgPSD1mt is nonessential for the survival but required for an efficient parasite growth. .................. 75 
Figure 32: Localization of the CDP-ethanolamine pathway in T. gondii tachyzoites. ............................................ 76 
Figure 33: PtdEtn synthesis in the parasite mitochondrion and ER are not mutually exclusive. .......................... 77 
Figure 34: T. gondii can survive a simultaneous knockdown of TgPSD1mt and depletion of ethanolamine. ....... 79 
Figure 35: Knockdown of TgPSD1 does not affect the mitochondrial ultrastructure. ........................................... 80 
Figure 36: Targeted gene disruption of TgPSD1pv and complementation ........................................................... 81 
Figure 37: The TgPSD1pv mutant lacks PSD activity in the secreted protein fraction. ......................................... 82 
Figure 38: The Δtgpsd1pv mutant shows a modestly enhanced growth phenotype but lower plaque numbers. 83 
Figure 39: Localization of PtdEtn synthesis in T. gondii ......................................................................................... 85 
Figure 40: Characteristics of eukaryotic PSD enzyme groups. .............................................................................. 87 
Figure 41:Post-secretory localization of GRA proteins .......................................................................................... 89 
Figure 42: Selective import of NBD-phospholipids by extracellular T. gondii tachyzoites .................................... 93 
Figure 43: Model of PtdEtn biogenesis in T. gondii ............................................................................................... 94 
 
VII. LIST OF TABLES 
10 
 
VII. List of tables 
Table 1: Oligonucleotide primers used in this study ............................................................................................. 34 
Table 2: Genes encoding putative enzymes for the synthesis of PtdEtn in T. gondii ............................................ 50 
Table 3: Predicted subcellular localization of putative PtdEtn synthesis proteins ................................................ 51 
Table 4: Catalytic domains, expression and modification of enzymes for PtdEtn synthesis ................................. 52 
 
1. INTRODUCTION 
11 
 
1. Introduction 
1.1. Apicomplexa 
Apicomplaxa [lat. apex = top/tip, lat. complexus = infolds] represent a large group of non-flagellated 
protists within the superphylum of Alveolata (1). The phylum comprises thousands of versatile 
species, which are exclusively obligate (endo)parasites in a variety of host organisms (2). Several 
members of this phylum have the capacity to cause severe diseases in humans and domestic animals, 
and are therefore of high medical, veterinary and (socio-) economic importance (3). Most 
Apicomplexa display a strict host-specificity and seven genera among them are known to infect 
humans. For example Plasmodium spp., the causative agent of malaria, inflicting approximately 0.5 
million annual deaths particularly in children (2,4). Other widely prevalent cyst-forming apicomplexan 
species, such as Eimeria and Toxoplasma, can cause coccidiosis and toxoplasmosis [see 1.2.1.] in 
animals and humans, respectively (5,6). 
The main characteristic of apicomplexan parasites is the presence of unique ultrastructural features, 
including the apical complex at the anterior end, which consists of specialized secretory organelles 
and longitudinal cytoskeletal structures. The apical complex facilitates attachment, penetration and 
invasion of the host-cell [see 1.2.2.]. The presence of a laterally located micropore for nutritional 
uptake via pinocytosis, as well as cortical alveolar structures, are other common features in this 
phylum (7). Most Apicomplexa harbour a non-photosynthetic but metabolically important plastid-like 
organelle surrounded by four membranes, termed as apicoplast (= apicomplexan plastid), which was 
likely derived by secondary endocytobiosis from an algal ancestor (8,9). With exception of the male 
gametes, all developmental stages lack flagella. In lieu thereof Apicomplexa show a unique form of 
active movement, described as gliding motility (10) [see 1.2.3.]. 
The general life cycle of Apicomplexa comprises alternating sexual and asexual generations produced 
via three distinct processes: sporogony, merogony/schizogeny and gamogony [schematized in Fig. 1]. 
Different characteristic forms of daughter cell formation are found during schizogeny for the 
generation of various numbers of progeny (2). All developmental forms, with exception of the zygote, 
harbour a haploid genome and vary in their organelle equipment and morphological characteristics. 
Whereas in monoxenous parasite species, like Eimeria sp., all developmental processes take place in 
the same host, heteroxenous Apicomplexa, such as Toxoplasma and Plasmodium, use different host 
species to complete their life cycle. 
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Figure 1: Developmental stages of 
Apicomplexa 
Female and male gametocytes and 
gametes are formed via gamogony, 
which fuse to form a zygote/ookinete. 
During sporogony, sporozoites develop 
within a resistant thick-walled oocyst. 
Sporozoites in turn can develop into 
merozoites by a process called 
merogony or schizogeny giving rise to a 
large number of infective merozoites. 
[adapted from Striepen et al. 2007 (11)] 
 
1.2. Toxoplasma gondii 
T. gondii is the most prevalent and cosmopolite species of the phylum Apicomplexa, which can be 
isolated from an enormous range of terrestrial and even marine hosts worldwide (12). The parasite 
was discovered and described first in the tissue of a small rodent named Ctenodactylus gundi in 1908 
by Nicolle and Manceaux (13). Based on its cellular morphology and the first described host 
organism, the crescent-shaped parasite was named Toxoplasma gondii (lat. toxo = arc, bow; plasma = 
life; gondii = from C. gundi). To date, three dominant clonal lineages (referred to as type I-III) and a 
large amount of atypical genotypes have been identified in T. gondii isolates, which differ in their 
global distribution, prevalence and clinical severeness of the disease (14-17).  
Approximately one third of the human population is estimated to be sero-positive for T. gondii. 
Seroepidemiology however strongly varies between countries and depends on the hygienic and 
nutritional conditions and habits in the respective area as well as the considered age cohort (18). 
1.2.1. Toxoplasmosis in humans 
The first indications for T. gondii as the inducing agent of a disease, was drawn in 1910 in an infected 
puppy. About 30 years later, T. gondii was also detected in an infant, which lead to an subsequent 
increased discovery of the parasite and its clinical outcome in a variety of hosts in the following years 
(19).  
In immune-competent humans the primary infection with T. gondii is seldom recognized, because it 
causes mild flu-like symptoms and is usually controlled by the humoral and adaptive immune system 
involving a strong TH1-cell/IFN-γ mediated immune-response (20). Immune-incompetent patients, 
however, can develop a serious or even fatal clinical outcome. In the acute phase of the infection, fast 
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replicating tachyzoites [greek. tachy = fast] are distributed throughout the body and are able to cross 
blood-tissue barriers. This can cause severe ocular and cerebral toxoplasmosis via tissue lesions, 
eventually (18). Congenital Toxoplasmosis can occur through dia-placental transmission of parasites 
to the developing, immune-immature foetus during primary infection of a pregnant woman. It can 
result in serious neurological disabilities or the death of the unborn child. The probability of fetal 
transmission and the fatality of the disease also coincide with the trimester of infection. In many 
cases in utero infections remain unrecognized until the child develops clinical symptoms in the first 
lifespan (2). 
Upon immune response, tachyzoites can convert into slow-dividing/quiescent bradyzoite [greek. 
brady = slow] stages, surrounded by a protective cyst wall, with a tissue tropism for neural and 
muscular tissue, leading to a chronic but mostly asymptomatic infection of the host (21). Upon a 
decline in immune-response of the chronically infected host, dormant tissue cysts can be reactivated. 
Hence, T. gondii poses a high-risk, especially for AIDS-patients and individuals that receive immune-
suppressive treatments, e.g. transplant recepients (18). Furthermore, chronic T. gondii infections may 
also be associated with neuropsychiatric disorders (22,23) and behavioural changes in animals and 
humans (24). 
Whereas acute toxoplasmosis can be treated with a combination therapy of pyrimethamine and 
sulfadiazine with folic acid supplementation (18), there is no effective treatment to prevent or 
eliminate chronic infections. Although vaccination strategies are successfully applied in sheep and 
goats (25) and experimentally tested in other animals, no vaccination protecting humans against T. 
gondii infection is available to date (26). 
1.2.2.  The life cycle of T. gondii 
The definite host of T. gondii are members of the genus felidae (27,28), whereas asexual reproduction 
can take place in all nucleated cell types of warm-blooded animals including humans (29). 
Merogony and gamogony [see 1.1.] take place exclusively in the feline intestine tissue where upon 
the fusion of male and female gametes resistant oocysts are formed. These are shed with the cat 
feces into the environment. The oocysts develop into two sporoblasts each containing four 
sporozoites. Sporulated oocysts can be infectious for several months or years (30) and upon oral 
ingestion, the released sporozoites can invade the gut epithelium of the intermediate hosts. Here, 
sporozoites differentiate into fast dividing tachyzoites. In immunocompetent organisms, tachyzoites 
will convert into quiescent bradyzoites, which are surrounded by a thick cyst wall and can persist in 
the neural or muscular tissue causing a lifelong chronic infection. By ingestion of contaminated food 
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(31), water (32) or soil, the life cycle can proceed in the infinite host closing the heteroxenous life 
cycle of T. gondii (33) [Fig. 2]. The parasite can also transmit from intermediate to intermediate host 
by predation, which is a major cause of its high prevalence. 
 
Figure 2: Life cycle of T. gondii  
The sexual reproduction of T. gondii takes place in the gut epithelium of feline species, where oocysts are 
formed and shed with the feces into the environment. Sporulated oocysts can be ingested by other vertebrates, 
e.g. rodents, where they can initiate an acute and subsequent chronic infection leading to the formation of 
tissue cysts. Predation of an infected animal by a cat, will initiate another round of the life cycle. If sporulated 
oocysts are taken up by an intermediate host via contaminated water, soil or food, they can generate acute and 
chronic infections, especially affecting neural and muscular tissues and are particularly harmful to immune 
incompetent hosts. [from Hunter and Sibley, 2012 (34)] 
In terms of T. gondii evolution and propagation, special attention is drawn to the house cat and house 
and wild mouse infection cycle (35). Wild type or knockout mice are widely used as infection model 
to explore the immune response that is triggered by the parasite infection. One drawback, however, 
is the difficulty of investigating the development of sexual stages of the parasite, because these 
processes take place exclusively in feline species, which are less amenable to experimentation and 
less suitable as laboratory animals.  
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1.2.3. Morphology and lytic cycle of T. gondii 
The most extensively studied developmental form of T. gondii is the tachyzoite stage, which causes 
the acute form of the parasite infection [see 1.2.1.]. Tachyzoites are highly-polarized, displaying 
several characteristic morphological features at the apical end of the cell. Besides common eukaryotic 
organelles, like the endoplasmic reticulum, Golgi apparatus, a single mitochondrion and nucleus, the 
parasite harbours unique secretory organelles, described as dense granules, micronemes and 
rhoptries [Fig. 3A].  
Whereas dense granules are present throughout the parasite body, elongated micronemes and club-
shaped rhoptries are located at the apical end, which is highly specialized to enable active host cell 
invasion, mediated by its enzymatic and cytoskeletal equipment. At the apical tip, a thimble-shaped 
cytoskeletal structure is found, called conoid (= cone shaped), which consists of two annular 
structures and spirally wound microtubules (36) [Fig. 3B]. The parasite is surrounded by a multi-
layered pellicle, built of the outermost plasma membrane, two tightly adjacent membranes (inner 
membrane complex = IMC) and longitudinal cytoskeletal structures to confer rigidity and flexibility to 
the highly dynamic parasite cell (37) [Fig. 3C]. 
 
Figure 3: Ultrastructure of T. gondii tachyzoites 
(A) The tachyzoite stage of T. gondii displays a highly polarized structure and is marked by the presence of 
parasite-specific secretory organelles (dense granules, micronemes, and rhoptries) and unusual cytoskeletal 
structures, like the conoid, a cone-shaped structure at the apical tip. A plastid-like organelle with four 
membranes - the apicoplast - is also present in the parasite body. Besides that, the tachyzoite cell contains a 
complete set of conventional eukaryotic organelles. (B) The conoid consists of a preconoidal and two polar ring 
structures containing two intra-conoidal microtubules (MTs). The preconoidal ring is anchored to the inner 
membrane complex. Spirally wound and longitudinal MTs stabilize the conoid and the parasite body. (C) 
Longitudinal section of a dividing tachyzoites showing the organellar and IMC (red) organisation during 
intracellular daughter cell formation. Besides, the organisation of the subpellicular microtubuli is shown (in 
green).[Tachyzoite morphology (38), inner membrane complex (37) and cytoskeletal conoid organisation (37)] 
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The asexual reproductive cycle is hallmarked by certain critical steps: Invasion of the host cell, 
intracellular replication, and egress from the infected cell to subsequently infect another cell [Fig. 4]. 
These processes are found to be highly complex and orchestrated. The non-flagellated parasites 
developed a specialized form of active movement, termed as gliding motility, which is driven by the 
secretion of adhesion molecules via an actin/myosin motor-complex, that is elementary for the 
invasion and egression process (39). After apical orientation and attachment to the host cell, the 
parasite forms a moving junction complex with the host cell membrane (40) and enters the cell while 
creating its own surrounding membranous replication niche, the so called parasitophorous vacuole 
(PV)(41). The vacuole is secluded from host endocytosis and exocytosis, but and is permeable to small 
molecules (42). Furthermore, it presumably functions as a protective barrier and nutritional interface 
with the host cell. Within the PV and coherent with secretion of dense granular content, an 
intramembranous filamentous network is formed, described as intravacuolar, nanotubular or 
tubovesicular network (43,44). The IVN (intravacuolar network) presumambly acts as a mechanical 
stabilisator (45) and is also discussed to be involved in nutrient acquisition (46). 
Tachyzoites replicate by an extraordinary process called endodyogeny, where two daughter zoites are 
formed synchronously within a mother cell following mitosis and organelle duplication [see Fig. 3C]. 
The doubling time varies from 6 to 8 hours generating approximately 64 - 128 progeny. Eventually the 
parasite replication leads to the physical rupture of the host cell and infectious tachyzoites can initiate 
another round of the lytic cyle [Fig. 4]. 
 
 
 
Figure 4: Lytic cycle of T. gondii 
During its acute infection phase in vivo and 
during in vitro cultivation, T. gondii 
undergoes a fast lytic cycle, where 
infective tachyzoites replicate in a 
parasitophorous vacuole to generate large 
amounts of progeny and eventually lyse 
the infected cell. New infective and motile 
tachyzoites egress, and initiate another 
round of the lytic cycle. 
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Infection and intracellular replication of T. gondii is accompanied by active remodelling and 
reprogramming of the host cell. Soon after invasion, host mitochondria and ER membranes are 
recruited to the PV membrane (47), which presumably provides nutrients to the parasite (48). 
Additionally, the parasite is known to manipulate the infected host cell via secretion of immune and 
apoptosis modulators to circumvent the detection and subsequent defense by the host cell, both of 
which enable unhindered intracellular multiplication of the parasite (21,34,49). Most extensively 
studied is the interaction of parasite secreted rhoptry (pseudo)kinases with downstream signalling 
pathways like the JAK/STAT pathway and INF-γ production of the host cell (50,51). Furthermore, the 
interaction of strain-specific rhropty kinases with immunity-related GTPases was shown as a critical 
determinant for virulence of T. gondii strains in mice (52-54). To ensure its fast intracellular 
replication, the parasite has to satisfy his extensive needs for nucleic acids, proteins, and membrane 
lipids, which must be either generated de novo by the parasite itself and/or scavenged from the host 
cell [see 1.3.3. and 1.3.4.]. 
1.2.4. Genetic manipulation of T. gondii 
Its capability to infect nearly all animal cells and the accessibility of an annotated genome (55,56) 
along with the relative ease of genetic manipulation and in vitro cultivation make T. gondii an 
excellent model to study parasite-host interactions. A variety of selection markers have been 
identified that enable stable expression and deletion of parasite genes: The hypoxanthine-xanthine-
guanine-phosphoribosyltransferase (HXGPRT) (57) and the uracil-phosphoribosyltransferase (UPRT) 
(58) targeting the nucletoide biosynthesis and salvage pathways can be used for positive and negative 
selection of drug-resistant parasites, respectively. Furthermore, the dihydrofolate reductase 
thymidilate synthase (DHFR-TS) conferring resistance to pyrimethamine (59) as well as the 
chloramphenicol-acetyltransferase (60) are other commonly used as selection markers in T. gondii. 
Since the haploid genome of T. gondii does not favour homologous recombination, long DNA 
sequences (2-3 kb) are needed to facilitate this event (61). The efficiency of gene replacement and 
tagging was significantly enhanced by the use of T. gondii strains lacking the non-homologous end 
joining (KU80) repair system (62,63). Meanwhile, a variety of single- or multi-stepped strategies have 
been developed to permit the conditional ablation of essential genes. The generation of a stable T. 
gondii TATi-1 line, carrying tetracycline trans-activator elements, can be used to repress the 
transcription of a gene of interest by anhydrotetracycline (64). While the original two-step strategy is 
relatively laborious, a variety of improved techniques have been established, such as the single-
stepped promotor-displacement/replacement directly targeting the genomic locus of interest (65). 
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The application of the DD/Shield-1 system in Toxoplasma allows the destabilisation of cytosolic 
proteins (66). Transgenic strains, particularly knockout mutants, can be analysed for their phenotype 
in vitro as well as for their virulence in vivo. The continuous development, improvement and 
refinement of methods to genetically manipulate and phenotype T. gondii opens the door for 
characterizing the molecular basis of the tachyzoite lytic cycle (67). Another important but 
understudied branch in Toxoplasma research is the analysis of intrinsic and extrinsic factors, which 
regulate tachyzoite to bradyzoite interconversion. This phenomenon is more complex to study, since 
genetic manipulation and cultivation of bradyzoite-forming strains is more challenging. 
1.3. Lipids and membrane biology 
Lipids [greek lipos = fat] are classically defined as amphipathic or hydrophobic molecules that are 
readily soluble in organic solvents. But lipids can be also described as fatty acids and their naturally 
occurring derivatives and functionally related molecules. These molecules display a wide diversity in 
molecular structure and biological function, like energy storage and signalling events, but most 
importantly serving as structural matrix of cellular membranes (68). Fatty acids build the fundamental 
structure of biological lipids, consisting of a hydrocarbon chain, most commonly with 14 – 20 carbons 
terminating with a carboxylic acid group. Neutral lipids, such as triglycerides (triacylglyceroles) mainly 
act as energy storage molecules [Fig. 5]. 
Polar lipids can be broadly categorized into (glycero)phospholipids and glycolipids. Furthermore, 
sphingolipids can be either glycosphingolipids or phosphospingolipids. Glycerophospholipids, 
commonly referred to as phospholipids, are the predominant molecule species in biological 
membrane bilayers [Fig. 5].  
 
 
 
 
 
 
 
 
Figure 5: Structure and classification 
of neutral and polar lipids 
[adapted from Lehninger (69)] 
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In eubacteria and eukaryotes, the diacylglycerol backbone of phospholipids is formed by sn-3-glycerol 
esterified with long chain fatty acids at positions 1 and 2 (68). In addition, the chain length and 
degree of acyl chain saturation as well as the polar head group extends the phospholipid diversity. 
Most commonly choline, ethanolamine, serine, glycerol and inositol are found as substituents of the 
diacylglycerophosphate [Fig. 6A].  
Due to their amphipathic nature, phospholipids self-assemble in aqueous solutions into micelles or 
bilayers [Fig. 6C]; the latter comprise a hydrophobic core and two hydrophilic interfaces constituting a 
robust but dynamic barrier. Phospholipid bilayers surround all living organisms and are a prerequisite 
for intracellular compartmentalization in eukaryotic cells, enabling a cross protection of diverse 
biochemical sub-milieus. The inherent capacity for membrane fission and fusion also enables cell 
division and vesicular trafficking of cellular metabolites (70). 
 
Figure 6: Structure and remodelling of major phospholipids 
(A) Phospholipids are generally composed of two fatty acid chains with different degree of saturation esterified 
to a glycerophosphate backbone carrying a polar amino alcohol head group (choline, ethanolamine, serine or 
inositol). Cardiolipin is a dimeric structure, which consists of two phosphatidylglycerol molecules. The charge of 
the aminoalcohol group is indicated in red colour. (B) Phospholipid remodelling and recycling occurs via the 
Lands´ cycle, a deacylation and reacylation reaction conferred by phospholipase A (PLA), and lysophospholipid 
acyltranserase (LPAT) enzymes, respectively. (C) Phospholipids show a differential geometry and behaviour 
based on the size and charge of the head group and the fatty acid composition. 
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1.3.1. Membrane composition of eukaryotes 
The major structural lipids in eukaryotic cells are glycerophospholipids, which reconstitute up to 65% 
of membrane lipids. Phosphatidylcholine (PtdCho) accounts for the vast majority (>50%) of lipids in 
most eukaryotic cells, followed by phosphatidylethanolamine (PtdEtn), phosphatidylserine (PtdSer), 
phosphatidylinositol (PtdIns) and phosphatidic acid (PtdOH) (70). Another class of structural lipids, 
the sphingolipids, with ceramide as hydrophobic backbone, account for ~10% of polar lipids. 
Sphingomyelin and glycosphingolipids are the most abundant sphingolipid species in mammals (68). 
Non-polar sterol molecules are another major lipid class in eukaryotic membranes (~25%). 
Cholesterol, as a predominant species in mammalian cells, serves as an important precursor for fat-
soluble vitamins and steroid hormones (70).  
The phospholipid composition, fatty acid chain length and degree of saturation, as well as the 
insertion of sphingolipid and sterol molecules, together determine the membrane fluidity and rigidity 
(71). A tremendous diversity of phospholipid species can be generated via the Lands´ cycle (72), 
which involves phospholipase A2 activity cleaving fatty acids at the sn-2 position to produce lysolipid 
species. The reverse reaction is accomplished by lysophospholipid acyltransferases reacylating 
lysophospholipids to constitute new phospholipid species for lipid remodelling [see Fig. 6B]. As a 
consequence of their head group charge and size as well as their fatty acid composition, 
phospholipids can show a conical, inverted conical or cylindrical structure [Fig. 6C] that influences 
their behaviour in aquous solutions. Inverse conical lysolipids form micellar structures and confer 
membrane curvature in bilayers, whereas cylindrical species will naturally form bilayers (70,73). 
Another fundamental constituent of biological membranes are integral and peripheral membrane 
proteins, which are either tightly intercalated into the hydrophobic membrane matrix or loosely 
bound to the hydrophilic membrane surface by electrostatic or non-hydrophobic interactions. Many 
of these proteins fulfil essential cellular functions, e.g. acting as transporters, channels or receptors 
(68). The composition and dynamics of cell membranes was postulated in 1972 in the fluid-mosaic 
model (74), which has been further refined, e.g. by the inclusion of membrane-associated 
cytoskeletal structures (75). Inter- and intramembranous as well as lateral and transversal diffusion 
and transport of lipids maintains a selective lipid distribution in different organelles and even 
between the leaflets of the bilayer (76,77). In addition to their structural role, phospholipids can fulfill 
a number of other important cellular functions, such as PtdIns and its phosphorylated derivates as 
important keyplayers in cellular signalling and membrane-trafficking (78,79). Furthermore, not only 
the molecule itself but also its membrane orientation can be crucial for the cellular function, like 
PtdSer exposed at the outer leaflet of the cell membrane, which acts as an apoptosis signal for 
macrophage clearance (80). 
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1.3.2. De novo phospholipid synthesis in the mammalian (host) cell 
The basic building blocks for the mammalian phospholipid biosynthesis are AcylCoA derivates and 
glycerol 3-phosphate (G-3-P) as a glycolytic by-product as well as head group precursors, such as 
choline, ethanolamine, serine or inositol [Fig. 7]. 
The main sites of phospholipid synthesis in the mammalian cell are the endoplasmic reticulum and 
the mitochondrion, where the major phospholipids, PtdCho, PtdEtn, PtdSer and PtdIns, are produced 
by multiple interconnected routes [Fig. 7]. The ER and Golgi apparatus produce the bulk of structural 
lipids, like PtdCho, sphingomyelin and cholesterol, which are distributed throughout the cell via the 
endomembrane system. The mitochondria produce and inherit high amounts of bacterial-derived 
lipids, like PtdEtn, phosphatidylglycerol (PtdGro), and cardiolipin (CL) (76).  
 
 
Figure 7: Major phospholipid synthesis pathways in the mammalian cell 
Phospholipids are generated via multiple interconnected routes. The synthesis starts with condensation of fatty 
acids and glycerol-3-phosphate (G-3-P) to produce phospatidic acid (PtdOH). Cytidine diphosphate 
diacylglycerol (CDP-DAG) is further metabolized into PtdGro, CL and PtdIns. DAG and CDP-choline or CDP-
ethanolamine are used as substrates in the Kennedy pathway to form PtdCho and PtdEtn, both of which can be 
converted into PtdSer by a base-exchange reaction using serine as a substrate. Decarboxylation of PtdSer 
produces PtdEtn, which can be further methylated to PtdCho. Headgroup precursors are shown in green, 
phospholipid species are marked pink. Cho: choline; Etn: ethanolamine; Ins: Inositol; Ser: Serine 
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The de novo synthesis of PtdCho and PtdEtn is mediated by the three-stepped Kennedy pathway. The 
final step is an aminoalcohol-phosphotransferase reaction in the ER, which uses sn-1,2-diacylglycerol 
and either CDP-choline or CDP-ethanolamine as substrates (81) [Fig. 7]. Both branches are 
interconnected by the PtdEtn-N-methyltransferase (PEMT) enzyme, converting PtdEtn into PtdCho by 
sequential trans-methylation in the ER (82). An alternative route of PtdEtn production is the 
decarboxylation of PtdSer, mediated by PtdSer decarboxylase (PSD) enzymes located in the inner 
mitochondrial membrane (83). PtdSer is synthesized by two PtdSer synthases (PSS) exchanging the 
choline or ethanolamine moiety of PtdCho or PtdEtn by serine (84) [Fig. 7]. The mitochondrial 
cardiolipin is synthesized by the fusion of CDP-DAG and PtdGro via a reaction catalyzed by cardiolipin 
synthase (85). PtdIns, PtdGro and CL are all synthesized from cytidine diphosphate diacylglycerol 
(CDP-DAG), which in turn is derived from condensation of phosphatidic acid (PtdOH) and cytidine 
triphosphate (CTP) (76,86). 
1.3.3. Membrane synthesis in T. gondii 
The membrane synthesis in T. gondii seems to reflect a balance of retained pathways for autonomous 
lipid synthesis and scavenging of host cell lipids. The lipid signature of the parasite shows a mixture of 
neutral and polar lipids as well as a few unusual species derived from bacterial- and plant-like 
enzymes. The fatty acid biogenesis in T. gondii is mediated by three different concerted intrinsic 
pathways and salvage of host fatty acids (87), which provide the essential building blocks for the 
synthesis of phospholipids [see 1.3.4]. 
Triacylglycerols (TAGs) are formed in the ER via the glycerol-3-phosphate-pathway and stored as lipid 
bodies (88). Upon nutritional stress, TAGs can be hydrolyzed into diacylglycerols (DAGs) that are 
another main constituent of membrane building phospholipids. Additionally, galactosylglycerolipids 
are synthesized in the apicoplast from fatty acids and glycerol-3-phosphate (89). The major sterol 
molecule in T. gondii, cholesterol, is incorporated from LDL-particles derived from host lysosomes 
(90). Sphingolipids and their precursors can be synthesized de novo or retrieved from the extracellular 
environment. General indications for the import of host lipids were drawn indirectly by the use of 
fluorescently labelled lipid-analogs (46,91). 
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1.3.4. Phospholipid biogenesis in T. gondii 
Phospholipids constitute for a majority of the parasite´s membrane mass and were shown to be 
derived from intra- and extracellular sources (46,91,92). 
Compared with human host cells, T. gondii has an unusually high content of PtdCho, which is also the 
most prevalent parasite lipid accounting for 60-75% of total phospholipid species (92-94). The 
parasite also harbours an unusual plant-related lipid, phosphoethanolamine-ceramide (PEtn-Cer) 
(95). Recently, an exclusive and naturally occuring phospholipid was identified in T. gondii, which 
harbours threonine at the headgroup (PtdThr) (96). The relative percentage of the different 
phospholipid species varies between the respective sample preparation and analysis methods used. 
But the general sequence of phospholipids ranked by quantity can be described as follows: PtdCho 
(60-75%) > PtdEtn (12-25%) > PtdIns (8-12%) > PtdThr (2-8%) > CL (~6-8%) > PtdSer (1-6%) > PtdOH 
(~1,5%) (92,95-97). Futhermore, the parasite was shown to be enriched in shorter and unsaturated 
fatty acid chains compared to the mammalian host cell (human foreskin fibroblasts) (95,98).  
To date, different enzymatic activities in T. gondii have been characterized, which catalyze the 
synthesis of major phospholipids in tachyzoites [Fig. 8]. The presence of a functional 
phosphatidlyinositol synthase (PIS), expressed exclusively in the tachyzoite stage, was shown by 
heterologous expression in yeast (99). The two functionally-related (base-exchange) 
phosphatidylserine synthase (PSS) and Phosphatidylthreonine synthase (PTS) enzymes have also been 
characterized for their activity and biological relevance in tachyzoites (96). 
Catalytic activity of the Kennedy pathway, leading to de novo PtdCho and PtdEtn formation, was 
proven by metabolic labelling and characterization of the choline and ethanolamine kinase enzymes. 
An active Phosphatidylethanolamine N-methyltransferase (PEMT) enzyme seems to be missing in the 
parasite, making The CDP-choline branch of the Kennedy pathway vulnerable to a lipid analogue, 
Dimethylethanolamine (DME) (92,100). 
An unusual high PSD activity had been described in T. gondii cell extracts compared to yeast and 
mammals (92) but the identity of the respective enzyme(s) remained elusive. 
Cardiolipin synthesis in T. gondii has also been demonstated by acetate-labelling experiments (101). 
However, the functional characterization of a cardiolipin synthase enzyme (CLS) as well as the identity 
of other key enzymes, such as cytidyldiphosphate-1,2-diacylglycerol-synthase (CDS) and 
phosphatidate phosphatase (PAP), remain undefined in Toxoplasma to date.  
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Figure 8: Model of phospholipid synthesis pathways in T. gondii 
Current model of the phospholipid biosynthesis pathways in Toxoplasma comprising several interconnected 
routes. A phosphatidate phosphatase (PAP) confers DAG formation from phosphatidic acid, which is an essential 
component for the synthesis of many lipid species. The synthesis of PtdEtn can be achieved via the CDP-
entanolamine pathway, which is comprised of ethanolamine kinase (EK) CTP: phosphoethanolamine 
cytidylyltransferase (ECT) and CDP-ethanolamine:1,2-diacyglycerol ethanolamine-phosphotransferase (EPT), or 
by decarboxylation of PtdSer by a phosphatidylserine decarboxylase (PSD) enzyme. A phosphatidylserine 
synthase (PSS) can use PtdEtn to form PtdSer. There is no evidence for an active PEMT 
(phosphatidylethanolamine methyltransferase) enzyme in T. gondii which indicates an essential CDP-choline 
pathway mediated by choline kinase (CK). CTP:phospho-choline cytidylyltransferase (CCT) and CDP-choline:1,2-
diacyglycerol cholinephosphotransferase (CPT) enzymes. PtdThr is proposed to be formed by a base-exchange 
reaction of the phosphatidylthreonine synthase (PTS) from PtdCho. The biogenesis of PtdGro, CL and PtdIns rely 
on CDP-DAG formation via CDS (Cytidyldiphosphate-1,2-diacylglycerol-synthase). A cardiolipin synthase (CLS) is 
likely involved in CL formation from PtdGro. Phosphatidylinositol synthase (PIS) activity is needed for PtdIns 
synthesis using CDP-DAG and inositol. Headgroup precursors are depicted in green, phospholipids are marked 
pink and the respective enzymes appear in blue colour. 
Besides the capability of de novo phospholipid biosynthesis pathways as shown in figure 8, the 
possibility of phospholipid salvage of host-derived lipids has also been postulated. Labelling 
experiments with fluorescent BODIPY-tagged PtdCho and PtdOH have shown accumulation of the 
phospholipid analogs into the parasite plasma membrane, intracellular compartments as well as the 
intravacuolar network (46,91). The biological significance of this process for membrane biogenesis is 
still unknown. 
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1.4. Objective of this study 
T. gondii, as an obligate intracellular parasite, has to sustain and expand its organellar and 
surrounding membranes during its fast proliferation inside the host cell. The parasite genome 
encodes a nearly complete enzymatic machinery to synthesize the major phospholipids by the 
utilization of glycolytic precursors and polar head groups (92). Phosphatidylethanolamine is the 
second most abundant phospholipid in T. gondii and is known to be a critical component for 
membrane stability and curvature as well as vesicular fusion and fission and mitochondrial function 
(102). 
The aim of this study was the identification of the concrete enzymes responsible for PtdEtn synthesis 
in the tachyzoite stage. Special emphasis was given to the parasite-encoded phosphatidylserine 
decarboxylase (PSD) enzymes, since previous work showed an exceptional high PSD activity in 
tachyzoites compared to yeast and mammalian cell extracts (92), and indicated the presence of two 
distinct PSD pools with differential enzymatic behaviour (103).  
In addition, the relative contribution of PtdSer decarboxylation for PtdEtn homeostasis and its 
connection to other PtdEtn routes should be determined within this study. 
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2. Materials and methods 
2.1. Materials 
2.1.1. Biological resources 
COS-7 cells     Isabelle Coppens, Johns Hopkins University, USA  
Human Foreskin Fibroblasts (HFF)  Carsten Lüder, University Göttingen, Germany 
      or Cell Line Service, Germany 
Jurkat T-cells c6.1    Carsten Lüder, University of Göttingen, Germany 
 
T. gondii (RH Δhxgprt and RH TaTi strains)  D. Soldati-Favre, University of Geneva, Switzerland 
T. gondii  (TaTi-∆ku80)     Boris Striepen, University of Georgia, USA  
T. gondi (∆ku80)   Vern Carruthers, University of Michigan, USA  
 
E. coli XL-1blue     Stratagene, Germany 
E. coli M15     Qiagen, Germany 
E. coli JA-200 (PSS overexpression strain) Dennis Voelker, National Jewish Health, USA 
 
S. cerevisiae BY23480 (Δpsd1Δpsd2)  Akio Toh-e, Chiba University, Japan 
S. cerevisiae PTY44 (Δpsd1Δpsd2)  Dennis Voelker, National Jewish Health, USA 
S. cerevisiae JSY9750 (Δpsd2)   Dennis Voelker, National Jewish Health, USA 
2.1.2. Chemical reagents 
Agarose         Biozym, Germany  
Anhydro tetracycline (ATc)       IBA, Germany 
Bromphenol blue        Merck, Germany  
DNA marker (1kb ladder)       Fermentas, Germany 
Delipidated fetal calf serum       Biowest or PAA, Germany 
Dialysed fetal calf serum      PAA, Germany 
dNTP-Mix (100mM)        Fermentas, Germany 
Dulbecco`s Modified Eagle Media (DMEM)    Biowest or PAA, Germany  
Fetal calf serum       PAN Biotech, Germany 
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Fluoromount-G + 4,6-diamidino-2-phenylindole (DAPI)   SouthernBiotech, USA  
GeneRuler DNA-Ladder (1kb)       Fermentas, Germany  
L-Glutamine (100x stock)      Biowest, Germany 
MEM essential amino acids (50x stock)      Biowest, Germany 
MEM non-essential amino acids (100x stock)     Biowest, Germany 
MEM vitamins (100x stock)      PAA, Germany 
Natural and synthetic lipids      Avanti Polar Lipids, USA 
NBD-Lipids        Avanti Polar Lipids, USA 
Paraformaldehyde        Merck, Germany 
Penicillin/ Streptomycin (100x stock)      Biowest, Germany 
Phosphat Buffered Saline (PBS)       Biowest or PAA, Germany 
Potassium hydroxide        Merck, Germany 
Protein marker (prestained)       Fermentas, Germany 
Pyrimethamine        AK Scientific, USA  
RPMI-1640 medium       PAA, Germany 
Sodium pyruvate (100x stock)      Biowest, Germany 
Tris-Hydrochloride        Promega, USA  
Trypsin/EDTA        Biowest, Germany 
 
Other standard chemicals were purchased from AppliChem (Germany), Carl Roth (Germany) or Sigma 
Aldrich (Germany), if not stated otherwise above. 
 
2.1.3. Materials for radioactive work 
L-[1,2-14C]-Ethanolamine      American Radiolabled Chemicals  
or Hartmann Analytic, Germany  
L-[1-14C]-Serine       ICN Radiochemicals, USA 
L-[1-3H]-Serine       American Radiolabled Chemicals 
Liquid scintillation cocktail      Perkin-Elmer, USA  
Scintillation vials      Perkin-Elmer, USA 
24-well scintillation plate      Perkin- Elmer, USA  
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2.1.4. Vectors 
Vector description    Source____________________________________ 
pcDNA3.1(+)     Isabelle Coppens, Johns Hopkins Univ. , USA  
pESC-Ura     Agilent Technologies, USA 
pNTP3      Isabelle Coppens, Johns Hopkins Univ., USA  
pNTP3-TetO7-Sag1    modified pNTP3 
pQE-60      Qiagen, Germany 
pTgS9(33-159)-GFP     Frank Seeber, RKI Berlin, Germany  
(DeRocher et al., 2000 (104)) 
pTet-UPKO     modified pNTP3 
pTKO-HXGPRT     John Boothroyd, Standford Univ., USA 
pTKO-DHFR     modified pTKO-HXGPRT 
pTub8-TgDer1-GFP    Boris Striepen, Univ. of Georgia, USA 
pYES2.1 TOPO     Life technologies, USA 
2.1.5. Antibodies and working dilutions 
Antigen (produced in)  Dilution Source______________________________________ 
α-TgActin (mouse)  1:1000  D. Soldati-Favre, Univ. of Geneva, Switzerland 
α-TgCK (mouse)  1:200  Sampels et al., 2012 (100) 
α-TgF1B (mouse)  1:1000  P. Bradley, Univ. California, USA (105) 
α-TgGap45 (rabbit)   1:3000  Plattner et al., 2008 (106) 
α-GFP (rabbit)   1:10000 Life technologies, Germany 
α-TgGra1 (mouse)  1:500  M. Cesbron-Delauw, CNRS Grenoble, France (43) 
α-TgGra3 (rabbit)  1:500  Bermudes et al., 1994 (107) 
α-TgGra5 (mouse)  1:500  M. Cesbron-Delauw, CNRS Grenoble, France (108) 
α-HA (mouse)    1:10000 Sigma Aldrich, Germany 
α-HA (rabbit)    1:1000  Sigma Aldrich, Germany 
α-His (mouse)   1:2000  Dianova, Germany 
α-TgHsp90 (rabbit)  1:1000  Echeverria et al., 2005 (109) 
α-KDEL  (mouse)  1:1000  Kaufusi et al., 2014 (110) 
α-TgSag1 (mouse)   1:1000  Dubremetz et al., 1985 (111) 
α-V5 (mouse)   1:1000  Abcam, United Kingdom 
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Secondary antibodies (produced in) Dilution  Source_________________________ 
Alexa Fluor 488 anti-mouse IgG (goat) 1:3000   Life technologies, Germany 
Alexa Fluor 594 anti-rabbit IgG (goat) 1:3000   Life technologies, Germany 
2.1.6. Enzymes 
Antarctic phosphatase       New England Biolabs, Germany 
Dream Taq polymerase      Fermentas, Germany 
Pfu Ultra II Fusion HS DNA polymerase    Stratagene, Germany 
Proteinase K        Sigma Aldrich, Germany 
Restriction endonucleases, Klenow enzyme    New England Biolabs, Germany 
T4 ligase        Life technologies, Germany 
2.1.7. Instruments 
Amaxa Nucleofector      Lonza, Switzerland 
Analytical balance FA-30100-2      FAUST, Germnay 
BioPhotometer       Eppendorf, Germany 
BTX Square Porator ECM 830      BTX, USA 
Centrifuges       Eppendorf, Germany 
Counting chamber (Neubauer improved)    Fuchs Rosenthal, Germany 
ELISA microplate reader      Biotek, Germany 
Fluorecence microscope Axio Image.Z2    Zeiss, Germany 
Gel documentation & EASY Enhanced Analysis    Herolab, Germany 
Gel electrophoresis system EasyPhor    Biozym, Germany  
Heraeus Function Line Incubator    Hereaus, Germany 
Incubation shaker „innova 4000“     New Brunswick, USA 
Invertical microscpe LABOVERT     Leitz, Germany 
Light optical microscope DM750     Leica, Germany 
Micropipettes       Eppendorf, Germany 
Multichannel-Pipettes      Brand, Germany 
NanoDrop ND-1000 Spectrophotometer    Peqlab, Germany  
PCR Thermocycler (FlexCycler)     JenaAnalytic, Germany 
Safety work benches HeraSafe     Heracell, Germany 
Scintillation counter (1450 MicroBeta TriLux)    PerkinElmer, USA 
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Thermomixer comfort      Eppendorf, Germany 
TLC developing tank       Sigma Aldrich, Germany 
Waterbath julabo U3       Julabo, Germany 
Ultra-Centrifuge Avanti J-26S XP    Beckmann Coulter, USA 
UV-screen UVT-20M/W      Herolab, Germany 
2.1.8. Plasticware and other disposables 
Cell culture well plates (6, 24, 96 well)    Costar, USA  
Cell culture dishes (60x15 mm)      Greiner Bio One, Germany 
Cryo preservation tubes (1.8 ml)     Sarstedt, Germany  
Borosilicate glass tubes (16 ml)     Sigma Aldrich, Germany 
DuraSeal Laboratory sealing film    Diversified Biotech, USA 
Electroporation cuvettes     Eppendorf, Germany 
Falcon-Tubes (15 ml; 50 ml)      Greiner Bio One, Germany  
Filter (5 µm)       Merck Millipore, Germany 
Filter sterilizer (0.22 μm)      Schleicher Schuell, Germany 
Glass bottom dishes (MatTek)     MatTek Corporation, USA 
Glass cover slips and microscopic slides    Carl Roth, Germany 
Hamilton Syringes      Hamilton, USA 
High performance chemiluminescence film    GE Healthcare, Germany 
Hypodermic needles       BD Bioscience, Germany 
Nitrocellulose transfer membrane     AppliChem, Germany 
Parafilm        Bemis Company, USA 
Pasteur pipettes       A. Hartenstein, Germany 
PCR-tube-stripes (0.2 ml)      Biozym, Germany 
PCR-tubes (0.2 ml)       Sarstedt, Germany 
Petri dishes (94x16 mm)      Greiner Bio One, Germany  
Pipette tips (10 – 1000 µl)     Greiner Bio One, Germany 
Polypropylene culture tubes (12 ml)     Greiner Bio-One, Germany 
Reaction tubes (1.5 ml; 2 ml)      Sarstedt, Germany   
RNAase-free barrier tips      Biozym, Germany 
SDS Electrophoresis Unit SE250 Mighty Small II   Hoefer Inc, USA 
Semi-dry Electro blotter SEDECM    Peqlab, Germany 
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Serological pipettes (10 ml; 25 ml)     Greiner Bio One, Germany 
Size exclusion columns (30 kDa)    Merck Millipore, Germany 
Syringes        BD Bioscience, Germany  
TLC silica gel 60 plates      Merck Millipore, Germany 
Whatman paper (3 MM)      A. Hartenstein, Germany 
2.1.9. Commercial kits 
Annexin-V-FLUOS staining kit     Roche, Germany 
cAMP Biotrak EIA kit      GE healthcare, USA 
cloneEZ PCR cloning kit      GenScript, Germany 
innuPREP DOUBLEpure kit      Analytik Jena, Germany 
innuPREP Plasmid Mini kit      Analytik Jena, Germany 
Lipofectamine 2000      Life Technologies, Germany 
Membrane recycling kit     Alpha Diagnostics Intl., USA 
pDrive PCR cloning kit       Qiagen, Germany 
Protein Assay kit (BCA)       Thermo Scientific, Germany 
Pure Link RNA Mini kit       Life Technologies, Germany 
PureLink HiPure Plasmid Midiprep kit    Life Technologies, Germany 
QIAGEN PCR Cloning kit     Qiagen, Germany  
Reverse transcription PCR (SuperScript III)   Life Technologies, Germany 
Trizol reagent       Life Technologies, Germany 
WesternBright Quantum WB Detection kit   Advansta Inc., USA 
2.1.10. Reagent preparations 
Media and buffers for E. coli 
 
Standard media (Lysogeny Broth, Super Optimal Broth or Super Optimal Broth for Catabolite 
repression) for the cultivation of E. coli were made according to Sambrock et al. (112) or other 
following standard protocols. 15 g agar-agar (Carl Roth, Germany) was added to 1 liter of liquid 
medium before autoclaving for the preparation of solid media. 
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Media and buffers for T. gondii 
 
Cytomix:     120 mM  KCl 
25 mM   HEPES (pH 7.6) 
5 mM   MgCl2 
2 mM   EDTA 
0.15 mM CaCl2 
10 mM   K2HPO4/KH2PO4 (pH 7.6) 
 
D10-medium:     500 ml  DMEM (4500 mg/l glucose) 
50 ml   iFCS (heat-inactivated) 
5.5 ml  Penicillin/Streptomycin (100x) 
5.5 ml   Non-essential amino acids (100x) 
5.5 ml   L-Glutamine (200 mM) 
5.5 ml   Sodium pyruvate (100 mM) 
 
Intracellular-type medium (ICM):  
 
2x Salts for ICM:  280 mM KCl 
20 mM  NaCl 
5 mM  MgCl2 
40 mM  HEPES/NaOH (pH 7.4) 
10 mM  Glucose 
0.2µM  CaCl2 
 
100 ml ICM contain:  50 ml  2x Salts 
1 ml  100x MEM Vitamins 
2 ml  50x MEM Amino Acids 
1 ml  100x Sodium pyruvate 
1 ml  MEM non-essential amino acids 
45 ml  dH20 
1 mM   MgATP (freshly added) 
 
Lysis buffer (gDNA-extraction):   10 mM   Tris-HCl (pH 8) 
5 mM   EDTA 
0.5%   SDS 
200 mM  NaCl 
0.1 g/ml  Proteinase K 
 
Parasite extract buffer   50 mM  Potassium phosphate buffer (pH 6.8) 
     0.25 M  Sucrose 
     0.5 mM  PMSF 
     3 mM  EDTA 
 
PBS     2.7 mM  KCl 
1.5 mM  KH2PO4 
136.9 mM  NaCl 
8.9 mM  Na2HPO4 7H2O 
 
 
Toxo-freezing medium:   10% DMSO in iFCS 
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Media and buffers for S. cerevisiae 
 
YPD-media    20 g   Peptone 
10 g   Yeast extract 
20 g   Agar-agar (for solid media) 
ad 950 ml dH2O 
2% filter-sterile glucose was added after autoclaving. 
 
10x amino acid mix 400 mg adenine hemisulfate, 200 mg L-Arg, 1000 mg L-Asp, 
1000 mg L-Gln, 200 mg L-His, 600 mg L-Leu, 300 mg L-Lys,  
200 mg L-Met, 500 mg L-Phe, 3750 mg, L-Ser, 2000 mg L-Thr, 
400 mg  L-Try, 300 mg L-Tyr, 1500 mg L-Val, 200 mg Uracil  
ad 500 ml ddH2O 
(Uracil was omitted for preparation of selective media.) 
 
Synthetic complete (SC) medium 1.7 g   Yeast nitrogen base (w/o (NH4)2SO4) 
5 g   (NH4)2SO4 
ad 500 ml dH2O.  
 
Sterile amino acids and glucose, galactose or lactate as 
carbon source (filter sterile 40% stock solution) were added 
after autoclaving to a final concentration of 2%. 
 
 
Standard buffers and reagents 
 
SDS loading buffer (5x)   0.25%   Bromophenol blue  
0.5 M   Dithiothreitol (DTT) 
50%   Glycerol  
10%   Sodium dodecyl sulfate (SDS) 
0.25 M   Tris-HCl (pH 6.8) 
 
SDS-running buffer (10x)  30 g  Tris base (pH 8.3) 
144 g   Glycine 
10 g   SDS 
ad 1000 ml dH2O 
 
SEM buffer     250 mM Sucrose 
     1 mM  EDTA 
10 mM  MOPS/KOH (pH 7.2) 
 
Semi-dry transfer buffer  5.8 g   Tris base 
2.9 g   Glycine 
0.37 g   SDS 
200 ml   Methanol 
Ad 1000 ml dH2O 
 
TBS-buffer (10x)   60.6 g   Tris-HCl (pH 7.6) 
87.6 g   NaCl  
ad 1000 ml dH2O 
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2.1.11. Oligonucleotide primers 
All oligonucleotides listed below were synthesized by Life Technologies, Germany. 
 
Table 1: Oligonucleotide primers used in this study 
Primer Name 
(restriction site) 
Nucleotide Sequence 
(restriction site underlined) 
Cloning Vector 
(research objective) 
Expression of TgPSD1mt-HA, TgPSD1mt(91-427)-HA und TgPSD1mt (113-427)  
in T. gondii (Δku80-hxgprt- and Δku80-TaTi strains) 
TgPSD1mt-F 
(NcoI) 
CTCATCCCATGGGCAGTTACTTGCGGTTTTCG 
pUPKO (Ectopic 
expression of 
TgPSD1mt-HA) TgPSD1mt-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGGGT
AGTAAAATGCAAACAGGCGTTC 
TgPSD1-IT-F  
(XcmI) 
CTCATCCCACCGGTCACCTGGGAGCCATGTGGCAGATATTC 
pTKO-HXGPRT (3’HA-
tagging of the 
TgPSD1mt gene locus) TgPSD1-IT-HA-R  
(HpaI) 
CTCATCCAATTGTCAAGCGTAATCTGGAACATCGTATGGGT
AGTAAAATGCAAACAGGCGTTC 
TgPSD1mt(91-427)-F  
(NcoI) CTCATCCCATGGTTGGCATGACCGCG 
pTETO7SAG1-UPKO 
(Ectopic expression of 
TgPSD1mt(91-427) at  the 
TgUPRT gene locus) 
TgPSD1mt(91-427)-HA-R 
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGTAAAATGCAAACAGGCGTTCATCTT 
TgPSD1mt(113-427)-F 
(NcoI) CTCATCCCATGGCGACAG ACAATGTTGCAGA 
pTETO7SAG1-UPKO 
(Ectopic expression of 
TgPSD1mt(113-427) at the 
TgUPRT gene locus) 
TgPSD1mt(113-427)-HA-R 
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGTAAAATGCAAACAGGCGTTC 
Expression of TgPSD1pv-HA in T. gondii (Δku80-TaTi and RH HX- strain) 
TgPSD1pv-5’UTR-F 
(EcoRV) CTCATCGATATCTGAAGGGAAGAAGCGAAGG pUPKO (Cloning of the 
TgPSD1pv gene 
promoter) TgPSD1pv-5’UTR-R 
(MscI) CTCATCTGGCCACCAGGGCCACGCACAC 
TgPSD1pv-F  
(MscI) CTCATCTGGCCATTTCGGTACCAGCAGCGT 
pUPKO (Expression of 
the TgPSD1pv-HA ORF 
under its native 
promotor) 
TgPSD1pv-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGTAAAATGCAAACAGGCGTTCA 
TgNTP3-3’UTR-F  
(PacI) CTCATCTTAATTAAAATGTCGATTGATGGTGTCG pUPKO (Cloning of the 
TgNTP3-3´UTR) TgNTP3-3’UTR-R  
(NotI) CTCATCGCGGCCGCACTAGTGTGGCGCCACGG 
TgPSD1pv-F2  
(EcoRV) CTCATCGATATCATGGCTAGGGTTATGAGGCTTATC pNTP3-DHFR (Ectopic 
over-expression of 
TgPSD1pv) TgPSD1pv-HA-R2 
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGAGATCCCCATTGGTAAGCA 
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Expression of TgPSD1mt, TgPSD1mt(113-427) and ScPSD1 in S. cerevisiae (BY23480 or PTY44 strain) 
TgPSD1mt-F  
(NotI) CTCATCGCGGCCGCATGCGCAGTTACTTGCGGT pESC-Ura (Ectopic 
expression of 
TgPSD1mt ORF) TgPSD1mt-R  
(NotI) CTCATCGCGGCCGCTCAGTAAAATGCAAACAGGCGT 
TgPSD1mt(113-427)-F 
(BglII) CTCATCAGATCTATGGCGACAGACAATGTTGCAGAGAT pYES2.1 (Ectopic 
expression of 
TgPSD1mt(113-427)) TgPSD1(113-427)-R  
(EcoRI) CTCATCGAATTCTCAGTAAAATGCAAACAGGC 
ScPSD1-F  
(NotI) CTCATCGCGGCCGCATGTCAATTATGCCAGTTAAGAACG pESC-Ura (Ectopic 
expression of the 
ScPSD1 ORF) ScPSD1-R  
(NotI) CTCATCGCGGCCGCTCATTTTAAATCATTCTTTCCAATT 
Expression of TgPSD1pv, ScmTP-TgPSD1pv, TgPSD1pv-CD and ScmTP-TgPSR 
in S. cerevisiae (BY23480 or PTY44 strain) 
TgPSD1pv-SC-R 
(NotI) CTCATCGCGGCCGCATGGCTAAGGTTATGAGGCTTATC 
pESC-Ura (Ectopic 
expression of 
TgPSD1pv ORF in 
yeast) 
TgPSD1pv-SC-R 
(NotI) CTCATCGCGGCCGCTCAGAGATCCCCATTGGTAAG 
ScPSD1mtp-F 
(EcoRI) CTCGAATTCATGTCAATTATGCCAGTTAAGAACG pESC-Ura (Targeting of 
TgPSDs to yeast 
mitochondria) ScPSD1mTP-R 
(NotI) CTCGCGGCCGCATCGAGACATCGCATTCAGC 
TgPSD1pv-woSP-Y-F 
(NotI) CTCGCGGCCGCATGCTCACGTTGAATCGACG 
pESC-Ura (for tagging 
with ScPSD1mTP) 
TgPSD1pv-CD1-F 
(NotI) CTCGCGGCCGCATGAGTGACAAGGACAGACGC 
pESC-Ura (Ectopic 
expression of 
TgPSD1pv catalytic 
domain in yeast) 
TgPSD1pv-CD1-R 
(NotI) CTCGCGGCCGCTCAGAGATCCCCATTGGTAAG 
TgPSD1pv-CD2-F 
(NotI) CTCGCGGCCGCATGTGGGAATTTCCTGACAC 
pESC-Ura (Ectopic 
expression of 
TgPSD1pv catalytic 
domain in yeast) 
TgPSD1pv-CD2-R 
(NotI) CTCGCGGCCGCCTAAAATGCGTTGCATCTCTCT 
Generation of the Δtgpsd1mt/TgPSD1mt-HAr mutant in T. gondii (Δku80-TaTi strain) 
TgPSD1mt-5´UTR-F1  
(XcmI) 
CTCATCCCACCGGTCACCTGGACTTCTTCAGCACATCGTGTG
T pTKO-DHFR-TS 
(Cloning of the 
TgPSD1mt-5´UTR) TgPSD1mt-5´UTR-R1  
(SpeI) CTCATCACTAGTGCAAACATCTCAAGAGAAGCAC 
TgPSD1mt-3´UTR-F1  
(HpaI) 
CTCATCGTTAACTTTGACTGAATCGCTTTGTTG pTKO-DHFR-TS 
(Cloning of the 
TgPSD1mt-3´UTR) TgPSD1mt-3´UTR-R1  
(ApaI) 
CTCATCGGGCCCACAGCGAAACCCCTTCAG 
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Screening for 5’ and 3’ recombination in the Δtgpsd1mt/TgPSD1mt-HAr mutant of T. gondii 
TgPSD1mt- 5´Scr-F1 GCGAGCAGGGACTAAGTGG pDrive (TA-cloning of 5’ 
PCR product for 
sequencing) TgPSD1mt-5´Scr-R1 CACAGTCTCACCTCGCCTTG 
TgPSD1mt-3´Scr-F1 CGGAAAGTGCTTACATCGAAC pDrive (TA-cloning of 3’ 
PCR product for 
sequencing) TgPSD1mt-3´Scr-R1 GACCGACGGCAGTATGTTG 
Generation of Δtgpsd1mt mutant in T. gondii (Δku80-hxgprt- strain) 
TgPSD1mt-5´UTR-F2 
(KpnI) CTCATCGGTACCTCTGAAACCGGTTACAGACCA pTKO-HXGPRT (Cloning 
of the TgPSD1mt-
5´UTR) TgPSD1mt-5´UTR-R2 
(XhoI) CTCATCCTCGAGCTCTGGAAGCCATAACTAGAGAAACA 
TgPSD1mt-3´UTR-F2 
(HpaI) 
CTCATCGTTAACTCATGCACATGGTTGCTGTG pTKO-HXGPRT (Cloning 
of the TgPSD1mt-
3´UTR) TgPSD1mt-3´UTR-R2 
(ApaI) 
CTCATCGGGCCCAACCAATGGTCGACGAAGC 
Screening for 5’ and 3’ recombination in the Δtgpsd1mt mutant of T. gondii 
TgPSD1mt-5´Scr-F2 CGGTTTCTTTGTCGTATTCCC pDrive (TA-cloning of 5’ 
PCR product for 
sequencing) TgPSD1mt-5´Scr-R2 GACGCAGATGTGCGTGTATC 
TgPSD1mt-3´Scr-F2 ACTGCCGTGTGGTAAAATGAA pDrive (TA-cloning of 3’ 
PCR product for 
sequencing) TgPSD1mt-3´Scr-R2 GAAAGGAGTGAAGGAGCCTATCA 
Expression of TgEK-HA in T. gondii (Δku80-TaTi strain) 
TgEK-F  
(XhoI) CTCATCCCTGCAGGATGGCTCTCCACACTGCA 
pTgGRA1-UPKO 
(Ectopic expression of 
TgEK-HA 
at the TgUPRT gene 
locus) 
TgEK-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGAACGACAAATGCGGGAC 
Expression of putative TgECT-HA in T. gondii (Δku80-TaTi strain) 
TgECT-F  
(NsiI) CTCATCATGCATATGACGGCGGTAGCGTCG 
pTgGRA1-UPKO 
(Ectopic expression of 
TgECT-HA 
at the TgUPRT gene 
locus) 
TgECT-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGAGTTCTGTCAGAGACACCATCTGT 
Expression of putative TgEPT1-HA and TgEPT2-HA in T. gondii (Δku80-TaTi strain) 
TgEPT1-F 
(NsiI) CTCATCATGCATATGATGGTCGGTGGCGT 
pTgGRA1-UPKO 
(Ectopic expression of 
TgEPT1-HA 
at the TgUPRT gene 
locus) 
TgEPT1-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAGGAGCTCTTTTTGAGAGCATTAA 
TgEPT2-F 
(NsiI) CTCATCATGCATATGGTGTTTGGACACTACATTCCCCC 
pTgGRA1-UPKO 
(Ectopic expression of 
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TgEPT2-HA-R  
(PacI) 
CTCATCTTAATTAATCAAGCGTAATCTGGAACATCGTATGG
GTAAGCCCCGCGCCGTCTG 
TgEPT2-HA 
at the TgUPRT gene 
locus) 
Expression of TgPSD1mt-V5 and TgPSD1pv-V5 in COS-7 cells 
TgPSD1mt-ME-F 
(NheI)  CTCATCGCTAGCATGCGCAGTTACTTGCGG pCDNA3.1 (Ectopic 
expression in 
mammalian cells) TgPSD1mt-ME-R 
(XbaI) CTCATCTCTAGAGTAAAATGCAAACAGGCGTTC 
TgPSD1pv-ME-F  
(HindIII) CTCATCAAGCTTATGGCTAAGGTTATGAGGCTTATC pCDNA3.1 (Ectopic 
expression in 
mammalian cells) TgPSD1pv-ME-R 
(XbaI) CTCATCTCTAGAGAGATCCCCATTGGTAAGCA 
Cloning of the pTKO-TgPSD1pv-5´TGD-HXGPRT-3´TGD construct 
TgPSD1pv-5´TGD-F 
(NotI) CTCATCGCGGCCGCTAGGTGTCTTGCCACTATGTGGT pTKO-HXGPRT (Cloning 
of the TgPSD1pv-
5´TGD fragment) TgPSD1pv-5´TGD-R 
(EcoRI) CTCATCGAATTCTCGCATAGAGGCACATCTAT 
TgPSD1pv-3´TGD-F 
(HindIII) CTCATCAAGCTTGGTGGGCATACACCAATGC pTKO-HXGPRT (Cloning 
of the TgPSD1pv-3´-
TGD fragment) TgPSD1pv-3´TGD-R 
(HpaI) CTCATCGTTAACTAGGTCGTCGTCTGGTG 
Screening for 5’ and 3’ recombination in the Δtgpsd1pv-TGD mutant of T. gondii 
TgPSD1pv-5´TGD-Scr-
F3 CAGACACACAAACTGACTCAAACAG 
pDrive (TA-cloning of 5’ 
PCR product for 
sequencing) TgPSD1-5´TGD-Scr-R3 GACGCAGATGTGCGTGTATC 
TgPSD1-3´TGD-Scr-F3 ACTGCCGTGTGGTAAAATGAA pDrive (TA-cloning of 3’ 
PCR product for 
sequencing) 
TgPSD1pv-3´TGD-Scr-
R3 CAATTTTCGTCGTCGCCA 
RT-PCR to analyse transcript abundance in T. gondii cDNA 
TgELf1α-F AGTCGACCACTACCGGACAC Control housekeeping 
gene for RT-PCR 
TgELf1α-R CTCGGCCTTCAGTTTATCCA 
Expression of TgPSD1pv-CD1 and TgPSD1pv-CD2 in E. coli 
TgPSD1pv-EC1-F1 
(BglII) CTCATCAGATCTATGTTCCGACGCCGTGG 
pQE-60 (Expression of 
TgPSD1pv without 
signal peptide in E.coli 
M15 strain) 
TgPSD1pv-EC1-R1 
(BglII) CTCATCAGATCTGAGATCCCCATTGGTAAGCA 
TgPSD1pv-EC2-F1 
(BglII) CTCATCAGATCTATGTTCCGACGCCGTGG pQE-60 (Expression of 
TgPSD1pv w/o SP and 
C-term. extention in 
E.coli M15) TgPSD1pv-EC2-R1 
(BglII) CTCATCAGATCTAAATGCGTTGCATCTCTCTTG 
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2.1.12. Software 
AxioVision     Carl Zeiss, Germany 
CLC sequence viewer     CLC bio, Netherlands 
FlowJo      FlowJo LCC, USA 
FigTree (v4.1)     http://tree.bio.ed.ac.uk/software/figtree/ 
GraphPad Prism 5.0    GraphPad software Inc., USA 
ImageJ (v1.45s)     http://imagej.nih.gov/ij/index.html 
Microsoft Office 2010    Microsoft Corporation, USA 
Protein Molecular Weight   http://www.bioinformatics.org/sms/prot_mw.html 
SnapGene     GSL Biotech LLC, USA 
2.2. Methods – Molecular Cloning and Protein analysis 
2.2.1. PCR reactions 
To amplify DNA fragments for molecular cloning Pfu-Ultra Fusion II high-fidelity polymerase 
(Stratagene) was used, whereas Fermantas Dream Taq Polymerase was used for analytical PCR 
reactions including colony PCRs. 10-200 ng of DNA was used as template in standard PCR reactions. 
The reaction was performed in a Thermocycler (FlexCycler, Analytik Jena) according to the 
manufacturer’s protocol. For the screening of bacterial colonies, cells were suspended in 20 µl of 
sterile dH2O, and 5 µl of the solution was used as PCR template. The DNA fragments mixed with DNA-
loading dye were separated on 0.8-1.2% agarose gels (stained with RedSafe DNA staining solution) at 
90-120 V in 1 x TAE buffer followed by UV-visualization. 
2.2.2. DNA restriction and ligation 
PCR products were analysed for their purity and expected fragment size. They were either column 
purified or cut from agarose gel and extracted using the innuPREP DOUBLEpure Kit (Analytik Jena). 
Plasmid DNA was isolated from E. coli overnight cultures using the innuPREP Plasmid Mini Kit 
(Analytik Jena). For DNA digestion, 0.5-50 μg DNA was used as substrate for the restriction 
endonucleases (New England Biolabs). 0.4 U/μg DNA was used for the linearization of plasmids, 
whereas 2.5 U/μg DNA was used for the restriction of PCR-fragments. The reaction was performed 
according to the manufacterers protocol. For non-directional cloning, plasmids were 
dephosphorylated using Antarctic phosphatase. Insert and plasmid DNA were used in a molar ratio of 
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3:1 or 5:1 (fmol insert : fmol vector) for sticky and blunt end ligation reactions, respectively. The T4-
DNA-ligase reaction was performed over night at RT or at 4 °C prior to transformation into chemical 
competent E. coli Xl1-blue or M15 cells. 
2.2.3. Transformation of E. coli 
90 μl of competent E. coli cells were mixed with the ligation reaction and incubated on ice for 30 min. 
The bacterial cells were heat-shocked for 45 sec at 42 °C in a waterbath and then immediately chilled 
on ice for 1-2 min prior to the addition of 700 μl liquid SOC-medium and incubation at 37 °C and 250 
rpm for 1 hr. Cells were pelleted by centrifugation and suspended in 200 μl of fresh SOC-medium for 
plating on selective LB-agar containing ampicillin (0.1 mg/ml) or kanamycin (0.05 mg/ml). Plates were 
incubated over night at 37 °C and appearing colonies were screened for plasmid expression by PCR. 
Positive clones were used for plasmid preparations and/or protein expression in E. coli M15 cells. 
Overnight cultures were cryo-preserved in 25% glycerol at -80 °C. 
2.2.4. Nucleic acid preparation 
For the preparation of plasmid DNA, 5 ml of E. coli liquid cultures were processed using the innuPREP 
Plasmid Mini Kit. The DNA was eluted in 2 x 20 μl dH2O. For large-scale plasmid preparation, 200 ml 
of bacterial overnight cultures were processed with the PureLink HiPure Plasmid Midiprep kit. The 
DNA was precipitated by addition of 2 volumes 96% ethanol and sodium acetate (0.3 M) for 1 h at 4 
°C and subsequently pelleted at 16.000 x g, washed with 1 volume 70% Ethanol, air dried and 
resuspended in an adequate volume of dH2O. Genomic T. gondii tachyzoite DNA was extracted by 
resuspending the parasite pellet in 200 μl of Toxo lysis buffer [2.1.10.] supplemented with 1 μl fresh 
Proteinase K (50 mg/ml) and incubation at 55 °C for 30 min. The gDNA was precipitated with 1 
volume of pure isopropanol and centrifugation at 16.000 x g for 45 mins. The final pellet was 
dissolved in 10-50 μl ddH2O. To extract RNA, RNase-free plasticware and DEPC-treated water were 
used throughout the procedure. Trizol reagent and PureLink RNA MiniKit were used for RNA 
preparation and purification, which was eluted with 10-30 μl RNase-free water. cDNA synthesis was 
performed using the SuperScript III First-strand synthesis kit (Life Technologies) with either oligo-dT- 
or random hexamer primers. To determine the nucleic acid concentrations, the NanoDrop 
Spektralphotometer 1000 was used, and samples were stored at -20 °C (plasmid DNA), -80 °C (RNA) 
or 4 °C (genomic DNA). 
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2.2.5. Expression of recombinant proteins in E. coli 
For heterologous expression of T. gondii proteins in E. coli, parasite cDNA was used to amplify 
truncated versions of TgPSD1pv. The DNA fragments were cloned into the pQE-60 expression vector 
at BglII restriction site, which resulted in a C-terminal 6xHis-tag fusion. The E. coli M15 strain was 
used for protein expression. 20 ml of E. coli overnight culture were diluted to an OD600 of 0.1 in 500 
ml medium and grown to an OD600 of 0.4 before induction with 1 mM IPTG over night at 30 °C. Cells 
were pelleted by centrifugation (3000 x g, 20 min) and stored at -80 °C until use. The pellets were 
resuspended in 6 ml of lysis buffer containing 20 mM sodium phosphate buffer (pH 7.4), 500 mM 
NaCl, 10 mM imidazol, 10% glycerol and 60 µl protease inhibitor cocktail (containing 2 mM AEBSF, 0.3 
μM Aprotinin, 130 μM Bestatin, 1 mM EDTA, 14 μM E-64 and 1 μM Leupeptin). Cells were disrupted 
by 6 x 30 sec probe sonication intervals on ice followed by centrifugation at 12.000 x g for 20 min to 
remove intact cells. The supernatant containing the cell lysate was loaded on a NiNTA column, 
washed with 8 ml washing buffer (20 mM NaH2PO4 pH 7.8, 500 mM NaCl, 20 mM imidazol) and 
eluted with 100 mM and 200 mM imidazole in 20 mM NaH2PO4 buffer (pH 7.8) containing 500 mM 
NaCl. The eluate was stored on ice and PIC was added before concentrating the sample using an 30 
kDa size exclusion column (Merck Millipore, Germany). Samples were stored at -80 °C until use. The 
protein concentration was determined by BCA assay and 5-10 µg of purified protein was used for 
SDS-PAGE and Western Blot analysis using an anti-His antibody. 
2.2.6. Protein extraction, preparation and Immuno-blot analysis 
Fresh extracellular parasites (~3-5 x 107) were washed with PBS and pelleted (400 x g, 10 min, 4 °C) 
before snap-freezing in liquid nitrogen. The pellets were either directly thawed in SDS-sample buffer 
or in 10 mM MOPS/KOH buffer (pH 7.2) containing 250 mM sucrose, and 1 mM EDTA supplemented 
with fresh PIC for the preparation of membrane proteins. The samples were probe sonicated on ice (3 
x 30 s burst) followed by centrifugation (2000 x g, 5 min, 4 °C) to remove intact cells. The cell free 
extract was centrifuged at 30.000 x g for 1 hr. The resulting membrane pellet was suspended in 1% 
Triton X-100 and 2x SDS sample loading buffer. SDS-PAGE and Western Blot Analysis were performed 
using standard protocols (112). Briefly, proteins were separated on 10-12% SDS-polyacrylamid gels at 
100 V in SDS-running buffer followed by transfer to a nitrocellulose membrane at 0.8mA/cm2. The 
membrane was blocked in 5% skim milk (in TBS-0.1% Tween) over night at 4 °C. Primary antibodies 
(α-HA 1:500 – 1:1000, α-His 1:2000, α-TgActin 1:1000, α-TgHsp90 1:1000 in blocking solution) were 
used for epitope binding for 2-4 hrs at RT or over night at 4 °C. HRP-conjugated secondary antibodies 
were used for primary antibody binding (1:20.000) and detection on X-ray film (WesternBright 
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Quantum WB Detection kit Advansta Inc., USA.). The membrane was washed 3 x 10 min with TBS-
0.1% Tween after primary and secondary antibody incubation. Where necessary, the membrane was 
stripped using the Membrane recycling kit (Alpha Diagnostics Intl., USA) and probed again as 
described above. 
2.3. Methods – Cell culture and transfection 
2.3.1. Host cell cultivation 
Human foreskin fibroblasts were cultured in D10 medium [2.1.10.] at 37 °C and 5% CO2 in a 
humidified incubator. Cells were harvested by trypsin/EDTA treatment and seeded into multi-well 
plates, dishes or cell culture flasks as required.  
2.3.2. T. gondii cultivation and genetic manipulation 
T. gondii tachyzoites were routinely propagated by serial passage in 60 mm cell culture dishes with 
confluent HFF monolayers at a multiplicity of infection (MOI) of 3, if not mentioned otherwise. 
Cultures were incubated in D10 medium [2.1.10.] at 37 °C and 5% CO2. Parasites were diluted 
appropriately and counted using a Neubauer counting chamber. To generate transgenic parasite lines, 
freshly egressed or syringe-released tachyzoites (1-2 x 107) were washed with PBS and resuspended 
in 700 µl cytomix solution supplemented with fresh ATP (30 µl of a 100 mM stock solution) and 
glutathione (2 µl of a 250 mM stock solution). 50 µg of circular or linearized plasmid was used for the 
transfection using a BTX630 instrument (2 kV, 50 ohm, 25 microfarads, 250 µs). Alternatively, 10 µg 
plasmid and 100 µl cytomix plus additives were used for parasite transfection using the Amaxa 
nucleofector (programm T-16). Transfected parasites were used to infect HFF cells immediately. The 
culture medium was replaced 4-12 hrs post transfection to remove dead parasites and residual 
transfection reagent. Drug selection was performed as listed below. Stable transgenic strains were 
used to generate clonal lines by limiting dilutions in 96-well plates and used for follow up assays. 
 
Selection drug Concentration used Drug target (Reference) Added post transfection 
Pyrimethamine 1 µM DHFR-TS (59) 8 - 24 h  
Mycophenolic acid/ 
Xanthine 
25 µg/ml 
50 µg/ml 
HXGPRT (57)  
 
8 - 24 h 
FUDR 5 µM UPRT (58) after 2 passages  (~96 h) 
Chloramphenicol 20 µM CAT (60)  8 - 24 h 
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2.3.3. Cultivation and transfection of COS-7 cells 
COS-7 cells were cultivated in D10 medium, and monolayers were harvested using trypsin/EDTA 
regularly to avoid overgrowing and reduced cell viability. For heterologous expression, the parasite 
ORFs were amplified from tachyzoite cDNA and cloned into the pCDNA3.1(+) vector at HindIII or NheI 
and XbaI sites, which resulted in a C-terminal fusion with a V5-tag and stable expression under the 
pCMV promotor. Prior to transfection, 800 ng of BglII-linearized plasmid was resuspended in 50 µl 
Opti-MEM (reduced serum) medium containing 0.5 µl Lipofectamine 2000. The solution was 
incubated at RT for 20 mins and then added to the COS-7 cells grown in a 24-well plate. After 24 h 
incubation (37 °C, 5% CO2), cells were harvested with trypsine/EDTA and seeded in T-75 flasks in a 
1:10 dilution. Geneticin (800 µg/ml) was added 2 days post-transfection for the selection of stable 
transgenic cells. Fresh medium was provided every second or third day. The cells were analysed for 
transgene expression 24-48 hrs post-transfection and after 4 weeks of drug selection by immuno-
fluorescence assay. 
2.3.4. S. cerevisiae cultivation and transformation 
The ethanolamine-auxotrophic yeast strains BY23480 (Δpsd1Δpsd2) and PTY44 (Δpsd1Δpsd2) were 
maintained at 30 °C on synthetic complete (SC) solid media containing 2 mM ethanolamine and 2 % 
glucose or 2 % lactate as carbon source, respectively. The strains were used for transformation with 
the pESC-Ura or pYES2.1-TOPO vector carrying ORFs amplified from T. gondii cDNA to test for 
complementation in ethanolamine-free media and the URA3 gene for selecting yeast transformants 
in uracil-deficient medium. Both plasmids allowed a galactose-inducible expression of a protein of 
interest under the control of the GAL promoter of S. cerevisiae. Empty plasmids and ScPSD1-
expressing plasmids were used as negative and positive controls, respectively. Transformation was 
performed using standard protocols (113,114). Briefly, yeast overnight cultures grown in 5 ml of 
synthetic complete media with 2% glucose or lactate at 30 °C on an incubation shaker, were used to 
inoculate a 50 ml culture at initial OD600 = 0.1 and grown to an OD600 of 0.4-0.6. Cells were collected 
by centrifugation (5 min, 2500 x g, RT) and washed with 25 ml of TE buffer (10 mM Tris-HCL, 1 mM 
EDTA, pH 7.5) for 5 min at 2500 x g and RT. The pellet was then washed in 10 ml of 100 mM lithium 
acetate (LiAc) buffered in TE (5 min, 2500 x g, RT) and suspended in 500 µl TE/LiAc and incubate at RT 
for 30 min. 100 µl of the competent yeast cells were mixed with 100 – 200 ng of plasmid DNA and 
100 µg of Salmon sperm carrier DNA. 0.6 ml of PEG3350/LiAc/TE solution was added to the 
transformation reaction and vortexed vigorously for 10 sec followed by horizontal incubation at 30 °C 
for 30 min at 200 rpm in a shaker. 70 µl of DMSO (100%) was added to each tube and inverted. Cells 
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were heat-shocked at 42 °C for 15 min in a waterbath and chilled on ice for 1-2 min. Cells were then 
pelleted and washed in 200 µl of TE-buffer (5 sec, 14.000 x g, RT). The final pellet was suspended in 
100 µl fresh TE-buffer and plated on in synthetic uracil-dropout minimal medium supplemented with 
2 mM ethanolamine and 2% glucose or 2% lactate at 30 °C. Positive clones were identified by PCR and 
sequencing. To test for complementation, yeast cells were grown in liquid medium to an OD600 of 0.1, 
and serial dilutions (1:5) were stamped, spotted or streaked on synthetic uracil-dropout plates with or 
without ethanolamine (2 mM) containing either glucose, galactose, or lactate (2%) as carbon source. 
Plates were incubated for 2-4 days at 30 °C. To perform plasmid loss assays, yeast cells were serially 
propagated for 5 days under non-selective conditions (2% yeast extract, 1% peptone, and 2% glucose) 
and then evaluated by replica plating on selective (uracil-free) and nonselective (uracil-replete) plates 
in synthetic minimal medium. They were also simultaneously examined for their ability to grow with 
or without ethanolamine to examine phenotypic reversion. 
2.4. Methods – Biological and Biochemical Assays 
2.4.1. Indirect immuno fluorescence assay 
Parasite-infected HFF monolayers cultured on glass coverslips were washed with PBS at 24-30 hrs 
post-infection, fixed with 2-4% paraformaldehyde (10 min), and then neutralized with 0.1 M 
glycine/PBS (5 min). Cells were permeabilized with 0.2% Triton X-100/PBS for 20 min, and nonspecific 
binding was blocked with 2% bovine serum albumin in 0.2% Triton X-100/PBS (30 min). Samples were 
stained using primary antibodies produced in mouse or rabbit for 1 hr [for dilution see 2.1.5.]. Cells 
were washed 3x with 0.2% Triton X-100/PBS, and stained with Alexa488- or 594-conjugated 
antibodies (anti-rabbit or anti-mouse, 1:3000) for 45 min. Following three additional washing steps, 
samples were mounted in fluoromount-G/DAPI (Southern Biotech, USA) and stored at 4 °C. Samples 
were analyzed and imaged using a Zeiss fluorescence microscope with the filter sets 49 (DAPI), 38 
(GFP) and 43 (DsRed). 
2.4.2. Transmission electron microscopy 
Parasite-infected HFF cells grown on glass cover slips were fixed with 2.5% glutaraldehyde and 2% 
paraformaldehyde in 0.1 M cacodylate buffer for 30 min at room temperature. The reaction was 
neutralized with 0.1 M glycine/PBS or cacodylate buffer followed by three subsequent washings for 5 
min in cacodylate buffer. Cells were then fixed with 2% OsO4 in 0.1 M cacodylate-buffer for 1 hr on 
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ice, washed 3 x 5 min with ddH2O and contrasted with 0.5 % uranylacetate for 1 hr in the dark. After 
another 3 x 5 min washing steps with ddH2O, cells were dehydrated with an ascending alcohol series 
as follows: 40% EtOH, 50% EtOH, 60% EtOH, 70% EtOH, 80% EtOH for 5 min each and 90% EtOH, 95% 
EtOH, 100% EtOH and a second 100% EtOH dehydration for 30 min each. Embedding of the cells was 
performed in 100% EtOH/EMBed 812 (3:1; v/v), 100% EtOH/EMBed 812 (1:1; v/v), 100% 
EtOH/EMBed 812 (1:3; v/v) and pure EMBed 812 for 1 hr each and subsequently in fresh pure EMBed 
812 over night with open lid. The glass cover slips were attached to an object plate and an EmBed 
812 filled capsule was imposed to the cell monolayer. The sample was hardned at 70 °C for 48 hrs, 
heated for 12 sec on a heating plate and ripped off the glass slide followed by trimming into 70 nm 
ultra thin sections with an ultra microtome (Reichert Ultracut S, Leica). Imaging was done using a 
Zeiss EM 900 transmission electron microscope. 
2.4.3. Correlative microscopy 
Correlative microscopy combines immunofluorescence and transmission electron microscopy (TEM) 
to superimpose antibody-stained epitopes with the cellular ultrastructures. Host cells were grown to 
a density of 50% in 35 mm cell culture dishes with gridded glass coverslip bottom (MatTek, USA). 
Infected cells were fixed 24 hrs post infection and immunofluorescently labled as described in 2.4.1.. 
Fluorescent signals were imaged with an inverse fluorescence microscope and located based on their 
position on the grid. Samples were subsequently subjected to transmission electron microscopy as 
described in 2.4.2.. Both microscopic images were combined to correlate the fluorescence signal with 
the respective cellular structures detected by TEM. 
2.4.4. T. gondii plaque assay 
Plaque assays, recapitulating successive rounds of lytic cycles [see 1.2.3], were used to examine 
parasite fitness. Confluent HFF cells in 6-well plates were infected with 200-400 parasites/well. 
Parasitized host cells were incubated in standard D10 medium with 10% FCS. For nutrient-depletion 
assays, normal FCS was replaced by dialyzed (PAA) or by lipid-depleted FCS (Biowest) with additives as 
indicated, at the time of infection. After 7 days of unperturbed incubation at 37 °C and 5% CO2, cells 
were washed twice with PBS, fixed with ice-cold methanol for 2 mins, and stained with crystal violet 
for 10 mins. The plaques were imaged and measured using the ImageJ suite. 
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2.4.5. T. gondii replication assay 
Confluent HFF cells cultured on glass coverslips in 24-well plates were infected with tachyzoites (MOI 
= 1), incubated for 12–60 hrs, fixed with 4% PFA, and then immunostained using an anti-TgGap45 
antibody (1:3000; rabbit). The mean numbers of parasites per vacuole were scored to compare the 
replication rates of different strains. 
2.4.6. Annexin binding on Jurkat T-cells 
Clonal Jurkat T-cells (E.61) were grown in RPMI medium supplemented with 10% iFCS, penicillin (10 
U/ml) and streptomycin (100 µg/ml) at 37 °C and 5% CO2 in a humidified incubator. The lymphoblast 
suspensions were grown to a maximum cell density of 6-8 x 105 cells and splitted 1:4 in T-75 cell 
culture flasks. For induction of apoptosis, 1x 106 Jurkat T-cells were resuspended in 1 ml of RPMI 
medium containing 1 µM staurosporine in DMSO or DMSO only for 2 hrs. Cells were harvested by 
centrifugation (400 x g, RT), washed twice with fresh medium and co-incubated with respective T. 
gondii tachyzoites at an MOI = 30 or plain medium as a control. Cells were then resuspended in 100 µl 
of annexin V-FLUOS labelling reagent, stained for 15 min in the dark and fixed for 15 min with 2% 
paraformaldehyde. Cells were washed according to protocol and resuspended in 200 µl HEPES buffer 
for FACS analysis or seeded on poly-L-lysine coated cover slips for microscopic analysis. FACS analysis 
was performed using LSRFortessa cell analyser (BD Biosciences). Parasites and T-cells were 
fractionated based on their cell size prior to analysis of annexin V-FLUOS staining. 
2.4.7. Subcellular fractionation of S. cerevisiae 
Yeast cells were grown to an OD600 of 0.4-0.8 in synthetic uracil-dropout medium supplemented with 
2 mM ethanolamine and 2% galactose. All subsequent steps were performed at 4 °C. Cells were 
washed once with ddH2O and suspended in 50 mM potassium phosphate buffer (pH 6.8) containing 3 
mM EDTA, 0.5 mM PMSF, and 0.25 M sucrose. Cell extract was prepared by disrupting yeast cells with 
glass beads (0.5-mm diameter) using a bead beater (Biospec Products) and removing the beads and 
cell debris by centrifugation (2000 x g, 5 min). Crude mitochondrial preparation was obtained by 
centrifugation of the cell extract at 10.000 x g for 10 mins and two washings with buffer. The resulting 
supernatant was used to obtain the microsomes and cytosolic fractions (100.000 x g, 1 h). Yeast cells 
expressing only mitochondrial ScPSD1 (Δpsd2) were included when indicated, to ascertain the 
efficiency of fractionation. 
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2.4.8. Radioactive phosphatidylserine decarboxylation assay 
PSD activity was measured by trapping 14CO2 (released from Ptd[U-14C]Ser or Ptd[1´-14C]Ser) on filter 
paper impregnated with 2 M KOH. Reaction samples were prepared in 50 mM potassium phosphate 
(pH 6.8) buffer containing 10 mM β-mercaptoethanol, 0.25 M sucrose, 0.5 mM PMSF, 1 mM EDTA, 
and standard protease inhibitors. Ptd[1-14C]Ser was purchased from ICN radiolabelled chemicals 
(USA) or made from L-[1-14C]serine and dioleoyl CDP-diacylglycerol using PtdSer synthase. PtdSer 
synthase was purified from E. coli strain JA-200 harboring the plasmid pPS3155 as described 
previously (115). Briefly, L-[1-14C]-serine was vacuum-dried, suspended in dH20 and mixed with a 4-
fold access of Triton-X solubilized CDP-DAG in 0.1 M KPO4 at pH 7.4, 1 mM DTT, BSA (1 mg/ml) and E. 
coli JA-200 membrane fraction. The reaction was incubated at 37 °C for 1 h in a shaking incubator 
followed by lipid extraction and Ptd[1-14C]Ser-recovery as described in 2.4.11. and liquid scintillation 
counting. 
The PSD assay was performed with either yeast or T. gondii cell extracts at 30 °C or 37 °C in 16x100-
mm borosilicate tubes sealed with an airtight rubber septum holding the KOH-saturated filter paper. 
The 0.8-ml assay mixture contained 60 mM potassium phosphate (pH 6.8), 0.17 M sucrose, 0.35 mM 
PMSF, 2 mM EDTA, 0.5 mM β-mercaptoethanol, 0.5 mM dioleoyl Ptd[U-14C]Ser (0.1µCi/µmol), and 
0.1% (w/v) Triton X-100. The reaction was started by addition of 0.2 ml of the protein fractions and 
terminated after 1 h by addition of 0.5 ml of 0.25 M H2SO4, introduced through the rubber septum 
using a hypodermic needle. The emitted 14CO2 was trapped for 1 h prior to recovering the filter paper 
for liquid scintillation spectrometry. 
2.4.9. Metabolic labelling of T. gondii and host cells 
For metabolic labelling of host-free parasites, HFF cells were infected with tachyzoites (MOI = 3), and 
parasites were collected 42 h post infection. Samples were maintained on ice throughout the parasite 
isolation procedure. Infected cells were passed twice through 27-gauge needles to release the 
parasites, followed by removal of host cell debris by centrifugation (30 x g, 5 min). Parasites in the 
supernatant were pelleted (2000 x g, 10 min) and washed twice with intracellular type medium. Fresh 
extracellular tachyzoites (5 x 107) were incubated with [1,2-14C]ethanolamine (20-40 nCi/nmol) or [1-
3H]serine (1 µCi/nmol) in 1 ml of intracellular type medium in glass tubes (2 h, 37 °C) followed by lipid 
extraction and quantification of radiolabeled phospholipids. To examine the scavenging of host-
derived lipids by intracellular parasites, HFF cells cultured in T-25 flasks were labeled with [1,2-14C]-
ethanolamine (5 µCi, 25 µM) in DMEM containing aforementioned additives and lipid-depleted FCS 
(24 h, 37 °C, 5% CO2). Cells were then infected with tachyzoites (MOI = 2). At the time of infection, 
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cultures were supplemented with a 200-fold excess of unlabeled ethanolamine (5 mM) to dilute the 
residual pool of radioactive ethanolamine in the host cell cytosol, if any. Parasitized cells were 
incubated (48 h, 37 °C, 5% CO2), and the parasites were released using 27-gauge needles. Tachyzoites 
were washed twice with PBS, counted, and subjected to lipid extraction. The total radioactivity 
accumulated in parasite lipids was quantified to deduce the import of host phospholipids by the 
replicating tachyzoites. 
2.4.10. Lipid extraction, separation and analysis 
Lipid extraction from T. gondii was performed using the Bligh and Dyer method (116). Briefly, cells 
were suspended in 1.8 ml water or buffer in a round bottom glass tube. The following chemicals were 
added with subsequent vortexing after each addition: 4 ml methanol, 2 ml chloroform, 1.8 ml 0.2 M 
KCl, 2 ml chloroform. The lipid-containing chloroform-phase was backwashed twice with practical 
upper (CH3OH:KCl (0.2 M):CHCl3 (1:0.9:0.1, v/v)). The lipid-containing chloroform phase was either 
used for liquid scintillation spectrometry or dried under nitrogen gas stream and suspended in 
chloroform and methanol (9:1). Lipids were resolved by one-dimensional TLC on silica gel 60 plates in 
chloroform, methanol, and acetate (65:25:10, v/v/v). To achieve a higher resolution, they were either 
separated twice in chloroform, ethanol, water, and triethylamine (30:35:7:35, v/v/v/v) (117), or by 
2D-TLC using chloroform, methanol and ammonium hydroxyide (30%) (84.5:45.5:6.5, v/v/v) in the 
first dimension and chloroform, glacial acetic acid, methanol and H2O (80:12:9:2, v/v/v/v) in the 
second dimension. Lipids were visualized by iodine or 8-anilino-1-naphthalenesulfonic acid staining 
and/or by autoradiography.  
The lipids were identified based on their co-migration with authentic standards and quantified by 
liquid scintillation counting or by lipid phosphorus assay (118). Briefly, 180 µl of perchloric acid (70%) 
was added to the lipid samples and heated for 30 min at 160-180 °C with a marble as lid. A silica-
blank was added when samples were scraped from TLC-plates. A phosphorous standard series was 
performed using a 1 mM Na2HPO4 stock solution. 1 ml of dH2O was added to samples and standards 
and vortexed followed by the addition of 200 µl ammonium molybdate (2.5 %) and freshly prepared 
ascorbic acid (10%). The reaction was accompanied by yellow colour change. Samples were heated in 
a waterbath at 50 °C for 15 min and developed a blue colour, which was measured at 820 nm using a 
spectral photometer. 
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2.4.11. Preparation of T. gondii secretome and NBD-PSD assay 
As an alternative to the radioactive PSD assay [2.4.8.] fluorescently-labled lipids were used to detect 
the enzymatic activity. For preparation of tachyzoite secretome, T-150 flasks containing HFF cells 
were infected with respective T. gondii strains at MOI = 3. Parasites were syringe released at 40-42 hrs 
p.i., pelleted at 400 x g for 15 min at 4 °C and washed with ICM. The parasite pellet was subsequently 
resuspended in 1 ml ICM containing 1 mM fresh ATP and stored on ice. Samples were counted and 
adjusted to similar parasite numbers (1-1.5 x 107) in 1.2 ml ICM containing 1 mM ATP in a 1.5-ml tube. 
Tachyzoites were allowed to secrete for 2 hrs at 37 °C in a waterbath or with slightly open lid in the 
incubator. Afterwards, parasites were pelleted for 10 min at 2000 x g and 4 °C, and then 1.1 ml of the 
supernatant containing the secreted proteins was transferred to a fresh tube whilst the pellet was 
stored on ice and resuspended in 900 µl ICM. The secretome was centrifuged again for 10 min at 
2000 x g at 4 °C, and subsequently 1 ml of supernatant was transfered to a fresh tube followed by 
another centrifugation step (10 min, 2000 x g, 4 °C) and transfer of 0.9 ml supernatant to a new tube 
to ensure gradual removal of parasites from the final secretome sample. Protease inhibitor cocktail 
was added to the samples, which were then snap-frozen in liquid nitrogen and stored at -80 °C until 
further use. Prior to the NBD-PSD-assay, the samples were thawed on ice and the cell extract was 
generated by repeated freezing and thawing of the pellet in liquid nitrogen/37 °C waterbath and 
vortexing.  
For the preparation of substrate, C6-labled NBD-PtdSer was mixed with L-α-PtdSer to a final 
concentration of 0.5 mM. The substrate was dried in a 15 ml falcon tube under nitrogen gas and 
disolved in 100 µl ICM (+0.1 mM ATP) per reaction and vortexed vigorously for 1 min and sonicated 
twice for 30 s on ice.  900 µl of secretome or cell extract were mixed with 100 µl of substrate. The 5 
mM substrate working stock solution was diluted 1:10 in ICM to a 0.5 mM final concentration in the 
reaction mixture. The reaction was performed for 1-2 hrs at 37 °C in a waterbath and the samples 
were subsequently subjected to lipid extraction and 1D-TLC analysis [2.4.11.]. NBD-PtdSer and NBD-
PtdEtn were used as migration standards and the fluorescent lipids were visualized under UV light. 
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2.5. Bioinformatics and data analyses 
Initial identification of the parasite gene sequences was performed using T. gondii genome database 
(ToxoDB) (55) and NCBI BLAST (119). The TargetP algorithm was used to predict subcellular targeting 
(120). SignalP was used to identify signal peptide sequences and their cleavage sites (121). The 
MitoProt tool is trained to identify mitochondrial proteins (122). PlasmoAP is designed to predict 
apicoplast-targeting sequences in Plasmodium species (123). And the TMHMM algorithm gives a 
general prediction of transmembrane domains (124). CLC sequence viewer was used for protein 
alignments. For phylogenetic analysis, protein sequences were aligned based on the PFAM Hidden 
Markov Modes (PF02666) using hmmer3 (125) and sequences were trimmed using trimAl (126). The 
phylogenetic tree was built using PhyML (127) and the LG model for amino acid substitution. Data 
plotting and statistical analyses were performed using the GraphPad Prism suite. All assays presented 
in this study were performed at least three independent times unless specified otherwise. The error 
bars in the figures represent the standard error of the mean. Statistics were done using the student’s 
t-test, ANOVA, or one-way variance tests (*, p<0.05, **, p<0.01; ***, p<0.001) using Graphpad Prism, 
as indicated in respective figure legends. 
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3. Results 
3.1. T. gondii encodes multiple pathways to synthesize phosphatidylethanolamine 
Previous studies have shown that tachyzoites are capable of producing PtdEtn from ethanolamine 
and serine as precursors, the latter of which involves phosphatidylserine decarboxylation (92). 
However, the identity of the underlying enzymes remained undefined. 
To investigate whether the T. gondii genome encodes the enzymes that are responsible for the de 
novo synthesis of PtdEtn, as described in other eukaryotic organisms [see 1.3.2.], database mining 
was performed using the Toxoplasma genome database (ToxoDB.org) (55). S. cerevisiae orthologs 
(128) were used to screen for the respective candidate genes in the Toxoplasma genome applying 
BLAST algorithms [Tab. 2]. It was found that the parasite encodes a complete set of coding genes to 
putatively perform an autonomous PtdEtn synthesis via PtdSer-decarboxylation and the CDP-
ethanolamine-pathway [Tab. 2].  
 
Table 2: Genes encoding putative enzymes for the synthesis of PtdEtn in T. gondii 
ToxoDB  
accession no. 
Gene  
description 
Protein 
length 
[amino 
acids] 
Genomic  
location 
Protein 
identities/positives 
[compared to Yeast via 
BlastX] 
Abbreviations 
used in this 
study 
TGGT1_225550 phosphatidylserine decarboxylase 427 Chr. X 
37%/55% 
 [ScPsd1p; GI:584373840] TgPSD1mt 
TGGT1_269920 phosphatidylserine decarboxylase 968 Chr. VIII 
37%/51% 
 [ScPsd1p; GI:584373840] TgPSD1pv 
TGGT1_306540 phosphotransferase enzyme family protein 547 Chr. X 
24%/40% 
 [ScEki1p; GI:628157091] TgEK 
TGGT1_310280 phosphoethanolamine-cytidyltransferase 1128 Chr.XI 
37%/52% 
 [ScEct1p; GI:766989628] TgECT 
TGGT1_261760 
CDP-alcohol 
phosphatidyltransferase 
superfamily protein 
449 Chr. VIIb 
30%/47% 
 [ScCpt1p; GI:767249243] TgEPT1 
TGGT1_257510 
CDP-alcohol 
phosphatidyltransferase 
superfamily protein 
467 Chr. VIIb 
33%/53% 
 [ScEpt1p; GI:768505096] TgEPT2 
 
The candidate proteins for PtdEtn-synthesis in T. gondii showed sequence similarities of 
approximately 50% to the queried yeast sequences that were used as a basis for further analyses. The 
parasite encodes two phosphatidylserine decarboxylases located on different chromosomes, which 
differ significantly in their sequence parameters. Consistent with the presence of an active 
ethanolamine kinase (TgEK) and a bifunctional choline kinase, which can also use ethanolamine as 
substrate (100), the parasites encodes a putative phosphoethanolamine-cytidyltransferase (TgECT), a 
phospocholine-cytidyltransferase (TgCCT) (94) and two CDP-alcohol phosphatidyltransferase proteins 
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(TgEPT), which could perform the second and last reaction of the three-stepped Kennedy pathway 
[see 1.3.4.].  
It should be noted that the annotated gene sequences were partially incomplete especially at their 5´ 
end at the beginning of this study. Therefore the start-codons had to be tested, sequenced and 
annotated by PCR and sequencing. Genome annotations have been significantly improved in the 
meantime, confirming the acquired cDNA sequences. Initial sequence screens were based on the 
genome of the T. gondii ME49 strain, which was best described and annotated in the ToxoDB. PCR 
primers for cDNA cloning were generated based on the T. gondii GT1 strain, however. This strain is 
more closely related to the T. gondii RH strain routinely used in the laboratory (129). The cDNA 
sequences used in this study and the ToxoDB accession numbers are attached in appendix 1. 
3.1.1. Predicted subcellular localizations of PtdEtn-synthesis proteins 
To predict the subcellular localization of the candidate proteins, a diverse set of in silico tools was 
applied. The information was subsequently used to compare the localizations with the corresponded 
targeting in other organisms and to design an appropriate tagging-strategy for microscopic detection.  
 
Table 3: Predicted subcellular localization of putative PtdEtn synthesis proteins 
mTP = mitochondrial targeting peptide; SP = Signal Peptide. [see also materials and methods section 2.5.]. 
Protein TargetP SignalP MitoProt PlasmoAP TMHMM 
TgPSD1mt 
0.859 mTP 
0.023 SP 
0.244 other 
No SP 
0.9850 
(Cleavage site: 
A 97^ S 98) 
No 0 
TgPSD1pv 
0.122 mTP 
0.960 SP 
0.012 other 
Yes 
(Cleavage site: 
S25^V26) 
0.9292 No 1  (= SP) 
TgEK 
0.662 mTP 
0.059 SP 
0.333 other 
No SP 0.2578 No 0 
TgECT 
0.688 mTP 
0.189 SP 
0.346 other 
No SP 0.3397 No 0 
TgEPT1 
0.227 mTP 
0.226 SP 
0.490 other 
No SP 0.0686 No 7 
TgEPT2 
0.208 mTP 
0.427 SP 
0.397 other 
No SP 0.1617 No 9 
 
Using different algorithms, TgPSD1mt was predicted to localize in the parasite mitochondrion (98,5%), 
which is in agreement with the localization of most PSD proteins in other eukaryotes (83,130). 
TgPSD1pv has contradictory predictions of being potentially localized in the mitochondrion (~93%) 
but also carrying a signal peptide with a very high probability (96%) [Tab. 3]. In fungi and plants 
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however, additional non-mitochondrial PSD proteins have been identified localizing to the Golgi and 
vacuolar/endomambrane compartments (131-134). The expression of a single, but non-
mitochondrial PSD enzyme was also reported in Plasmodium falciparum (135). The proteins of the 
CDP-Ethanolamine pathway could not be clearly allocated to a certain subcellular compartment. But 
ethanolamine kinases are known to be cytosolic in other organisms (136,137) including T. gondii (94). 
ECT enzymes are considered to be mainly soluble cytosolic but can also interact with nuclear and ER 
membranes (138). Consistently, TgCCT showed nuclear localization in tachyzoites as well (94). The 
final reaction of the CDP-ethanolamine pathway is known to take place in the ER in other eukaryotes 
(81,137). No signal peptide or ER-retention signals could be identified by the used prediction tools in 
the two T. gondii EPT candidate proteins however [Tab. 3]. Unlike the other proteins, both EPTs 
harbour 7 and 9 predicted transmembrane domains, respectively [Tab. 3]. 
To gain insight into the biological importance of the candidate proteins, they were analyzed for 
functional domains and post-translational modifications as well as for transcript and protein 
abundance in different T. gondii life cycle stages, including tachyzoites, bradyzoites and oocysts.  
 
Table 4: Catalytic domains, expression and modification of enzymes for PtdEtn synthesis 
Tz = tachyzoites; Bz = bradyzoites; Ooc = Oocysts  
Protein Interpro domains Transcript detection 
MS-based 
 expr. 
evidence 
 in Tz 
Post-transl.  
modifications 
TgPSD1mt 
PF02666 
Phosphatidylserine 
Decarboxylase 
Tz 
Bz 
Ooc 
Yes --- 
TgPSD1pv 
PF02666 
Phosphatidylserine 
Decarboxylase 
Tz 
Bz 
Ooc 
Yes --- 
TgEK PF01633 Choline/ethanolamine kinase 
Tz 
Bz 
Ooc 
Yes 14 phosphoryl. sites 
TgECT PF01467 Cytidylyltransferase 
Tz 
Bz 
Ooc 
Yes 25  phosphoryl. sites 
TgEPT1 
PF01066 
CDP-alcohol 
phosphatidyltransferase 
Tz 
Bz 
Ooc 
Yes 6  phosphoryl. sites 
TgEPT2 
PF01066 
CDP-alcohol 
phosphatidyltransferase 
Tz 
Bz 
Ooc 
Yes 3 phosphoryl. sites 
 
As shown in table 4, all enzymes were expressed during the three considered stages of T. gondii, 
indicating a requirement of PtdEtn synthesis throughout the parasite life cycle. The presence of 
functional domains and the expression evidence in tachyzoites was a good prerequisite for the 
experimental characterizations in terms of their subcellular localization, enzymatic function and 
biological relevance. 
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3.1.2. Phylogenetic origin of phosphatidylserine decarboxylases in T. gondii 
To analyse the phylogenetic context of the two PSD homologs in Toxoplasma, a phylogenetic analysis 
of various PSD enzyme sequences was performed. Therefore, a maximum likelihood tree (127) of 
various pro- and eukaryotic, pathogenic- and non-pathogenic organisms was generated [Fig. 9]. The 
PS decarboxylase PFAM domain PF02666 was used as a basis for the protein alignments. 
 
 
Figure 9: TgPSD1mt and TgPSD1pv are of different phylogenetic origin. 
Phylogenetic clades of TgPSD1mt, TgPSD1pv, and orthologs. Branch support was estimated by 100 bootstrap 
replicates. AtPSD1, Arabidopsis thaliana (GI 42566885); AtPSD2, A. thaliana (GI 240256448); AtPSD3, A. 
thaliana (GI 186513660); BmPSD, Babesia microti (GI 399218717); BpPSD, Bordetella pertussis (GI 33592417); 
CaPSD1, Candida albicans (GI 68473808); CaPSD2, C. albicans (GI 68468048); DrPSD, Danio rerio (GI 63102372); 
EcPSD, E. coli (GI 15804752); EfPSDa, Eimeria falciformis (unpublished); EfPSDb, E. falciformis (unpublished); 
FcPSD, Felis cattus (GI 410976945); HsPSD, Homo sapiens (Q9UG56); MmPSD, Mus musculus (GI 74195621); 
NcPSDa, Neospora caninum (GI 401409734); NcPSDb, N. caninum (GI 401408937); OsPSD, Oryza sativa (GI 
115450115); PfPSD, Plasmodium falciparum (XP_001352149), PpPSD, Physcomitrella patens (GI 168030155); 
PsPSD, Picea sitchensis (GI 116788855); ScPSD1, S. cerevisiae (GI 6324160); ScPSD2, S. cerevisiae (GI 841244); 
SmPSDa, Selaginella moellendorffii (GI 302802812); SmPSDb, S. moellendorffii (GI 302818837); VcPSD, Vibrio 
cholera (GI 446280068); XlPSD, Xenopus laevis (GI 148236972); YpPSD, Yersinia pestis (GI 22124534). 
The indicated PSD orthologs from different organisms show a distinct clustering pattern and were 
therefore categorized into prokaryotic, eukaryotic type I (mitochondrial) and eukaryotic type II PSDs. 
The phylogenetic clustering showed that TgPSD1mt belongs to the eukaryotic type I PSD enzymes, 
and is distinct from the TgPSD1pv protein. Database search identified only one PSD in most protozoan 
parasites, except for a small subgroup of coccidians (Eimeria, Hammondia, Neospora), which express 
two discrete PSD enzymes related to TgPSD1mt and TgPSD1pv. TgPSD1pv can therefore be considered 
as a coccidian-specific subtype of PSD enzymes [Fig. 9]. 
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Alignment of TgPSD1mt with P. falciparum and human orthologs revealed a fairly high conservation, 
particularly in the PSD domain [Fig. 10]. TgPSD1mt is 40% identical (62% similar) to PfPSD and 35% 
identical (51% similar) to HsPSD. The PSD proenzymes in prokaryotes as well as in eukaryotes are 
proteolytically processed between the G and S residues into a membrane-anchored β-subunit and a 
smaller α-subunit harboring the pyruvoyl-moiety at its N-terminus (139,140). The pyruvoyl prosthetic 
group is part of the active site and needed for the catalytic function of PSD enzymes (83). A similar 
processing of TgPSD1mt is predicted to yield a mature protein with ~32-kDa β-subunit and ~6-kDa α-
subunit, when cleaved at the predicted LG^ST motif [Fig. 10]. 
 
Figure 10: TgPSD1mt shares sequence homologies with type I PSDs. 
Alignment of PSD sequences from T. gondii (TgPSD1mt), P. falciparum (PfPSD) and H. sapiens (HsPSD). Entirely 
and partially conserved residues are shown in dark and light blue, respectively. The green and red boxes 
represent the predicted mitochondrial targeting peptide and conserved cleavage motif at the catalytic site, 
respectively. The PSD domain in TgPSD1mt spans from 184-408 (PFAM domain PF02666). TgPSD1mt and PfPSD 
have extended C-termini. NCBI accession numbers: TgPSD1mt, DQ450198; PfPSD, XP_001352149; HsPSD, 
Q9UG56. 
The second PSD, TgPSDpv, cannot be adequately aligned to PSD orthologs, other than from the 
coccidian PSD subgroup, which are all relatively big proteins showing a conserved FG^ST motif at the 
active site [Appendix 2B]. 
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3.2. Phosphatidylserine decarboxylases localize to distinct organelles 
To assess the subcellular localization of the two PSD enzymes of T. gondii, we performed different 
tagging approaches using a C-terminal fused haemagglutinin-tag under different promotors, and co-
localized their expression-patterns with established organelle markers. 
3.2.1. TgPSD1mt is localized in the mitochondrion of T. gondii tachyzoites 
To determine TgPSD1mt localization, the ORF was amplified from T. gondii cDNA and cloned 
downstream of the TET07SAG1 promotor flanked by the 5´and 3´UTR elements of the TgUPRT gene. 
The sequence of TgPSD1mt was verified by PCR and sequencing (NCBI accession number DQ450198). 
Parasites expressing a single copy of the C-terminally tagged TgPSD1mt-HA protein show a clear 
mitochondrial localization in intracellular as well as in extracellular parasites as verified by co-staining 
with TgS933-159-GFP, an established mitochondrial marker (104) [Fig. 11]. 
 
Figure 11: Ectopic expression of TgPSD1mt-HA in intracellular and extracellular tachyzoites. 
Immunofluorescence imaging of intracellular parasites 24 hrs post infection, and fresh extracellular parasites of 
the Δku80/TaTi strain. The complete TgPSD1mt ORF with the predicted mTP and a C-terminally fused HA 
epitope-tag was expressed under the control of the pTETO7SAG1 promoter at the UPRT locus of T. gondii. 
Stable transgenic parasites expressing TgPSD1mt-HA were co-transfected with a plasmid encoding for the 
mitochondrial marker TgS933-159-GFP (green) and stained with anti-HA/Alexa594 (red) antibodies as described in 
materials and methods. DIC = differential interference contrast, HA = haemagglutinin, mTP = mitochondrial 
targeting peptide 
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Because ectopic expression of a protein is prone to localization artefacts, we generated stable 
transgenic parasites by 3’-HA tagging of the TgPSD1mt gene, which subsequently expressed 
TgPSD1mt-HA under the control of its native promoter [Fig. 12]. Immunostaining of the intracellular 
parasites showed a clear mitochondrial localization of TgPSD1mt-HA, which co-localized with a known 
organelle marker, the mitochondrial ATPase subunit TgF1B (105). 
 
Figure 12: 3´-insertional-tagging of TgPSD1mt confirms its mitochondrial localization. 
Genomic tagging of the TgPSD1mt gene and immunofluorescence imaging of intracellular parasites expressing 
TgPSD1mt-HA under the control of its endogenous promoter and TgGra2-5´UTR. The construct for 3´-HA tagging 
of TgPSD1mt (pTKO-HXGPRT-TgPSD1mt-3´IT) was transfected and selected in the Δku80-Δhxgprt strain. 
Parasitized cells were stained with anti-HA and anti-TgF1B antibodies after 24 h of infection. COS = crossover 
sequence; mTP = mitochondrial targeting peptide; R.C. = resistance cassette 
We next tested the importance of the predicted mitochondrial targeting peptide for localization and 
enzymatic activity [see 3.4.2.], by expressing two HA-tagged deletion variants of TgPSD1mt lacking 
the N-terminal peptide (TgPSD1mt(91–427)-HA and TgPSD1mt(113–427)-HA). None of the two truncated 
forms localized in the parasite mitochondrion, and displayed a diffuse fluorescence throughout the 
parasite body instead [Fig. 13]. 
Taken together, these localization studies demonstrate that TgPSD1mt is indeed a mitochondrial 
protein in T. gondii tachyzoites, as suggested from in silico analyses [see 3.1.] and that the predicted 
mitochondrial targeting peptide is crucial for correct subcellular localization. 
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Figure 13: The mTP-deletion variants of TgPSD1mt-HA fail to localize in the mitochondrion. 
Immunofluorescence imaging of the two truncated HA-tagged TgPSD1mt forms (TgPSD1mt(91– 427)-HA and 
TgPSD1mt(113– 427)-HA) expressed in T. gondii tachyzoites of the Δku80-Δhxgprt strain under the control of the 
TETO7SAG1 promoter. Intracellular parasites were stained using anti-HA (green) and anti-TgF1B (red) antibodies 
after 24 h of infection. 
3.2.2. TgPSD1pv is secreted into the parasitophorous vacuole via dense granules 
Since the bioinformatical prediction did not reveal a clear indication for the subcellular localization of 
TgPSD1pv, and due to the observation that this protein seems to be highly divergent from other PSD 
enzymes, the determination of its localization was particularly crucial. The full length ORF of 
TgPSD1pv was amplified from tachyzoite cDNA and sequenced (annotated at NCBI as accession 
number JN003619). For localization studies, the protein was expressed in T. gondii tachyzoites, C-
terminally fused with a HA-tag (TgPSD1pv-HA) under the control of the TgNTP3 promoter [Fig. 14]. 
Immuno-staining of the transgenic parasites present within the host cell revealed that TgPSD1pv was 
secreted into the parasitophorous vacuole. The secreted PSD co-localizes with TgGra1, TgGra3 and 
TgGra5, which are bona fide markers of the dense granules and secreted into the parasitophorous 
vacuole (141). TgGra1 is completely soluble within the vacuolar space (43), and TgGra3 and TgGra5 
are associated with the vacuolar membranes (108,142). Depending on the focal plane used for 
microscopic imaging, TgPSD1pv was detectable within the dense granules of the intracellular 
parasites as well as in the vacuolar space and at the vacuolar membrane [Fig. 14A]. Fluorescence 
images of parasites after their release from host cells [Fig. 14B] reveal co-localization of TgPSD1 with 
TgGra1 and TgGra3. These results confirm that TgPSD1pv resides in the dense granules of T. gondii, 
prior to its secretion into the parasitophorous vacuole. 
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Figure 14: TgPSD1pv is stored in the dense granules and secreted into the PV. 
Immunofluorescent co-localization of TgPSD1pv with dense granule proteins in intracellular (panel A) and 
extracellular parasites (panel B). Purified tachyzoites of the TaTi strain (1x106) were transfected with the 
TgPSD1pv-HA expression construct under the control of pNTP3 elements. Stable pyrimethamine-resistant 
transgenic lines were generated prior to immuno-fluorescence detection using the indicated antibodies. A 
schematic version of the TgPSD1pv construct is shown with the signal peptide (SP), core enzyme (TgPSD1pv) 
and epitope tag (HA) domains highlighted.  
Since the overexpression of proteins under a strong promotor, like pNTP3, could have misdirected 
TgPSD1pv into the secretory pathway, as shown for micronemal proteins (143), we additionaly 
expressed the TgPSD1pv-HA protein under its native promotor. Stable integration of TgPSD1pv was 
achieved at the TgUPRT-locus. The respective immunofluorescence analysis confirmed its secreted 
nature and co-localization with the dense granule protein TgGra5 [Fig. 15]. 
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Figure 15: Localization of TgPSD1pv in the parasitophorous vacuole under its endogenous promotor element. 
Intracellular parasites stained for TgPSD1pv-HA expression under the control of its native promoter and 
TgNTP3-3´UTR at the UPRT locus. The parasite periphery is stained by anti-TgGap45 antibody (red, upper panel), 
whereas the TgGra5 antibody stains the PV lumen (green, lower panel). SP = signal peptide. 
Electron microscopic analyses were performed to examine whether TgPSD1pv binds to intravacuolar 
membranes and/or the PV membrane after its secretion. Unfortunately, the detection of the HA-tag 
using immuno-gold-labelling was not successful. Therefore, correlative microscopy was used, 
combining immune-fluorescence and transmission electron microscopy [Fig. 16]. 
The correlation of the fluorescence signal with the electron micrograph showed that TgPSD1pv is 
located in the PV lumen [Fig. 16D], as well as at the PV membrane. No definite conclusion could be 
drawn whether the protein binds to the intra-vacuolar or PV membrane structures. In comparison to 
TgGra5 (108), which accumulated at the parasite and PV surface, TgPSD1pv showed a more diffused 
localization pattern within the PV space [Fig. 16B]. No fluorescence signal within the parasite interior 
(dense granules) was detected with both antibodies in this experiment. 
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Figure 16: Localization of TgPSD1pv-HA in the parasitophorous vacuole by correlative imaging. 
(A) HFF cells infected T. gondii tachyzoites stabily expressing pUPKO-pTgPSD1pv-TgPSD1pv-HA grown on a 
gridded glass cover slip were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M cacodylate 
buffer 24 h post infection. (B) Samples were used for immuno-fluorescence analysis with anti-HA (green) and 
anti-TgGra5 antibodies (red). (C) The same vacuole was subsequently analysed by transmission electron 
microscopy (TEM). (D) Merge of TgPSD1pv-HA fluorescence and TEM-image. 
 
 
These results also coincide with previous biochemical experiments showing two pools of PSD activity 
in T. gondii tachyzoites, of which one is soluble and the other membrane-bound. They also confirm 
previous data for the presence of a secreted PSD activity in axenic parasites (103). 
 
3.3. Expression and subcellular localization of TgPSD enzymes in COS-7 cells 
To assess the localization of the two parasite enzymes in mammalian cells, the cDNAs of TgPSD1mt 
and TgPSD1pv were cloned into the pCDNA3.1 vector and transfected into COS-7 cells, derived from 
monkey kidney tissue. Transgenic COS-7 cells expressed the C-terminally V5-tagged parasite proteins.  
TgPSD1mt-V5 revealed a mitochondrial localization, as verified by co-localization with mitotracker 
reagent. Additionally, the protein showed a nuclear (membrane) localization [Fig. 17A]. TgPSD1pv 
showed a diffuse expression in the parasite cytosol or endomembrane system and partial co-
localization with the anti-KDEL antibody designating ER and Golgi compartments [Fig. 17B].  
A stable expression of both proteins in the COS-7 cell line by drug-selection with geneticine was not 
successful, however. Prolonged cultivation under drug-selecton led to impaired cell viability and the 
eventual loss of the V5-signal, which impeded further analysis of the catalytic activity in this cell line. 
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Figure 17: TgPSD1mt localizes to the mitochondria and nucleus and TgPSD1pv to the endomembrane system 
in monkey kidney fibroblasts. 
TgPSD1mt and TgPSD1pv cDNAs fused to a C-terminal V5-tag were expressed in COS-7 cells under the control of 
the CMV promotor. Cells were fixed 48 hrs post-transfection for immunofluorescence analysis with an anti-V5 
antibody. (A) For mitochondrial visualization cells were stained for 20 min with 10 nM Mitotracker reagent in 
serum-free DMEM prior fixation. (B) For co-localization of TgPSD1pv-V5, an anti-KDEL antibody was used to 
stain endomembrane compartments. 
These localization studies demonstrate that the mitochondrial targeting peptide of TgPSD1mt allows 
mitochondrial expression of TgPSD1mt in a mammalian system. TgPSD1pv is targeted to the cytosol 
or endomembrane compartments in COS-7 cells. 
However, the use of a different heterologous expression system was needed for stable expression of 
these parasite proteins for their functional analysis. 
3.4. TgPSD1mt can functionally complement a S. cerevisiae PSD mutant 
To verify the catalytic function of the predicted PSD enzymes expressed in T. gondii, TgPSD1mt and 
TgPSD1pv were expressed in a S. cerevisiae mutant strain lacking its endogenous psd1 and psd2 
genes. The yeast Δpsd1Δpsd2 strain is auxotrophic for ethanolamine, which can be utilized to produce 
PtdEtn via the Kennedy pathway in the ER [Fig. 18]. 
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Figure 18: Schematic overview of the phospholipid synthesis in S. cerevisiae 
Yeast expresses two PSD enzymes, ScPSD1 and ScPSD2 to produce PtdEtn from PtdSer in its inner mitochondria 
and the Golgi apparatus, respectively. The last reaction of the three-stepped CDP-Etn pathway is located in the 
ER generating PtdEtn. Exchange of PtdSer and PtdEtn between the organelles requires membrane contact sites 
and lipid transfer proteins (PstA/B and PeeA/B routes). [Adapted from Voelker (144)] 
Different variants of the parasite PSDs were amplified from cDNA and cloned into the pESC-Ura 
vector, which allowed expression under the control of the galactose-inducible ScGAL10 promotor. The 
transformed yeast strains were then examined for their growth under ethanolamine starvation. 
3.4.1. TgPSD1mt is expressed in its active form in yeast mitochondria 
TgPSD1mt cDNA was expressed in the Δpsd1Δpsd2 yeast mutant strains BY23480 and PTY44. Empty 
vector and ScPSD1-expression plasmid served as negative and positive controls, respectively [Fig. 19]. 
As expected, all transgenic yeast strains were able to grow in ethanolamine-replete conditions. The 
empty-vector negative control did not show any detectable growth in ethanolamine-free medium, 
whereas TgPSD1mt and ScPSD1 rescued the growth of the mutant in a galactose-inducible manner 
[Fig. 19A].  
Next, subcellular fractions of the transgenic yeast strains were produced to determine the 
distribution of TgPSD1mt in the mitochondrial, microsomal and cytosolic fractions. A Δpsd2 yeast 
strain (JSY9750), expressing only the native ScPSD1 in the mitochondria, was included to ascertain a 
successful fractionation [Fig. 19B]. Each fraction was used to perform PSD assays by trapping 14CO2 
that was released by decarboxylation of radioactive PtdSer. As anticipated, the Δpsd1Δpsd2 mutant 
harbouring the empty vector did not show any measurable activity, and overexpression of TgPSD1mt 
via the ScGAL10 promoter was quite evident when compared to the positive control. Similar to 
ScPSD1 (131,145), a majority of the recovered TgPSD1mt activity (>80%) was expressed in the 
mitochondria-enriched fraction.  
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Figure 19: TgPSD1mt can rescue the growth of a S. cerevisiae mutant lacking its endogenous PSD activity. 
(A) Yeast complementation by heterologous expression of TgPSD1mt in a S. cerevisiae Δpsd1Δpsd2 mutant 
(BY23480). TgPSD1mt was expressed under the control of the ScGAL10 promotor. Empty pESC-Ura and ScPSD1-
expression vectors were included as negative and positive controls. (B) PSD activity in subcellular fractions of 
the yeast strains expressing TgPSD1mt, or endogenous ScPSD1, or harbouring empty vector. Indicated 
organelle-enriched fractions were subjected to PSD enzyme assays. ND, not detectable 
To validate the specificity of the complementation, we allowed yeast cells to lose the plasmid by 
growing for several generations without selection pressure in full growth medium and subsequent 
analysis under different selective conditions via replica plating. As a result, cells that lost the vector 
also lost their ability to grow on uracil-dropout plates, as well as in ethanolamine-deficient non-
selective medium [Fig. 20].  
These results verify the predicted specific enzymatic function of the mitochondrial PSD enzyme of T. 
gondii in baker’s yeast. 
 
Figure 20: Loss of TgPSD1mt results in a phenotypic reversion of the Δpsd1Δpsd2 S. cerevisiae mutant. 
The transgenic yeast strain BY23480 (Δpsd1Δpsd2) expressing TgPSD1mt was grown in non-selective medium 
for multiple generations, and plated on the indicated media to screen for the colonies that had lost or retained 
the plasmid. Colonies in dotted circles show a plasmid loss and subsequent reversion to ethanolamine 
auxotrophy, whereas colonies fully circled retained the plasmid and grow in the absence of ethanolamine. 
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3.4.2. TgPSD1mt is active in yeast irrespective of its mitochondrial localization 
We also expressed TgPSD1mt(113-427) in the Δpsd1Δpsd2 strain of yeast to test the role of the N-
terminal sequence for its catalytic activity and subcellular distribution. Notably, the truncated enzyme 
was catalytically active and functionally complemented the yeast growth in ethanolamine-free 
cultures [Fig. 21A], even though most of the TgPSD1mt(113-427) activity (>70%) was present in the 
microsomes and ~13% was cytosolic [Fig. 21B]. Only ~17% of the total enzyme activity was 
distributed in the mitochondria-enriched fraction. 
These assays demonstrate that the N-terminal mitochondrial targeting peptide of TgPSD1mt is 
required for its mitochondrial localization but not for the catalytic function in yeast. 
 
Figure 21: The mitochondrial targeting peptide in TgPSD1mt is required for an efficient localization but not 
for enzyme activity in S. cerevisiae. 
(A) Complementation of S. cerevisiae Δpsd1Δpsd2 mutant (PTY44) by TgPSD1mt(113-427) in medium containing 2% 
lactate / 0.5% galactose.  Empty pYES2.1 and ScPSD1-expression vectors were used as negative and positive 
controls. (B) Enrichment of the PSD activity in subcellular fractions of yeast cells expressing TgPSD1mt or 
TgPSD1mt(113-427). The PSD assay was performed by radioactive 
14CO2-trapping. 
 
3.4.3. TgPSD1pv is not able to complement for PSD function in S. cerevisiae 
We also tested TgPSD1pv for its ability to rescue the growth of the aforementioned yeast Δpsd1Δpsd2 
mutant strains. Our initial attempts to complement the S. cerevisiae BY23480 strain by the expression 
of full lengh TgPSD1pv cDNA were futile, unlike ScPSD1 and TgPSD1mt, that were used as positive 
controls [Fig. 22]. Based on the assumption that the predicted signal peptide of TgPSD1pv could 
mistarget the protein in yeast, we replaced the N-terminal targeting sequence by a yeast 
mitochondrial targeting peptide (Scmtp). Additionally, we expressed truncated forms of TgPSD1pv 
carrying only the catalytic domain (CD, 392 – 730 AA) fused with or without Scmtp [Fig. 22A]. 
Targeting of the T. gondii proteins to yeast mitochondria inhibited growth of the respective mutants 
even under uninduced culture conditions [Fig. 22A, 4-6]. We also expressed full length TgPSD1pv and 
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TgPSD1pv-CD in a different Δpsd1Δpsd2 yeast strain (PTY44), growing on a non-fermentable carbon 
source [Fig. 22B]. However, none of the TgPSD1pv variants were able to restore the growth of the 
mutant strains on ethanolamine-free media [Fig. 22]. 
 
 
Figure 22: TgPSD1pv fails to rescue Δpsd1Δpsd2 yeast mutants. 
(A) Different versions of TgPSD1pv were cloned in the pESC-Ura vector and expressed in the yeast BY23480 
strain. ScPSD1 and TgPSD1mt served as positive and the empty vector as negative control. Galactose-
supplemented media was used for induction of protein expression. (B) TgPSD1pv and TgPSD1pv-CD were 
expressed in the PTY44 strain on the pYES2.1 vector and lactate as a carbon source. Galactose was used to 
induce expression via the ScGal10 promotor. Scmtp = S. cerevisiae mitochondria targeting peptide, CD = 
catalytic domain (392 – 730 AA). 
3.5. Overexpression of TgPSD1pv in T. gondii  
Due to the fact that heterologous expression of TgPSD1pv in yeast had been futile, a parasite strain 
overexpressing the protein under control of a strong promotor (pNTP3) [see 3.2.2.] was further 
analysed for its PSD activity to verify the enzymatic identity and behaviour of TgPSD1pv. 
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3.5.1. The TgPSD1pv overexpression strain displays a many-fold higher PSD activity 
To examine whether the pNTP3-TgPSD1pv-HA strain indeed displays an increased PtdSer 
decarboxylation, we incubated extracellular parasites or secretome of the transgenic strain with 
fluorescent NBD-PtdSer and performed lipid extraction and thin-layer chromatography [Fig. 23]. 
 
 
Figure 23: The pNTP3-TgPSD1pv-HA strain shows increased decarboxylation of NBD-PtdSer 
Fresh syringe-released tachyzoites of the pNTP3-TgPSD1pv-HA and parental strain were incubated in ICM 
medium for the collection of secretome as described in the scheme. After centrifugal separation, extracellular 
parasites and secretome were used for NBD-PSD assays. Fluorescent lipids were resolved by TLC and detected 
with UV light. 
The observation that the TgPSD1pv-HA mutant converted a higher amout of PtdSer substrate into 
PtdEtn, indicated the overexpression of a functional and secretory PSD enzyme [Fig. 23]. 
To quantify the overexpression, the transgenic tachyzoites were fractionated into soluble and 
membrane-bound proteins by ultra-centrifugation [Fig. 24A]. Uninfected host cells and the parental 
strain were used alongside as controls. 
Immunoblotting of the subcellular fractions revealed that the majority of TgPSD1pv-HA is found in 
the high speed pellet (HSP), containing membranes and dense granules. The enzyme was detectable 
almost excusively in its processed form (~33 kDa α-subunit), which indicated that nearly all of the 
proenzyme was efficiently processed to the mature enzyme [Fig. 24B,C]. A schematized protein 
structure and its predicted processing compared to the yeast PSD2 enzyme, which is composed of a 
large β- and a very small α-subunit, is shown in appendix 3. 
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The overexpression of TgPSD1pv-HA was quantified by measuring the enzyme activity in the 
subcellular fractions isolated of infected HFF cells. The transgenic strain displayed a ~10-fold higher 
PSD activity in homogenates compared with the parental strain and ~20% of the enzymatic activity 
was detectable in the soluble protein fraction represented in the HSS [Fig. 24D]. 
 
 
Figure 24: Overexpression of TgPSD1pv causes a 10-fold higher PSD activity in T. gondii. 
(A) Experimental setup of the cell fractionation procedure. HFF cells infected with the parental (TaTi) strain or 
the transgenic TgPSD1pv-HA overexpression strain were used to generate cell free extract (CFE) that was further 
separated into a high speed supernatant (HSS) and a high speed pellet (HSP) by ultra centrifugation. Uninfected 
HFF cells were used as a control. (B) Scheme of the TgPSD1pv protein and its predicted processing. (C) Cell 
fractions were analyzed by Western Blot using anti-HA (1:500) and anti-TgActin (1:1000) antibodies. (D) The PSD 
activity of the homogenates and cell fractions were used to measure PSD activity with [14C]dioleoyl-PtdSer (2 
nCi/nmol, solubilized in 0,1% Triton X-100). 
The respective parasite strains were further analysed for PSD activity in the soluble secreted protein 
fractions [Fig. 25]. The transgenic TgPSD1pv-HA strain secreted ~10-times more soluble PSD activity 
than the parental strain, and neither strain showed a significant amount of active PSD in the 
secretome, when active secretion was inhibited by low temperature. 
Collectively, the data confirm the activity of TgPSD1pv as well as its soluble and secreted nature in T. 
gondii. 
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Figure 25: Overexpression of TgPSD1pv leads to 
an increased secretion of soluble PSD activity. 
Freshly released extracellular parasites were used 
to prepare the high speed supernatant (HSS) from 
the parasite secretome collected after secretion 
at 4 °C and 37 °C respectively. The PSD activity in 
the soluble secreted fraction was assayed for 2 
hrs at 37 °C in intracellular type medium (ICM) 
using [14C]dioleoyl-PtdSer (2 nCi/nmol, 0.2 mM 
solubilized in 0.1% Triton X-100). 
 
3.5.2. TgPSD1pv can perform interfacial catalysis at mammalian plasma membranes 
In an effort to understand the biological role of TgPSD1pv, we examined the ability of the secreted 
enzyme to act upon PtdSer exposed on cell surfaces. Therefore, we compared the amounts of 
externalized PtdSer present on Jurkat T-cells treated with staurosporine, either in the absence or 
presence of axenic parasites secreting TgPSD1pv. Staurosporine elicts an apoptotic host cell response 
that induces PtdSer externalization at the plasma membrane (146). The exposed PtdSer was detected 
by measuring fluorescent annexin binding (147) [Fig. 26]. 
Cultures of DMSO-treated control Jurkat cells contained a minor population of cells that stained with 
fluorescent annexin V, detected by microscopy and cell sorting. Treatment of cells with staurosporine 
increased the annexin staining in almost the whole cell population. When drug-treated cells were 
exposed to wild type parasites for 2 hrs, the annexin binding remained unchanged. In contrast, a co-
incubation with transgenic T. gondii overexpressing TgPSD1pv caused a significant 34% reduction of 
fluorescence intensity of staurosporine-treated cells [Fig. 26B]. 
These experiments reveal that under the given experimental conditions, TgPSD1pv can reduce the 
amount of surface PtdSer present on host cells. From a biochemical perspective, the data show that 
the interfacial catalysis performed by TgPSD1pv with a liposomal substrate (103) is recapitulated with 
PtdSer present in the exofacial leaflet of plasma membranes. 
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Figure 26: Secreted TgPSD1pv can decarboxylate PtdSer on the surface of Jurkat T-cells. 
(A) Microscopic imaging of Jurkat cells following induction of apoptosis with 1 µM staurosporine for 2 h at 37 
°C. DMSO was included as a control. PtdSer exposed on the cell surface was visualized by staining with annexin 
V-FLUOS. Cells were fixed with 2% PFA and immobilized on poly-L-lysine-coated coverslips. (B) Quantification of 
the annexin binding by FACS analysis. Jurkat cells were treated with staurosporine or DMSO and co-incubated 
with axenic T. gondii tachyzoites as indicated, followed by staining with annexin V-FLUOS. Cells were subjected 
to FACS analysis and fluorescence intensity of the fractionated Jurkat cells was determined using FlowJo 
software. Statistical analysis was determined by one-way analysis of variance test. Values are the ± S.E. for three 
experiments. Statistics was done using one-way ANOVA *** p˂0.005. 
3.5.3. Overexpression of TgPSD1pv does not affect tachyzoite growth 
Plaque assays were performed to assess whether the 10-fold higher expression of the active 
TgPSD1pv enzyme has an influence on the parasite in vitro growth. The assay allows quantification of 
the parasites ability to complete their lytic cycle in a host cell monolayer. The transgenic TgPSD1pv-
HA strain showed no significant difference in plaque number and area compared to its parental strain 
[Fig. 27]. 
Furthermore, the overexpression strain was analysed for its phospholipid composition by 1D and 2D 
thin layer chromatography. Surprisingly, no obvious changes in the relative amount of PtdEtn could 
be detected (Appendix 4), suggesting a strict homeostasis of the PtdEtn content. If, however, the 
protein is only active after its secretion into the PV, potential changes in intravacuolar or PV 
membranes in the strain overexpressing TgPSD1pv could not be determined using extracellular 
tachyzoites. 
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Figure 27: Overexpression of TgPSD1pv does not affect tachyzoite growth. 
The transgenic TgPSD1pv-HA strain and its parental were used to infect a monolayer of HFF cells. 400 parasites 
were inoculated into a 6-well plate, and the plate was incubated for one week without disturbance (37 °C, 5% 
CO2) prior to methanol fixation and staining with crystal violet. (A) Schematized lytic cycle of T. gondii 
tachyzoites depicting the events of invasion, replication, and egress. Successive rounds of parasite cycles in 
confluent human fibroblasts over a 1-week period are leading to plaque formation. (B) Representative plaques 
formed by the parental and TgPSD1pv-HA strains. (C) Plaque area of parental and TgPSD1pv-HA strain. (D) 
Number of plaques per well were scored from three independent assays.  
3.6. Overexpression of TgPSD1pv variants in E. coli 
TgPSD1pv fused to a 6xHis-tag in the pQE60 expression vector was expressed in E. coli M15 cells for 
subsequent protein purification. Since earlier attempts to express the full-lengh enzyme in E. coli 
were not successful, two isoforms of TgPSD1pv lacking the predicted signal peptide (EC1) and/or the 
C-terminal extension (EC2) were used in this approach [Fig. 28A]. 
Both TgPSD1pv variants, EC1 and EC2, could be successfully expressed and purified as confirmed by 
Western Blot analysis. The purified proteins displayed different protein sizes as predicted, however 
[Fig. 28B]. To test the purified proteins for their activity, decarboxylation assays using fluorescent 
NBD-PtdSer were performed. Subsequent lipid assays revealed a moderate PSD activity in 
theTgPSD1pv-EC1 and -EC2 protein samples [Fig. 28C].  
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Figure 28: Expression of functional TgPSD1pv-6xHis isoforms in E. coli. 
(A) Schematic depiction of the truncated TgPSD1pv forms expressed in E. coli M15 cells. PSD enzymes are 
proteolytically cleaved into a β- and α-subunit. Proteins were C-terminally fused with a 6xHis-tag. (B) Western 
Blot analysis of 5 µg NiNTA-column puried TgPSD1pv-EC1 and -EC2 probed with anti-His antibodies. EC1 showed 
two protein bands both with higher molecular weight as expected, whereas EC2 showed high expression of a 
~80 kDa protein as well as two smaller anti-His signals at approximately 35 and 30 kDa. (C) 35 µg of purified 
TgPSD1pv-variants were used for NBD-PSD assays (1 hr, 37 °C). NBD-PtdSer and NBD-PtdEtn were used as 
migration standards on TLC. Both TgPSD1pv variants showed a moderate decarboxylation of NBD-PtdSer. A 
second non-specific (ns) fluorescence signal was detected in both samples as well as in the buffer control. 
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3.7. Conditional and direct knockout of TgPSD1mt 
Ablation of mitochondrial PSD is known to cause severe mitochondrial dysfunction in other 
eukaryotes (148-150) and genetic knockout of PSD causes embryonic lethality in mice (151). 
Therefore, our further work focused on examining the physiological significance of TgPSD1mt for 
tachyzoite growth and survival.  
3.7.1. TgPSD1mt is dispensable for the parasite survival 
First, we generated a tetracycline-regulatable conditional mutant in Δku80-TaTi tachyzoites [Fig. 29A]. 
To this end, we ectopically expressed a tetracycline-repressible TgPSD1mt-HA ORF (TgPSD1mt-HAr) at 
the TgUPRT locus. Then, the merodiploid strain expressing TgPSD1mt-HAr was subjected to the 
deletion of the TgPSD1mt locus by double homologous recombination. The mutant strain lacking the 
TgPSD1mt gene showed PCR bands specific for 5’- and 3’-crossovers [Fig. 29B]. Subsequent DNA 
sequencing confirmed the successful recombination events. The Δtgpsd1mt/TgPSD1mt-HAr mutant 
showed an anhydrotetracycline-dependend regulation of TgPSD1mt mRNA by RT-PCR [Fig. 29C], 
which confirmed the conditional nature of the strain. 
As expected, TgPSD1mt-HA was localized in the mutant’s mitochondrion, and displayed a significant 
expression in the on-state (no tetracycline) [Fig. 29D]. Its expression was markedly downregulated by 
anhydrotetracycline within 1 day, and disappeared after 3 days (off-state). Immunoblot data 
confirmed a complete knockdown of TgPSD1mt-HA in the conditional strain treated with the drug for 
one (2 days) or two (4 days) passages [Fig. 29E]. The presence of three distinct anhydrotetracycline-
repressible bands corresponding to pre-proenzyme, proenzyme and α-subunit indicated proteolytic 
maturation of TgPSD1mt. We were able to culture the mutant in its off-state for a prolonged duration, 
which implied a nonessential nature of the mitochondrial PSD in T. gondii. 
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Figure 29: Conditional mutagenesis allows a tetracycline-regulated knockdown of TgPSD1mt in T. gondii. 
(A) Scheme for generating the Δtgpsd1mt/TgPSD1mt-HAr strain. An anhydrotetracycline-regulatable copy of 
TgPSD1mt-HA was inserted at the UPRT locus, and the TgPSD1mt gene was deleted using a knockout plasmid 
(pTKO-TgPSD1mt-5’UTR-DHFR-TS-TgPSD1mt-3’UTR). The primer pairs to screen for 5’- and 3’-recombination are 
depicted in blue. (B) PCR verification of the Δtgpsd1mt/TgPSD1mt-HAr mutant. Pyrimethamine-resistant 
parasite clones were screened by genomic PCR using 5’ and 3’ crossover-specific primers (5’Scr-F1/R1, 3’Scr-
F1/R1). The parental gDNA was included as a negative control. (C) PCR analysis to verify the regulation of 
TgPSD1mt mRNA by anhydro-tetracycline (ATc). Total RNA isolated from the mutant or parental strain was used 
to generate cDNA and amplify TgPSD1mt using ORF-specific primers. (D) Immunostaining of the mutant 
showing ATc-regulated expression of TgPSD1mt-HAr. The untreated control and drug-treated (1 d, 3 d) parasites 
were stained using anti-HA and anti-TgF1B antibodies. (E) Immunoblot image confirming the proteolytic 
processing and the regulation of TgPSD1mt-HAr protein in the conditional mutant. ATc-treatment was 
performed for 2 or 4 days in cultures, and fresh host-free parasites were subjected to protein isolation and 
immunoblot analyses. Note that pre-proenzyme, proenzyme and α-subunit of TgPSD1mt-HA exhibit an aberrant 
migration in SDS-PAGE. A nonspecific band, which was not regulatable, was also observed in both strains. 
TgHsp90 served as the loading controls. [The final mutant was generated in cooperation with M. Hellmund 
during her Bachelor´s thesis (152).] 
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3.7.2. TgPSD1mt is necessary for an optimal parasite growth and replication 
Following a successful genetic mutagenesis of TgPSD1mt, we examined the overall growth of the 
mutant in human fibroblasts by performing plaque assays. Parasites were allowed to grow in host cell 
monolayers for multiple rounds of lytic cycles [Fig. 30A,B] and the numbers and areas of plaques 
were evaluated to assess the relative growth fitness of the mutant. The Δtgpsd1mt/TgPSD1mt-HAr 
mutant displayed ~20% reduced plaque growth even in the absence of tetracycline (on-state), which 
is probably due to a relatively weaker strength of the conditional promoter. A 7-day exposure to the 
drug accentuated the growth defect to 35% in the conditional mutant, whereas it had no apparent 
effect on the parental strain. Prolonged drug exposure for 10 days exerted a cumulative 45% growth-
impairment in the conditional mutant [Fig. 30B]. 
Determination of the average numbers of parasites per vacuole during the course of infection 
confirmed that the observed growth defect is caused by an impaired replication of the mutant 
tachyzoites [Fig. 30C]. 
 
 
Figure 30: The Δtgpsd1mt/TgPSD1mt-HAr mutant displays a growth defect due to an impaired replication. 
(A) Representative plaques of the parental and TgPSD1mt mutant in the absence or presence of anhydro-
tetracycline (ATc, 0.5 µM). For drug treatment exceeding 7 days, parasites were pre-cultured in ATc for an 
appropriate duration prior to the plaque assays. (B) Relative plaque areas of the parental and mutant strains. 
200 plaques of each strain from three assays were quantified with the ImageJ software to estimate the parasite 
growth. Statistics was done using student´s t-test; *** p-value<0.0001. (C) Replication assay of the parental and 
mutant strains. Parasites were cultured for 7 days in ATc, as indicated, and used to infect human fibroblasts. 
Parasitized cells were fixed at different time points following infection and immuno-stained with anti-
TgGap45/Alexa594 antibodies.  
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3.7.3. Direct knockout of TgPSD1mt and phenotyping 
To further support the data generated with the conditional mutant, suggesting a nonessential 
function of TgPSD1mt, we generated a direct knockout of T. gondii lacking its tgpsd1 gene by 
replacing the TgPSD1mt ORF with the HXGPRT resistance cassette by double homologous 
recombination of TgPSD1mt UTR elements [Fig. 31A]. The ∆tgpsd1mt strain exhibited about 35% 
decrease in plaque size compared to its parental strain, which is in agreement with the growth 
reduction in the conditional mutant [Fig. 30B and 31B]. 
The Δtgpsd1 mutant could be maintained in culture for multiple generations, which confirmed a 
nonessential role of TgPSD1mt for the in vitro lytic cycle. Taken together, these results reveal that 
TgPSD1mt is needed for an optimal growth and replication of T. gondii, even though it is dispensable 
for the parasite survival. 
 
Figure 31: TgPSD1mt is nonessential for the survival but required for an efficient parasite growth. 
(A) Scheme for generation of the Δtgpsd1mt strain. The TgPSD1mt gene was deleted using a knockout construct 
(pTKO-TgPSD1mt-5’UTR-HXGPRT-TgPSD1mt-3’UTR). The deletion of TgPSD1mt was confirmed by 5’ and 3’ PCR-
screening using the indicated primers (5’Scr-F2/R2, 3’Scr-F2/R2). The parental gDNA was included as a negative 
control. (B) Representative plaques formed by the Δtgpsd1mt mutant and parental (Δku80-hxgprt-) strains and 
quantification of their sizes. In total, 200 plaques of each strain from 3 assays were measured for their area 
using the ImageJ software. Statistics was done using student´s t-test; *** p value<0.0001. 
3.8. The TgPSD1mt mutant upregulates its CDP-ethanolamine pathway 
The parasite is also known to produce PtdEtn from ethanolamine, presumably via the three-stepped 
CDP-ethanolamine pathway (92) but its subcellular location in T. gondii has not been defined, so far. 
We identified the respective candidate proteins in the parasite genome encoding for a putative 
ethanolamine kinase (TgEK), a CTP:phosphoethanolamine cytidylyltransferase (TgECT) and two 
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putative EPT proteins [3.1.], which could catalyze the first, second and final step of PtdEtn synthesis. 
The ORFs of all candidate proteins with a C-terminal HA-tag were expressed as a single copy at the 
TgUPRT-locus under control of the TgGra1 promotor [Fig. 32]. TgEK-HA was expressed in the cytosol 
and showed accumulation at the nuclear membrane, whereas TgECT-HA showed a perinuclear and 
ER-related expression pattern (138). Both TgEPT-HA proteins co-localized with the known ER-marker 
TgDer1-GFP [Fig. 32](153). 
 
Figure 32: Localization of the CDP-ethanolamine pathway in T. gondii tachyzoites. 
Schematic depiction of the constructs used to express the CDP-ethanolamine pathway proteins in T. gondii 
tachyzoites. All proteins were fused to a C-terminal HA-tag and expressed at the TgUPRT locus under control of 
the TgGra1 promotor. Cells were fixed 24 h post infection in HFF cells and used for immuno fluorescence assays 
with anti-HA or anti-TgActin antibodies or co-transfected with a vector expressing TgDer1-GFP in the ER. Cells 
were embedded in Fluoromount G/DAPI. 
We determined the phospholipid composition of the Δtgpsd1mt/TgPSD1mt-HAr mutant [Fig. 33A]. 
And consistent with former results (92), PtdCho was the major lipid in the parental and mutant 
strains, followed by PtdEtn. Unexpectedly, no significant reduction in PtdEtn was apparent in the 
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conditional mutant irrespective of ATc-exposure. The relative amounts of other major lipids were also 
unperturbed [Fig 33A]. These results prompted us to study the alternative routes of PtdEtn synthesis 
in the mutant. To determine the role of TgPSD1pv, we performed metabolic labeling of parasite lipids 
with radioactive serine [Fig 33B], which is mainly incorporated in PtdSer, and in PtdEtn following 
decarboxylation of the nascent PtdSer (92). Compared to the parental strain, only a modest (but 
statistically not significant) decline in lipid decarboxylation was detected despite a shutdown of 
TgPSD1mt protein synthesis in the off-state mutant. The data indicated a continual PtdEtn synthesis 
by decarboxylation of PtdSer in the mutant, which is likely due to TgPSD1pv present in the dense 
granules (103). 
 
Figure 33: PtdEtn synthesis in the parasite mitochondrion and ER are not mutually exclusive. 
(A) Phospholipid fractions of parasite lipids. Lipids isolated from the parental (Δku80-TaTi) and mutant 
(Δtgpsd1mt/TgPSD1mt-HAr) strains were resolved by TLC and quantified by phosphorous assay. (B) Labeling of 
parental and Δtgpsd1mt/TgPSD1mt-HAr strains with radioactive serine. Fresh extracellular parasites (5 x 10
7) of 
the parent or mutant strain (untreated or treated with ATc for two passages) were incubated with [3H]serine (1 
µCi/nmol, 2 h, 37 °C). Lipids were resolved by 1D-TLC (chloroform, methanol, acetate (65:25:10, v/v/v)) and 
subjected to liquid scintillation counting (n = 3 parental; n = 5 mutant). Differences between the conditions are 
not significant. (C) Metabolic labeling of the parasite lipids with ethanolamine. Axenic parasites (5x107) of the 
parental or mutant strain were incubated with 14C-ethanolamine (20-40 nCi/µM) for 2 hrs prior to lipid 
extraction and TLC. The radiolabeled lipids were visualized by autoradiography. (D) Individual phospholipid 
bands from panel C were visualized by iodine vapor staining and subjected to liquid scintillation counting. Error 
bars indicate S.E. from three independent assays. Statistics was done using student´s t-test; *** p< 0.001, ** 
p<0.01. 
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To test whether the ER-derived lipid can alleviate depletion of the mitochondrial PtdEtn, we 
performed labeling of parasite lipids with radioactive ethanolamine [Fig. 33C,D]. As expected, 
ethanolamine was primarily incorporated into PtdEtn, and into phosphoethanolamine-ceramide 
(PEtn-Cer). Its metabolism was not affected by tetracycline in the parental strain, whereas the mutant 
in its on state showed a modest increase in the nascent PtdEtn. The off-state mutant, on the other 
hand, incorporated about 36% more substrate into PtdEtn than its own on state, and 60-77% more 
with respect to the parental strain [Fig. 33D]. Collectively, these data show a sustained PtdSer 
decarboxylation as well as an upregulation of the CDP-ethanolamine route in the parasite ER 
following a knockdown of mitochondrial PtdEtn synthesis. 
3.9. The TgPSD1mt mutant can tolerate a depletion of ethanolamine 
To dissect the observed metabolic plasticity in T. gondii, we assessed whether the conditional mutant 
can survive simultaneous knockdown of TgPSD1mt and depletion of ethanolamine in culture [Fig. 
34A]. To this end, we set up plaque assays using dialyzed FCS. As anticipated, the TgPSD1mt mutant in 
the on state behaved similar to the parental strain, whereas in the off state it exhibited an 
accentuated 56% growth defect that was partially restored by addition of ethanolamine [Fig. 34B]. A 
further inhibition of the mutant’s growth, albeit modest, was observed when lipid-depleted serum 
was used instead of dialyzed FCS [Fig. 34C]. 
The survival and durable growth of the off-state mutant in both sera types implied yet another route 
to drive PtdEtn biogenesis, potentially involving import of host-derived lipids. To test this, we first 
radioactively labeled the lipid pool in human fibroblasts, and then allowed the conditional mutant to 
replicate and perform lipid biogenesis in pre-labeled host cells [Fig. 34D]. We measured a nearly 2-
fold higher accumulation of radiolabeled lipid in the off-state mutant. Although these data do not 
rule out a contribution of the CDP-ethanolamine pathway within the parasite, they are indicative of 
PtdEtn scavenging from the host cells when de novo synthesis by TgPSD1mt is shut down. Taken 
together, these results reveal a surprising level of metabolic plasticity in the parasite with respect to 
its growth and lipid biogenesis under varying nutrient conditions. 
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Figure 34: T. gondii can survive a simultaneous knockdown of TgPSD1mt and depletion of ethanolamine. 
(A) Representative plaques formed by the parental or Δtgpsd1mt/TgPSD1mt-HAr strains in media containing 
dialyzed serum with or without ethanolamine supplementation. The off-state parasites were pre-treated for 2 
passages with ATc and treatment was maintained during plaque assays. (B) Relative plaque areas of the parental 
and mutant strains from panel A. In total, 250 plaques of each strain or condition from three assays were 
quantified. (C) Plaques formed by the conditional mutant in medium supplemented with either dialyzed or 
lipid-depleted serum. (D) Accumulation of radioactive lipids in conditional mutant following its replication in 
human fibroblasts labeled for PtdEtn. Isotope labeling of host cells was performed with 14C-ethanolamine (40 
nCi/nmol) in medium containing lipid-depleted serum (24 hrs, 37 °C, 5% CO2). Host cells were then infected 
with parasites (MOI, 2), and incubated for an additional 48 hrs. Lipids isolated from freshly egressed parasites 
were analyzed by scintillation counting to estimate the import of host-derived lipids (n = 4 assays; * = p<0.05; 
*** = p<0.001). 
3.10. TgPSD1mt depletion does not influence mitochondrial morphology 
To test whether the replication defect is caused by an impairement of mitochondrial integrity as 
reported in other organisms (150,151,154), an ultrastructural analysis of the parasite mitochondrion 
was performed. Intracellular parasites of the parental and the Δtgpsd1mt/TgPSD1mt-HAr strain were 
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examined by transmission electron microscopy. Unexpectedly, the Δtgpsd1mt/TgPSD1mt-HAr strain 
did not show apparent alterations in size or internal christae structure [Fig 35]. 
 
Figure 35: Knockdown of TgPSD1 does not affect the mitochondrial ultrastructure. 
Transmission electron micrographs of intracellular tachyzoites of the parental (Δku80-TaTi) and 
Δtgpsd1mt/TgPSD1mt-HAr strain after 12 days of ATc-treatment. mt = mitochondrion 
In addition, an unperturbed expression pattern of the mitochondrial ATPase subunit TgF1B shown in 
immunofluoresce analyses in the TgPSD1mt mutant compared to the parental strain indicates an 
unaltered mitochondrial morphology (and function) in the TgPSD1mt mutant [Fig. 29D]. However, 
further experiments are needed for clarification. 
3.11. Targeted gene disruption of TgPSD1pv 
Because the genomic locus of TgPSD1pv encodes upstream and downstream coding genes in close 
proximity, a targeted gene disruption approach was preferred over a conventional ablation of the 
gene locus. The experimental design is depicted in figure 36, showing the insertion of the HXGPRT 
resistance cassette into the catalytic domain of the TgPSD1pv gene. The vector used to generate the 
gene disruption is attached in appendix 6. Targeted gene disruption was verified by recombination-
specific PCR reactions on genomic DNA of the clonal mutant [Fig. 36A]. A copy of the TgPSD1pv ORF 
under control of its native 5´ promotor region was inserted at the TgUPRT-locus to complement the 
mutant [Fig. 36B]. Immunofluorescence analysis verified the successful expression of TgPSD1pv-HA in 
the complemented strain and indicated also an unaltered secretion of TgGra5 in this mutant [Fig. 
36B].  
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Figure 36: Targeted gene disruption of TgPSD1pv and complementation 
(A) Schematics of the TgPSD1pv-TGD mutant and PCR verification of homolougous recombination of the 5´ and 
3´TGD elements. (B) The TgPSD1pv complementation strain expressed the TgPSD1pv-ORF C-termially HA-tagged 
under control of its native promotor element at the TgUPRT locus. Successful gene disruption in the TGD-
mutant and complementation with TgPSD1pv-HA was verified by PCR using TgPSD1pv-specific primers and 
TgElf1alpha as a control for successful cDNA synthesis. The expression of the TgPSD1pv-HA protein was verified 
by immunofluorescence assays using anti-HA (green) and anti-TgGra5 (red) antibodies. PSD = PSD domain; R.C. 
= resistance cassette; Scr = screening; SP = signal peptide; TGD = targeted gene disruption, UTR = untranslated 
region.  
3.11.1. The TgPSD1pv mutant does not secrete PSD activity 
To assess whether the TgPSD1pv gene disruption mutant indeed lacks its PSD activity in the 
secretome and if the same was restored in the complementation stain, secretion assays were 
performed. Secretome and cell extracts were analyzed for their PSD activity using NBD-PtdSer as a 
substrate [Fig. 37]. As expected, the parental and complementation strain showed decarboxylation 
activity in the secretome, whereas no PSD activity could be detected for the tgpsd1pv-TGD mutant. 
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NBD-PtdSer decarboxylation was detectable in all cell extract preparations, due to TgPSD1mt activity. 
A reduced overall catalytic activity in the tgpsd1pv-TGD mutant cell extract also confirmed successful 
disruption of TgPSD1pv [Fig. 37]. 
 
Figure 37: The TgPSD1pv mutant lacks PSD activity in the secreted protein fraction. 
Fresh syringe-released tachyzoites were used for the preparation of secretome and cell extracts for PSD assays 
using fluorescent NBD-PtdSer as substrate. TLC-resolved lipids were visualized by UV light. [Secretion 
experiment and picture: Theresa Ring] 
 
3.11.2. TgPSD1pv is not essential for the lytic cycle of T. gondii in vitro 
The genetically and enzymatically characterized Δtgpsd1pv mutant strains were used for subsequent 
analysis and phenotying. In routine cultures, the mutant (tgpsd1pv-TGD) and complemented 
(TgPSD1pv-HA) strains did not show any apparent differences in their in vitro growth compared to the 
parental strain, which suggested a nonessential function of TgPSD1pv for the tachyzoite growth. 
Therefore, we tested the strains for their in vitro phenotype in plaque assays under different 
nutritional depleted and repleted conditions [Fig. 38]. 
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Figure 38: The tgpsd1pv mutant shows a modestly enhanced growth phenotype but lower plaque numbers. 
The tgpsd1pv-TGD mutant and parental and complemented control strains were used to infect 6 well plates 
(200 parasites per well). The growth was examined under various nutrient conditions including standard D10 
culture medium with normal FCS, as well as in nutrient-depletion medium containing delipidated FCS. For 
nutrient-repletion experiments, indicated lipid precursors were added in 3 ml of medium during the incubation 
period of one week. (A) The plaque size was measured using microscopic images and the ImageJ software. (B) 
The number of plaques per well was counted and plotted from n= 3-5 independent experiments. 
Plaque assays revealed that disruption of the tgpsd1pv gene and absence of secreted PSD activity did 
not negatively affect the fitness of the mutant, which in fact showed slightly larger plaques compared 
to the parental strain under standard culture conditions [Fig. 38A]. The TgPSD1pv-HA strain showed 
enhanced growth under all given culture conditions [Fig. 38A]. Interestingly, the tgpsd1pv-TGD 
mutant strain showed a reduced number of plaques under all examined nutritional conditions. The 
phenotype was specifically restored in the complemented parasite strain [Fig. 38B]. It can be 
suggested that the absence of secreted PSD activity causes a moderate decrese in tachyzoite 
infectivity in vitro. This observation needs to be further analysed by invasion assays, however. 
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4. Discussion 
4.1. Phosphatidylethanolamine biogenesis in T. gondii tachyzoites 
Phosphatidylethanolamine (PtdEtn) is the most abundant phospholipid in prokaryotes and the 
second most prevalent lipid in most eukaryotes, including T. gondii. It accounts for ~12-25% of total 
parasite phospholipids (92,96). Besides its function as a structural component of biological 
membranes, the conical-shaped PtdEtn plays a critical role for membrane fusion, fission and 
curvature and the stabilization of membrane proteins (86,137). Unlike the synthesis of PtdCho, which 
seems to exclusively depend on a functional CDP-Cho-pathway (92,100), this work revealed multiple 
routes of PtdEtn biogenesis in T. gondii. Here, PtdEtn can be produced via the CDP-ethanolamine 
pathway using ethanolamine (Etn) and diacylglycerol as well as by decarboxylation of 
phosphatidylserine (PtdSer). The latter reaction is catalized by two distinct PtdSer decarboxylase 
enzymes (PSDs) in T. gondii.  
We were able to identify the enzymes which constitute the main routes for PtdEtn biogenesis in the 
parasite endoplasmatic reticulum and the mitochondrion, as well as in the parasitophorous vacuole 
of T. gondii [Fig. 39]. The presence of a functional Kennedy pathway was initially shown by 
incorporation of Etn and choline into PtdEtn and PtdCho (92). The enzymatic activity of a cytosolic 
TgEK enzyme and a dual substrate specific TgCK have been shown previously (94,100). These enzymes 
catalyze the first step of the Kennedy pathway in the parasite. However, the enzymatic nature of 
TgECT/CCT and TgEPT/CPT and their potential overlapping functions in performing the second and 
final step of this pathway remain to be investigated. 
The localization and characterization of the two PSD enzymes in T. gondii was the main focus of this 
work. Besides the identification of a conserved mitochondrial PSD enzyme (TgPSD1mt), whose 
enzymatic identity was verified by heterologous expression in yeast, the parasite harbours a unique 
and partially soluble Coccidia-specific PSD enzyme, which could be allocated to be secreted into the 
parasitophorous vacuole (TgPSD1pv) via dense granule secretory organelles [3.2.2.]. 
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Figure 39: Localization of PtdEtn synthesis in T. gondii 
Schematic overview of the PtdEtn-biosynthetic pathways and their subcellular localization in intracellular 
tachyzoites. CK: choline kinase; EK: ethanolamine kinase; ECT: CTP:phosphoethanolamine cytidylyltransferase; 
EPT: CDP-ethanolamine:1,2-diacyglycerol ethanolamine-phosphotransferase, P-Etn: Phospho-ethanolamine 
PSD: phosphatidylserine decarboxylase. TgCK was immunostained using an anti-TgCK serum (1:200) showing 
subcellular organization in cytosolic clusters, as described by Sampels et al. (100). The enzymatic specifity of the 
proteins marked with “*” are not experimentally verified. 
While PtdSer decarboxlation is the only way to produce PtdEtn in prokaryotes (155), eukaryotic 
organisms harbour different routes of PtdEtn synthesis (81,86,156). Besides the CDP-ethanolamine 
and PSD pathways, that are present in most eukaryotes including T. gondii, S. cerevsiae can also 
generate PtdEtn via acylation of lyso-PtdEtn. The Acyl-CoA dependent acyltransferase (Ale1) enzyme 
is located at the mitochondria-associated membranes (MAM) and harbours also broad activity for 
other lysolipid species (157-159). The T. gondii genome encodes one hypothetical protein 
(TGGT1_259155) with partial sequence similarities to ScAle1, but for which no functional 
acyltransferase domain is predicted. In mammals, LPEAT (MBOAT) proteins catalyze the acylaction of 
lyso-PtdEtn as part of the Land´s cycle (160). No similar enzymes could be identified in the T. gondii 
genome so far, indicating that a re-acylation of lysolipids may not contribute to phospholipid 
synthesis and remodelling of the parasite membranes. 
Many differences and exceptions to the conventional PtdEtn pathways can be found in other 
protozoan parasites (98,161). PtdSer decarboxylation activity was shown to occur in T. brucei 
procyclic and bloodstream forms (81,150). Likewise, PSD genes are encoded in the genome of 
Leishmania spp and T. cruzi (98), but the respective enzymes have not been localized or 
characterized, since The CDP-Etn pathway seems to represent the main PtdEtn source in these 
species and PSD enzymes are thought to play only a minor role for PtdEtn formation in kinetoplastids 
(81,150). Interestingly, Leishmania can redirect its sphingolipid metabolism to make P-Etn via 
sphingosine-1-phosphate lyase, which constitutes yet another mechanism to produce PtdEtn. This 
pathway appears to be crucial for stage differentiation and virulence of the parasite (162). Respective 
genes are not present in the genomes of Plasmodium, Toxoplasma and Theileria species, however 
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(98). Additionally, T. brucei expresses a bidirectional ceramide ethanolamine-phosphotransferase, 
which is capable of converting PtdEtn and ceramide to Phosphoethanolamine-ceramide (PEtn-Cer) 
and DAG and vice versa (163). The enzyme producing this unusual sphingolipid PEtn-Cer in T. gondii 
still remains unknown (95). A BLAST search in the T. gondii genome identified one conserved 
hypothetical protein (TGGT1_246780) with minor similarities to the respective T. brucei sequence 
(TritrypDB.org; Tb927.9.9400). Plasmodium species express a functional Kennedy pathway (98), but in 
contrast to Trypanosoma and Toxoplasma, encoding separate EPT and CPT enzymes, Plasmodium 
encodes a single fusion CEPT enzyme used for both, the PtdEtn and PtdCho synthesis (164). The 
Kennedy pathway seems to be essential for blood stage development in P. berghei (165). As already 
indicated, P. falciparum encodes a single type I-like PSD enzyme that is likely expressed in the ER 
(135). Therefore, PtdEtn synthesis is probably confined to the ER in Plasmodium species unlike shown 
for T. gondii. The relative importance and contribution of the different pathways used to synthesize 
PtdEtn appears to be highly divergent among different organisms and tissues (86,150,156). Moreover, 
different pathways produce functionally-distinct PtdEtn pools with different acyl chain signature 
(166,167). 
The individual phospholipid profile, the loss of the phosphatidylethanolamine methyltransferase 
reaction and the gain of novel parasite-specific lipid biosynthetic enzymes, such as TgPSD1pv and 
TgPTS (96), presumambly reflect an adaptation to the intraparasitic lifestyle in T. gondii. The resulting 
phospholipid composition likely enables an interaction with and the exploitation of the host cell 
whilst achieving unimpaired/undetected growth, movement and propagation within host tissues. 
4.2. Evolutionary context and characteristics of TgPSD enzymes 
Phosphatidylserine decarboxylases belong to an unique subgroup of decarboxylases harbouring a 
pyrovoyl at the prothetic group (83). They are maturated post-translationally by an auto-proteolytic 
cleavage reaction, which splits the pro-protein into an α- and β-subunit at a conserved (L)G^ST motif 
(83) [Fig. 40]. The unusual non-mitochondrial PSD enzyme of P. falciparum (135) carries a VG^SS 
cleavage motif and T. brucei shows a WG^SS at its catalytic site, both representing minor exceptions. 
All coccidian-specific PSD enzymes display a FG^ST-motif and are predicted to form a relatively large 
α-subunit upon autoproteolytic cleavage when compared to other PSD enzymes [Fig. 40]. 
Phylogenetic analysis revealed that both PSD enymes expressed in T. gondii are of different 
phylogenetic origin [3.1.5.]. TgPSD1mt is a conserved mitochondrial protein sharing high similarities 
to other type I PSD enzymes, whereas the secreted TgPSD1pv forms a novel cluster with other 
putative PSD enzymes exclusively found in coccidian species [Fig. 9]. The latter are not related to the 
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type II PSD clade, which includes fungal and plant PSD enzymes, such as PSD2 from S. cerevisiae (148) 
or PSD2 and PSD3 from A. thaliana (130,132). The three eukaryotic clades display differential protein 
features as depicted below [Fig. 40]. The fact that TgPSD1pv seems to be highly different from other 
characterized PSDs may underlie its inability to functionally complement the yeast PSD double 
mutant [3.4.3.]. 
 
Figure 40: Characteristics of eukaryotic PSD enzyme groups. 
Schematic depiction of the proteins features of different eukaryotic PSD enzyme clades. Topological signals, 
characteristic domains and the conserved cleavage motifs are shown as well as the average protein size. mTP = 
mitochondrial targeting peptide; EMS = endomembrane sorting sequence; EFh = EF-hand, calcium binding-
motif; C2 = protein kinase C conserved region 2, calcium binding motif; SP = signal peptide. 
In line with the observed subcellular localizations observed for various type I and II PSD-proteins, 
localization sequences are predicted at their N-termini, targeting the enzymes to the mitochondrion 
or the endomembrane system, respectively. Some PSD enzymes of the type II group carry EFh -Ca2+-
binding domains and/or Ca2+-dependend C2-domains, known to be involved in lipid-protein 
interactions. The C2-domain of ScPSD2 was shown to be nonessential for catalysis but required for 
sufficient lipid trafficking (168,169). None of these domains are predicted for the PSDs of the 
coccidian subgroub, but the latter carry a predicted 20 – 26 aa long signal peptide at their N-terminus 
[Fig. 40], which is consistant with its secretory nature in T. gondii. 
The successful expression of active recombinant TgPSD1pv variants in E. coli [Fig. 28] will enable the 
study of interfacial catalysis and structural determination, which have not been possible with other 
membrane-bound PSD enzymes so far. 
Occurrence and perpetuation of a coccidian-specific PSD clade suggests a special role of this enzyme 
in coccidian development, which needs to be further investigated [see 4.6.]. Interestingly, blastx 
searches using the TgPSD1pv cDNA sequence revealed partial sequence identities to parasitic molds 
of the Saprolegina and Phytophora genus and to certain insect species, such as the house fly and the 
pathogen vector Aedes aegypti as well as to the human whipworm Trichuris trichiura. This 
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observation could suggest that coccidian PSD enzymes may be evolutionary related to the PSD 
enzymes of other (parasitic) pathogens and were probably acquired by lateral gene transfer between 
different parasitic or symbiontic species and insect vectors (170,171). This hypothesis needs to be 
analysed in greater detail for further conclusions. 
4.3. TgPSD1pv – a common dense granule protein? 
The TgPSD1pv protein of T. gondii is an exceptional PSD enzyme, displaying certain protein features 
not shared with other PSDs. It belongs to a novel subgroup of coccidian-specific PSD enzymes [4.2.]. 
This work revealed that the protein is a functional, partially soluble enzyme, which is secreted by 
intracellular tachyzoites [3.5.1.]. The secretion of TgPSD1pv was shown to be temperature- and ATP-
dependent but remains unimpaired upon Ca2+-depletion with BAPTA-AM (103). Immunofluorescence 
analysis of C-terminally epitope tagged TgPSD1pv revealed that the protein is secreted into the 
parasitophorous vacuole via secretory dense granule organelles [Fig. 14]. 
Whereas the protein is divergent from other PSD enzymes in terms of protein structure and 
enzymatic properties, it shares many similarities with other dense granule proteins (GRAs) of T. 
gondii, which may provide insights into its biological role. The content of the dense granules is 
secreted constitutively by subapical exocytosis in a Ca2+-independent manner during as well as after 
host cell invasion (172,173). Over the last decades an increasing number of canonical GRA-proteins 
and GRA-like proteins have been described. Their similarities and differences were recently reviewed 
by Mercier & Cesbron-Delauw (174). 
Most of the described GRA-proteins, including TgPSD1pv, harbour a predicted hydrophobic signal 
peptide at their N-termini, but are in contrast to TgPSD1pv (predicted molecular weight ~ 108 kDa) 
relatively small proteins of 20 -50 kDa (174). As also observed for TgPSD1pv, GRA-proteins often show 
aberrant migration behaviour in SDS-PAGE, which is probably due to post-translational modifications, 
membrane binding domains and a proline rich composition (172,173). Most described GRA-proteins 
are post-secretory targeted to the PV membrane, the intravacuolar network (IVN) or to the vacuolar 
space. Interestingly, some GRAs, such as GRA15, 16 and 24 can also be secondary exported to the 
host cell nucleus (174) [Fig. 41].  
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Figure 41:Post-secretory localization of GRA proteins 
Transmission electron micrograph of a cell infected with T. gondii tachyzoites, and localization of dense granule 
proteins (GRAs) after their secretion into the parasitophorous vacuole (PV) via dense granules (DG). GRAs are 
mainly shown to localize to the intravacuolar network (IVN), the PV membrane (PVM) or the PV space, but can 
also be secondary exported to the host cell nucleus. [Modified from Mercier and Cesbon-Delauw (174), TEM 
picture from Coppens and Joiner (175)] 
 
With the exception of GRA1, described as a soluble protein, all GRAs were shown to adopt an 
intriguing dual behavior, being partly soluble and partly membrane-associated (174), which is also 
common with TgPSD1pv [Fig. 24]. Whether TgPSD1pv becomes associated with IVN or PV membranes 
could not be determined due to futile immune-gold labelling of TgPSD1pv-HA in intracellular 
parasites. However, correlative microscopy indicated that the protein shows a differential localization 
to TgGRA5, which is known to bind to the PVM (108). In direct comparison to TgGRA5, TgPSD1pv 
displays a more uniform distribution in the PV-space [Fig. 16]. 
The biological function of most GRA proteins remains unknown. GRA15, GRA24 and 25 are shown to 
act as virulence factors by manipulating the host immune system (176-178). Another set of GRA-
proteins, GRA2, 6 and 7, are involved in formation, remodelling or stabilization of membranous 
structures, such as the IVN or host-organelle-sequestering structures (44,179).  
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Crosslinking-experiments could reveal whether TgPSD1pv interacts with other GRA-proteins, since 
GRAs proteins usually form high molecular weight complexes by protein-protein interactions (180) 
and rely on the expression of partner proteins, like GRA2 and GRA6. Here GRA2 was shown to induce 
IVN-tubulation whilst GRA6 stabilizes the pre-formed tubules (44). A potential role of TgPSD1pv in the 
remodelling or stabilization of intravacuolar or surrounding PV membranes and proteins is also 
plausible, because PtdEtn is known to modulate bilayer behaviour. This hypothesis could be 
addressed by performing electron microscopic imaging with special attention to the morphology of 
the intravacuolar membranes using the mutant strains generated during this work [Fig. 36]. 
Like TgPSD1pv [3.11.], most GRA-proteins seem to be non-essential for in vitro tachyzoite growth 
under standard culture conditions (173), but display reduced growth under nutrient starvation 
(181,182). The TgPSD1pv mutant as well as the parental strain showed reduced plaque formation in 
lipid-depleted medium [Fig. 38]. These experiments should be repeated in medium supplemented 
with dialysed serum to discern whether the lack of certain nutrients leads to a specific growth 
reduction or -enhancement of the mutant. The observation that the TgPSD1pv-mutant shows 
reduced plaque numbers should also be further analysed to reveal if TgPSD1pv could be possibly 
involved in parasite invasion. 
Deletion of GRA2 makes the mutant strain less virulent in mice, disregarding its normal growth 
behaviour in in vitro fibroblast cultures (183). Albeit the secreted TgPSD1pv seems to be not essential 
for in vitro growth [3.11.], this work indicated a reduced virulence of the TgPSD1pv mutant [Fig. 38]. 
The reduced infectivity observed in vitro could also be further tested in vivo in mice.  
A recent report showed the involvement of GRA17 and GRA23 in passive transport of small molecules 
through the PV membrane (184). Another indication for a possible role of TgPSD1pv in influencing the 
PVM permeability by accumulating non-bilayer forming PtdEtn, probably interacting with other GRA 
proteins, may also enable nutrient/lipid uptake from the host.  
Almost all GRAs expressed in T. gondii tachyzoites are also found in the bradyzoite stage (185). Based 
on the expression data extracted from ToxoDB, TgPSD1pv is slightly lower expressed in type II strains 
(Pru, ME49) compared to non-cyst forming type I strains (RH, GT1), but is expressed also in 
bradyzoites and oocysts at similar levels as found in the tachyzoite stage. Furthermore, Fox and 
collegues revealed that GRA4 and GRA6 are important for cyst wall formation (63). Our multiple 
attempts to disrupt the TgPSD1pv gene in a type II (Pru) background were futile, which could suggest 
an essential role of TgPSD1pv in bradyzoite/cyst development.  
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4.4. Other putative functions of TgPSD1pv 
Regardless of its allocation as a GRA-protein [4.3.], other possible functions of the Coccidia-specific 
TgPSD1pv can be hypothezised based on its enzymatic features, the preliminary knockout phenotype 
[3.11.], as well as consideration of potentially related proteins, which are known to interact with 
PtdEtn in other organisms. 
A possible function of TgPSD1pv could be to promote the parasite invasion process by introducing 
large amounts of the non-bilayer forming PtdEtn at the site of cell entry at the host cell surface. In 
line with that, TgPSD1pv shows perferred catalysis with liposomal substrate and is able to 
decarboxylate PtdSer at membrane surfaces, as shown by reduced annexin V-binding on apoptotic T-
cells when co-incubated whith a TgPSD1pv-overexpression strain secreting significant amounts of 
active PSD [3.5.]. Additionally, the Δtgpsd1pv mutant showed a decreased plaque formation [Fig. 38]. 
Whether this observation is indeed related to its physiological function in vivo requires further 
investigation. 
The vacuolar PtdEtn may also be involved in determing the parasite virulence by influencing the host 
autophagy system, which is in general responsible for lysosomal degradation of intracellular 
components (186). Here, PtdEtn functions as an anchor for the autophagy-related protein Atg8 in 
yeast (187) and its respective mammalian orthologue LC3 (188). It has been reported, that the host 
autophagy proteins are also required to target IFN-γ-regulated effectors (immunity-related GTPases) 
to the PVM of T. gondii for parasite clearance. An increased PtdEtn content of the PVM through 
intravacuolar TgPSD1pv could make it more susceptible for LC3- and/or IRG-binding. Furthermore, it 
was shown that TgAtg3 is essential for the mitochondrial integrity of T. gondii, and that Δtgatg3 
parasites fail to conjugate Atg8 to the autophagosomal membrane, indicating the presence of a 
functional autophagy system in the parasite (105).  
In addition, recent studies have shown that a knockout of either PSD1 or PSD2 in yeast and the 
resulting decrease in cellular PtdEtn promotes autophagy through production of reactive oxygen 
species, and that the lifespan of the yeast mutants could be extended by providing exogenous Etn or 
overexpression of ScPSD1 (189). These findings resonate with our results for a sustained and flexible 
PtdEtn synthesis in T. gondii tachyzoites. 
PtdEtn was also shown to be involved in additional cellular signalling processes via interaction with a 
a highly conserved protein family, known as the PtdEtn-binding proteins (PEBPs), which display serine 
protease inhibitor function and are involved in regulation of several signalling pathways such as the 
MAP kinase and the NF-κB pathways (190,191). T. gondii also encodes a PEBP homologe 
(TGME49_207930), which may be a component of PtdEtn signalling pathways in T. gondii. 
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4.5. Cooperativity of PtdEtn routes ensures membrane integrity of T. gondii 
This work revealed that T. gondii expresses two functional PSD enzmes in the parasite mitochondrion 
(TgPSD1mt) and the parasitophorous vacuole (TgPSD1pv) and indicated the expression of a putative 
TgEPT, catalyzing the last enzyme of the CDP-Etn branch of the Kennedy pathway, in the 
endoplasmatic resticulum of tachyzoites [Fig. 39]. The presence of multiple pathways for the de novo 
synthesis of PtdEtn and the emergence of a novel secreted PSD enzyme suggests the importance of a 
secure PtdEtn supply and homeostasis for the parasite survival. 
PtdEtn is generally enriched in mitochondrial membranes, where it accounts for approximately 25-
35% of phospholipids (192,193). Another non-bilayer forming phospholipid, cardiolipin (CL), 
constituting ~12-25% of mitochondrial lipids (193,194), was shown to have overlapping functions 
with PtdEtn in stabilizing membrane proteins and conferrering structural organisation of the inner 
mitochondrial membrane (149,192,195,196). Eukaryotic cells generate CL via a multienzyme cascade 
in the inner mitochondrial membrane with eventual fusion of CDP-DAG and PtdGro catalyzed by CL 
synthase (CLS) (192). In contrast, a diphosphatidylglycerol synthase enzyme catalyzes CL formation in 
prokaryotes (197). There is no experimental evidence for CL synthesis in T. gondii and other 
apicomplexan parasites. But it was shown that T. brucei encodes a prokaryotic-type cardiolipin 
synthase that is essential for mitochondrial function (198). The T. gondii genome encodes a protein 
(TGME49_109940), with high similarities to the TbCLS (Tb927.4.2560), but a relatively low predicted 
probability of export to mitochondria (~40%), as predicted by MitoProt. Our attempts to localize the 
respective protein were futile. A compensatory function of CL in maintaining mitochondrial integrity 
in the absence of TgPSD1mt can not be excluded, however. 
Furthermore, metabolic labelling revealed that the TgPSD1mt mutant shows increased utilization of 
ethanolamine for incorporation into PtdEtn whilst maintaining its cellular PtdEtn levels [Fig. 33]. The 
mutant strain was able to survive nutrient depletion albeit a ~56% growth defect, which could be 
partially restored by the addition of exogenous Etn [Fig. 34]. These results indicated that the CDP-Etn 
pathway can partially compensate for the loss of TgPSD1mt under the given culture conditions and 
implies an interregulated PtdEtn transport system from ER-derived lipids to the mitochondrion. The 
highly complex meachnisms of interorganellar lipid transport are still at an early stage of research, 
but it was shown that phospholipids can be transported between the ER and mitochondria at the so 
called mitochondria-associated membranes (MAMs) (199-201). MAMs are enriched in certain lipids 
and lipid-synthetic enzymes (192). It is therefore likely that the parasite also uses this conserved 
mechanism for interorganellar exchange of PtdEtn. 
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Extracellular labelling of tachyzoites using [3H]-serine, which is mainly incorporated into PtdSer and 
PtdEtn (92), revealed only a moderate decline in PSD activity in the Δtgpsd1mt mutant [Fig. 33B]. The 
residual PSD activity is very likely contributed by TgPSD1pv in the dense granules. Nevertheless, it is 
not yet known how TgPSD1pv is post-translationally transported and maturated, and whether it 
contributes to the intracellular PtdEtn synthesis or exclusively acts post-secretory in the PV. 
The relative contributions of the three distinct PtdEtn de novo pathways in T. gondii could not be 
ascertained within this study. Generating a Δtgpsd1mtΔtgpsd1pv double mutant could reveal 
whether PtdSer decarboxylation in general is essential for T. gondii, and whether the Kennedy 
pathway can provide sufficient PtdEtn to ensure parasite survival. Likewise, contribution of host-
derived lipid would have to be evaluated by generating a triple mutant lacking PSD activity and the 
CDP-ethanolamine pathway. 
To study a possible role of host lipids or lipid intermediates in supporting PtdEtn biogenesis in T. 
gondii, we pre-labeled HFF-cells with [14C]-Etn for 24 hrs prior to infection with tachyzoites of the 
TgPSD1mt conditional mutant in its off-state. After 48 hrs post infection, the TgPSD1mt mutant 
displayed an increased incorporation of radioactivity into its phospholipid-pool [Fig. 34]. These results 
imply import of host-derived lipids or lipid intermediates. Former work using radioactive and 
fluorescently-labled phospholipids already indicated the contribution of host lipids as a source of IVN 
and parasite lipids (46,91). Labelling of extracellular parasites with NBD-lipids revealed a selective 
import of PtdEtn and PtdSer into tachyzoites (202) [Fig. 42], which supports the possibility of exteral 
PtdEtn (or PtdEtn derivates) contributing to the parasite membrane lipid pool. 
 
Figure 42: Selective import of NBD-phospholipids by extracellular T. gondii tachyzoites 
Labelling of extracellular T. gondii tachyzoites with NBD-lipids. NBD-sphingomyelin (SM) served as a negative 
control. [from S. Marquardt, diploma thesis (202)] 
Analysis of the parasites labled with NBD-PtdSer revealed that a large fraction of NBD-PtdSer was 
converted into PtdEtn, which could be inhibited by the use of the PSD inhibitor hydroxylamine 
[Appendix 7]. These results indicate either external decarboxylation by the secreted TgPSD1pv and 
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subsequent import of PtdEtn and/or decarboxylation by TgPSD1mt (and TgPSD1pv) after 
internalization of NBD-PtdSer. 
It is known that during T. gondii infection, host ER and mitochondrial membranes are recruited to the 
PVM (47), both of which represent the major sites of lipid biogenesis in the host. These membranes 
could also serve as contact zones for lipid exchange to the PV. Here, host-derived PtdSer could also be 
used as a substrate for the vacuolar TgPSD1pv to produce PtdEtn. It was shown that yeast and 
mammalian cells are capable of transporting (lyso)-phospholipids via P4-type ATPases (203,204), and 
that the T. gondii genome encodes their orthologs (202). Some putative P4-ATPases could be localized 
in the cytosol and the apical tip of T. gondii tachyzoites (205), which rules out their involvement in 
lipid transport at the parasite surface. 
In summary, these results show that T. gondii harbours multiple intracellular routes to produce 
PtdEtn besides a putative mechanism to import host-PtdEtn [Fig. 43]. 
The remarkable ability of T. gondii to perform PtdEtn synthesis via multiple independent routes 
enables a greater autonomy from the host cell, which may ensure its replication in varying nutritional 
conditions encountered in different host organisms, tissues and cell types.  
 
 
Figure 43: Model of PtdEtn biogenesis in T. gondii 
Schematic overview summarizing the PtdEtn routes in T. gondii comprising PtdSer decarboxylation in the 
mitochondrion and the parasitophorous vacuole as well as the CDP-Etn pathway in the ER. Host ER and 
mitochondria could serve as potential sources of parasite PtdEtn. Additionally, yet undefined lipid-transporters, 
such as P4-type ATPases, could potentially mediate the import of PtdEtn to the parasite interior. 
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4.6. Future perspective of PtdEtn research in T. gondii 
This work established the first model which comprises the major routes for PtdEtn biogenesis in T. 
gondii. Whilst the PSD pathway has been characterized in sufficient detail, the enzymatic identity and 
importance of the enzymes related to the CDP-ethanolamine pathway remain to be determined. 
To reveal the concrete role of the Coccidia-specific secreted TgPSD1pv for the parasite biology, 
further experiments are needed, which involve invasion assays and electron microscopy of the 
intravacuolar network. In vitro tubulation experiments using parasite secretome preparations and/or 
purified TgPSD1pv could show whether the protein can indeed induce membrane tabulation or 
curvature. Moreover, the TgPSD1mt and TgPSD1pv mutant strains should be analysed for their 
lipidome to detect potential minor changes in the membrane lipid composition and to assess 
substrate-specificity of the PSDs and the CDP-ethanolamine pathway. The generation of PSD double 
mutants and TgPSD1mt/TgPSD1pv/TgEPT triple mutants could reveal the relative importance of the 
individual routes. 
Analysis of the TgPSD mutants together with other strains deficient in phospholipid metabolism 
related enzymes could elucidate the interregulation of phospholipid pathways in T. gondii. Functional 
characterization of all putative T. gondii P4-type ATPases and other yet undetected lipidtransporters 
could establish a putative role of host phospholipids for T. gondii membrane biogenesis. 
An epitope-tagged TgPSD1pv enzyme should be expressed in T. gondii type II parasites to follow its 
expression and subcellular localization in bradyzoites to assess its putative role in cyst formation. 
Ideally, a genetic knockout in type II parasites should be performed to determine a possible role of 
TgPSD1pv in bradyzoite development.  
The identification of putative interaction-partners of TgPSD1pv, such as GRA- or Atg-proteins, via 
crosslinking experiments could help to reveal its putative biological function. In addition, immuno-
gold labelling of the TgPSD1pv-HA strain should demonstrate whether the protein binds post-
secretory to the IVN in the PV space and/or the PVM membrane in infected cells. 
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IX. Appendix 
Appendix 1 
(A) Table of previous and new gene accession numbers of the phosphatidylethanolamine synthesis 
enzymes in T. gondii: 
Abbreviations 
used in this 
study 
ToxoDB  
accession number 
ToxoDB 
old accession 
number 
NCBI accession 
number 
TgPSD1mt TGGT1_225550 TGGT1_080780 EPR62136 
TgPSD1pv TGGT1_269920 TGGT1_108450 EPR64713 
TgEK TGGT1_306540 TGGT1_040800 EPR57537 
TgECT TGGT1_310280 TGGT1_086510 EPR60847 
TgEPT1 TGGT1_261760 TGGT1_008370 EPR62697 
TgEPT2 TGGT1_257510 TGGT1_013180 EPR63017 
(B) List of coding sequences used for in silico analysis and primer design: 
>TgPSD1mt 
ATGCGCAGTTACTTGCGGTTTTCGGATCGCCATCGTCAACGACCAACACGTCCCCGTAAACGCGTGATTTGTAGTAGCGCACATTTCATTTGCAGCCGCATGTC
GCCAGCCGCGACGGCGCAGTCGCCTTTTGGCATCTCCCTCCACTCTTTGTCTTTCCGTTTGCTGCTGATATTCCGCGGTTCCATCGTAGCCATGTCGCGTCGTTT
TGTATACAAGCTTGATCAGGCAGTAACAGCCGCACTCGGGCCAAATGGCCGCTACATCGCGATGGTTGGCATGACCGCGTCAGCAGTCCTCCTCACTTTCCATT
ACAAGTTCCGGGAGGTCATTGCGGCGACAGACAATGTTGCAGAGATACAGAGCCCCTCCAAGCTCTTCTATCTGAGGTTGCTCTTTGGTCGCACTCGATCCCG
GATCACCGGGTCTGTCATGAACATCAACATCATGCCGGCTTTGAGGGATCCGATTTACCGAACTCTGGCGTCCGTCGGCGGCATTGACACAGAAGAAATTCGT
TACCCCTTGCGCAGCTACAAATGCATCGGCCATCTCTTTGCGCGCACACTCAAAGACAAAGAGAGAGAAATCGAAGACATTGGAACGCAGTCGCTTGCAAGC
CCAGCAGACGGCGTGGTCACGGCGCTGGGAGATGTGAGTTCCGAACGCGTTGAGCAGGTGAAGGGCGCAACTTATAGCCTTCGAGCGTTCCTCGGTCTCAT
GCCGAAGGTCACCAACCCGGAGAAAAATACGCTCAAGTTCGTCGTTCTTCACCTGAAACCGAAGAATTACCACCATTTCCACGCGCCTGCAAAGTTCGACGTC
AACGTGCTGCGGCACATGACAGGAGAAACGCTTCCAGTATTCTCGTCATTCTTGAAAAGATTTAACGACATCTTCTCAGTAAACGAGCGTGTTGTTATGAGCG
GAAACTGGAAATATGGCTGCATGCACATGGTTGCTGTGGCTGCGTACAATGTCGGCAACATCCGAATCGACAAAGAACCAAGTTTGCGGACTAACGAACTAA
GGGTCGTGCTCCGACACCTTGGAGGCGATGTGGAAACCAGAACCTACTCCCGCCAGCCCTTCGAGTACTCTGTGGGCCAGCATGTAGGCGAGTTCCGCCTGG
GTAGCACAATCGTCCTTATTTTTGAAGCACCTCACAACTTCACATGGGATATGAAACCAGGACAAGAAGTCCGTGTGGGTCAGAGGCTTGGCGGCGTCGGCC
CTATTCGGCGTGCCCAAACGGAAGATGAACGCCTGTTTGCATTTTACTGA 
 
>TgPSD1pv  
ATGGCTAAGGTTATGAGGCTTATCATTTTCGTGTGCGTGGCCCTGGTGGCCATTTCGGTACCAGCAGCGTCCTCGGTGCAGAGTCAACAAGAGCGGATCAGAC
CTGGCTTCCGGCAACAGCTCCCTTCGTCCATTAGACCATTTTCCGCTTTCCGACGCCGTGGACAAGAAGCCTCAGACTCAGTGGTATATCTCAACATCGTCTACT
TGAGGCTAGTGGGCACCCGACAATGTGCGACTGGAGAGCTCACCGTCGTTGTTCACGGCAAAGCGCTAAATAACGCAACACTGGGCGATGTGCAGACTAGC
CTTACGCGCACATTCGCTTCCAGCCTGAAGGAACCTTCGTCGACGTTGGCAATCCGCAGGTGGTCCTGGAAGGACCCATTGTTTTTGATGCTCACGTTGAATC
GACGCGCTGTTCGCACTGGCACCGGCTTGCCCCGCAGTACTCCGCTTTATCAAGTTGCTAAACAGCGACTTTTCGTGTTTGTTCGCAAACCAACACCGACTTCA
TCATGCAGGCGGGCTGCGCTGGACCCACGGCCCCTGTACGGTGTGCCGAAAGTGGGTGTCCAAGACAAATACACCCTTCACGTCAGCATGGATGTGTTGGGA
ATGTCTCTGCGAGAACCGCTCGAACACCAAGAGGAAGAACCCGGGCCTGCGAGTGTGTCCACTTACGCAGCAGCTCAAGCGATTCTTGATGGCGCGTCGAG
CTTTGGCATAGGCGCGTTTGGTAGTGCAAAACCGAACCTCAAACAGATTTCCATGTATGCCAGCGGCGCAGAGCTCGAAAAACAGGTGTACACTCCCACCACC
AGTCAACTGGCTCTGTTTCTTCCCTCGAAGACTTTTTTTGGCGTTGAAGTGACCTCTGTTTCGGATGGCACTTTCCGAATTCCGGTCTCCGCGTCTCGCCTCGTT
CCCTTCTCTGCGATGTCGTACATGTGCACCGGATCTCAGACACACAAACTGACTCAAACAGGCATGAACGTCTTGGAGAAACGCGTGCATGGCAAAGAAAAC
CCGCCCAGTGAGGGTGCCGAAGTGCTTCTCAATCTGTTGGCTGCTCGCAAACCCGTAAACGGTGTATTCGAACAAGATCCGACGGTCGTCCTCCTACAGCTTT
GGCGCACACCCGAAGGCTCTGAGAGCTGGCAAGAGACTCCGCTTATGTGGGAATTTCCTGACACGCTCGAGGCAATCGAAGATGCAGGCGAATATCGCAGC
GGCATCCTTTCCAGTATTGCCGCCAACACACGGATCATAGGGAAAATGGCTGGCTGGCTGGCTTCCCGATCTTTTTCGAGAAGGTTCATTAGAACACTGATTAG
GCTAAATAATATTGATCTGGAAGAGGCCTTCAGCATGAGTGACAAGGACAGACGCCACTCTGCAGCAGATTTTCGGAGCGTGCAAGAGTTCTTCACCCGACCT
ATCAACTACCACGTCTATCGCGACATGGACCCTCGAGCATCCATTATGGCTCCGGCGGATTCTCTAATTCAAAATATTTACACGATTCGACCTGATTTTAAAGGCG
AGATTTCTCATCCAATCATTCCTCAGGTGAAATCGACGTCGTTCAATCTGCGGGAGTTTCTCTATGGAGCACGACAAGTGCCTCCTCTCCAGCTTCAGTCGCCTT
CAAACCGCCTCTTCGTTAGCATTTTGTATCTTGCCCCGAGTGACTACCACCGAGTTCATTCTCCGGCAGACTGGAGAGTCACATCACAGACCTATATCCCGGGG
TGCACTCCCTCGGTGAGCCGCAGAAATCTGGAGGCGGGCGATTTGCTTCACCGATACGAGCGCACGGCGCTCATTGGACACTGGGATCCAGAGAAAAATGG
TCAGCAATTGTTTTTCTCCGTGACCATGGTGGCAGCGATGTTCGTCGGAGGCTTGCGTCTCTCTTGGGAGGAAGAGCCCCTCGGTGCGAGCATGAGATTGGG
CCGCTGCACGAGATACACCGAGTCCTACGAGAAGCAAGTCGACGTGGAATTGTGTGCGAGCCAGGAAATCGGAGCATTTCGCTTTGGAAGTACAGTCGTCAT
IX. APPENDIX 
110 
 
GATCTTCGAGGCACCTGAAGACTTCGATATGACTTCTGTCGGCCAGTGCTCCCACGTTGCGGCAGGCCAACCAGCAGGCTATCTGGGACAAGGCCGCGAAAG
GCCTCTTCAAGAGAGATGCAACGCATTTCGTGGAAACTTTGAATCACCTTTCCACTTTTGGAAGCACCTCCAGAAAACATCCAGTGTTGATGACATTTTGAAAC
AAAACACGCTCGCTCCTCGCGCTTGGCGTCAGGAGCCTGGGCGTGTGTGGGCCGAAGTTCTCCGCGCCACAGAACGTGGACTTCTCTATGGCTTCGCTCTTT
CACACTACCTCTTGAAACGATGGGCTACGGAAAATGGTAATCTTGGGGAGCTTGTGCTGGGCCAGCCGGAAGTTCTACGGCAAAACATCAACGGTAGCGACT
CCGTCATCCGTGAGGGCTTTCGATGCTTTGCGGCAAAAGACAAGAAGCAGATCAGACTGCAGATGTCGGGACGGCAGAGCCAAGTTTCTCTCACTGCTACGG
TAACCCCAGATGAACAATTTCTTTTCCAGCATCCCTTTTATGGATGCGTTGGAGACGAGAAATTGGGCAAACTTGTCCGGGGCATCGATGCGACGTGGATCCTT
CTACCTGAGCGAGCTGTGCTGCTCACGCTCAAGGTGTCCACAGGAAGCAAACAAGAGGACGGTCGCGTTCTACGAGTGGCGACGACGAAAATTGAAGTCCA
AACAGAGCCTTGCCAGGGTGGCTGGGAAGAGAGCCGAGTCGGTACCACATCTACAACCTGTGCAATTCGTACGGTGGAGAAGCGAGAGGAGTCCATCTCGG
AGGGTGTGCTTACCAATGGGGATCTCTGA 
 
>TgEK 
ATGGCTCTCCACACTGCATGCACACCCTCGCCTCTGGGCGGCGCAGCTTCGGCTTCTCGCTCGTCGTCAGAGGCCGCGAATTCCGCGGCTTCTCTCTCCGCCGT
ATCTCCACGCGGCAGCGACTGGCGGCAAGGCGGCGCGCTGCATGCGCCTTCGGGCTCTGTTCAGACATTTCTTGCGTACGAAGTCTCTCGCGAGTGTCGCAT
GACCAGCAAGGCAGAGAGAACCTCCTCGAGCACCCCGTTCTCCTCCGCTTCCTCTCCCACACACGCAGGGTCTCCGAAGGCGGGAGAGCACTGCTGCGCTG
CCGAGAACTGTCGAGGCGTCGAGAGAAGAGATCTCTCCCCATCTTCTTTGCCCGCAAGCCGCGGAGAGGTCTCGGCTTCCAGGAGAGAGCTCAACGGCGGA
GAAGAAGAGAGCGAGGTCGCGGCGAATGAGGAGGAACTTGCAGAAACTCTCTCGAAGGCGAAGGACATCGTCGCGCGTCTCGCCGCAGCGCGCCTCGGT
GTGGAGCCCGACGCGAAACTCCTGGAAGCCGAGGCGGTCGAAGTTGGGTCGACCAATCGGATGGTCCACGTGTGGAGCAGACGCGATCCGAAAAAATCTT
GCGCCGTGAAGTTCTTCGGGAAGCACACAGGGAAGTACATTTGCAGAGACAAAGAGCTCCGTCTGCTGCGGCTTCTGGGAGCGAATGACGTGGGCAAGGA
AATCTTCGCAACTTTCGAGGAAGGCGGGGGCGGCTTAATCGAGAGCTGGCTAGCAGGGTCGAGTCTGGAGCCCAGCGACCTTCACAGGGAGGCTGCGAAG
ATTGCAAGCGAAATGGCGCGCATGCATGCAATCGATGCAAAGCCGCAGTGTCTCTTGGTGTCTCCAACTTCAAGAGACTCTCGCGGCGAACCCGCGATCGGC
GAGGCGCTTGCAAGCCCAGAGGCAACCTCCGATCTTTGGAAGCACTTGTTCAAATTCCTCAAACTCTGCAAAGAAGAACAAGAGCGCGCGCGGCGCGGCGA
GGACTCAGAGGCTTCTTCCGACGGCTGCGAAGAACCTGCGGACAGCCCCAAGCGAACTGTGTTTTCTCGGCGCATTCTTCTGTTTGATTTAAGAACTGTTGAA
GAGCGCCTTCGAGAGCTGCATGCGCTTGCGAGCGAGGTTCAATCTCCCGTCGTCTTGTGTCACGGCGACCTCCTTTCTGGCAACATCATCAAGACGGACGAA
GGAGAGGTGCGGTTCATCGACTTTGACTACTCGGGATTTATGGAGCGCGGCTTCGACATCGCGAACCACTTCGCGGAGTACTCAGGGGTCGAGTGCGACTTT
AGCAGGTGCCCCTCGGAGGAGGAGCGGGACGCTTTTTTGCGAACGTATCTGCGCGCTCTCCGCCGGCAGCGAGAGCGAAAGGCGAAGGCTGCAGCAGCC
GAGACACAGGCCTCTGCCCAGCCTGCCCAGGAAGAAGATCTCGAGGCAGAAGTCGCAGCTCTCCGACGCGAAATCAATGTCTTCTTTCCTCTCAGCAACATT
CTATGGGGTTTATGGGCTCTCATCCAGGCTGTCCATGTGAAGCCCCGAGAGATGAATTACTGGAGATTCGCCTTCGATCGACTGGCGGCGGCCGTCGTTCCAC
CAGTCCCGCATTTGTCGTTCTGA 
 
>TgECT 
ATGACGGCGGTAGCGTCGTCGGAGGTGCTCGGCCCCGCCCGGTCGGGAGCCTTGCCTTCCTCTCCATCCAAAAGCTGGTCTTCTCCGTTTATTTCTTCTTCCTA
CCTCCACAAACTCATTTTCCTCTACCTCCGCATCAATGCTGACGAAACGCTCTCGGCGAAACTCAGGCACTGGCCTTCGGTGTGCTGTCACTGCTCTTCCCGCG
TTCGAGTTTCCCTTCCACATGCGGCGGTCCGCTCCTCTTCTCACGCGTCTTCCGTCTCTTCGTTGACAACGTGTGCGACTGGGAACAAGAGCGCATGCAGCTAC
TGCGGAGCCGGAGCCGGAGGGGCGACAGAGCCGATGGAGGAGACTGAGGACGCAGATTCAGCCGCCTCCCGGCACCCTTGCTGCTTCTGCTGCTGTGTGA
AGGACCCCAAATGGACAGCCGAGGCAGACGCAGAGTTCTCAGCTCTGCGGGCGCATCTCCTTCAGTTTGTGGCGCGTAGCGAAGCTTCTCCAAACCCAGGG
GAGACGTCGCCTGCCGGTGAGACGGCGGAGACAGAAACTCCAGGCTTCTCTCCATTGTCCAGTCAATCTACGGGGGAAAATCGAATGCACGCGAGTTCCAG
AGACTGCTCTGCCTTATCGGCGCCTCTTTCTGGAGACCGAGCTAAGACCGACAAAAAAGGCGAGGAGACGGACGCCGGTGCCGGGGCAGGGACGGAGAC
GAGTGAGCAGACCAGAGAACGCTTGGGCAGACTGCATGCGTATGCGGCGTCTGGACTACGCAGCGAGACGGAGACGCAAGGAAGCACTCTCGGCTCCGGA
CGGATCGAGGAAGAGCAGAAGATCACAGAGGACGAAACGAAGGGCCATCGAGGCGTCTCTCCACTGGAACAAGAGACCCTGTGCAGCGAGGTAGTTTCGC
CCTGTGACTGCGAAGAGGAGGCAACGCCCGTCGCGCAGGTGGAAAGCGACCAAGTGACGCCTGCAAAACCTGCCTGCGTCCGGGACGCCAGTGTCTGTAC
ACATGAGCAGACCAGGAACGACGACGGCGGCGTTCCAGACACGGAGGAAAACCGCGTTCAAGAAGAAGCGTCTGCTTTTTTCTCTGGAGAAGCGCGGAAG
GCGGAGAGTCACAAACATTTTTCTGCTTGTCGAGGACCGCAGAGTCGCGCAACAGATGCTGAACTCGGAAGAACAAATGTCTCTCCTGCAGGCCGCTCAGA
GACAGGACGAGGGGCGTTGCCTTCTGAGCAGGCAGACGCGCCGCCTTGTCCCCCCTCTTCCCCCGCGAGTTCGTTTCTTGCGGACTGTGTCTCTGGACGCCA
ACATGTCTCTCTGTCTCCTCTCGGCGTCTCTTCCTCGAGCGCGTGTCTAGACAGCGTCCCGGCGTATCACTGGAACGCGCTTCCTCTGGTCTTGCCCGTTCCATC
TGCCTTTTCGTCTTTCCAGCATCTGGCAAGTCCCTGTGCGTCTCCGTCCTCTCCCTTGGCTTCGCCGTCCTCTCCCGTGGGTTCGCCGTCTGCGAAGTCACTCGT
TTTTCGACCGTCTCCGTCTTCAGGTCCGGCCGAGGAGACTCCCCCGCATGCGTCCTTCGCTCTCGCGCCAGTGGCTCCGTCGCCGCAGCTGTCTCCGTTCCCC
GCGCGATCCGCATGCGCTCCGGGAGCTCCTGTGCGGATCTACGTGGACGGCGTATTCGACCTCCTGCACTCGGGGCACTTCAACGCGCTTCGCCAGGCTCGA
CAGCTGGGCGGGAAGTTGGTGGTGGGCGTCTGCAGCGACGCGGCGACTTTCGCGGCAAAGAAAGTCCGGCCTATCTACACGGAGACGGAGCGAGCGGAA
ATCGTTCGCGGGTGCAAGTGGGTCGACGAAGTGATCGTCGGGACGCCGTACGAGGTGTCTGTCCACCTGCTCGATCGACTGAACTGCGCCTTCGCGGCTCAC
GGCGACGATTGGGTGGTTGGTGCCGACGGAGAGGACGCGTACGCGGGACCTCGGCATGCGGGGCGCATGAAGATTTTTAAGCGCACCGAGGGGATCAGTA
CTTCGACGATTGTCTCGCGTCTCCTGCAGGCCACAGCTCACGTGGAGCAGCGCCACTCACTCCCGCCTCTCCAGGCTGAAGGCCAGCTGCTGGACGCTGGCG
AAGTGCAGAGCAAAAAGCCGTTGAGGAGCCAGGCGGTAATGCAGCCGACCCGCGTGCAACGCTTCGCGAGAGACTCTCTGAGAGAACAGAAGGAGAACTT
GCTGGCGTGTTCCTGCAAGAAGAAACGCGATAAGGACGAGGACGAGCGACGCCGAGGGCGAGCAGAGAGACTCGGAAAGAGGCGCGACGTCCACGCGG
CGGACGCTCGCTCGCGGGACTGTTTAGACGCCCGAGGAGGCGAAGAAGAAGAGCGGGGAGGCAGCGACGCGGCGTCTTCAGCGAATTTGTCGAGTTTCTT
CTGCTCGTCGAGCGACGAGGGCGGCCGCAGCAACGGCGATAACTCGGCGCACAGAAGGAGACAGGAGTGGCGAGCGAGCTCAAGGGGGAGCGACGCGC
GAGGCGTCAGCGTCGGAGACGGTGACGCGAGCCGGGAGACAGAAAGGAGAAGGGGAAACGTGGAGGAGCCGAGACAAAAGAAGTCCTGCTGCGCCGTT
GGTGGCCGGCACCATCGACCGCGGAAGCCTCAAGACCCTGAAGAACGCAGAATGCTCATGTCAACGAAGCGCCTCCTGCAGTTCATTGGTCAACCGAAGCG
TCCGAAAGCCGGCGGCAAAATCGTCTATGTCGATGGTTCTTTTGATGTCTTTCATGTGGGTCACCTGCGCATTTTGGAGAAGGCGAAGCAGCTGGGAGATTAC
CTGATTGTCGGCATCCACGACGATGAGACGGTCTCGAGAATCAAAGGTCCCGGGTTCCCTGTCTTGAATCTACACGAGCGAGCGCTCAACGTCCTCGCCATGA
GAGTCGTGGACGAAGTCATCATTGGAGCCCCGTGGGTGATTCCACACTACATGCTGAAGCAGTTTCAGATCGATGTGGTGGTGCGCGGGAGTCGCATCGATT
CGATCGCGTATCCGTTTTCTGGAGACGCGAGTGGAGAGGGGGCAGGAGAGCCTGAGGCGCAGGCGGGCAGAAGAAAGGAGACGGAGGGTCGAGACAGC
TCCTGCTCCCTCGCAGTTCTCTCCTCTGGCGAGGAAGACGAGGACGCGGTCGATCCTTACCGCGTACCGAAGGAACTCGGCGTCTATAGAGAAGTGGAGAGC
TCCTCCTCCTGGACAACCAGAGCGCTCGTGGAGCGCATTCTTGCCAACAGGGAGGCTCTGATGGCAACCATCGAAACCCGATGCTCCAAGGAAGCAAAGTTC
TGGCGCGAACAAGAGCAGGGACAGATGGTGTCTCTGACAGAACTCTGA 
 
>TgEPT1 
ATGGTGTTTGGACACTACATTCCCCCTCTGGGGCTAAAAAATTTGCACAGCTACAAGTACTCGTCTGGAGGCTACACACCCTTGGACAAGGTCATGAACCCGT
GGTGGGAATTCGTCGCTTCCCTCGTCCCCCCTACAGTCCACCCAAATGTCCTGACAGTTGTCGGCTTTCTCTGCGCCATCGGCGCGGCTGTGCTTCAGCTTACC
TACTCACCGACGTTGTCGGAAGAAGCACCTCGGTGGGTCTATCTTGCAGTCGCCCTTTTCTTTTTCCTTTACCAGACTTTTGACGCAATCGACGGAAAACACGC
GCGACGAAACGGCCTCAGTTCCCCCCTGGGACAGCTCTTCGACCATGGATGCGACATCATGCTCACCACCCCCCTCACTCTTGTCAGCATCGCTGTCATTACAG
CCGGGACAGGCGTCACACAACACGCGATAGCCATGTGGAGCTCACAGGCACTCCAGTTCATCTACATGTGGTGGGAACTGCACTTCCACGTGTTTTACGCGG
IX. APPENDIX 
111 
 
CCACAGGCTTCATTGGTGTGACGGAGGCGCAAATGGGGGTCATGGGAATGGCGCTGATTTCCGGAACCGTCGGCTCGTGGGTGTGGAAATACAACCTCTTG
CAGCTGCTTCCTTCCCCCTTCCAGGACGTTGTCGGTTCCATCATGAACATATTCCACACAGAGCTGAATGGCCTTTTCCTGGTCCAGGTAGCTCTCGTTGCTTGC
AATGTACCAGCTCTCCTGTACGATATCGTCATGGGGATTGCACGTGCTCCGAAACGACGCTTGGCTGCATGCCAGGTCGCGGGCTTCGTTGGCTACATGGCTCT
TCAAGGGGCTCTGTGGCACACATGTCTTGAGGGTCCTTGGGAAGCGCGGACGTCTCCGGGCCTCATCTACTTCACAGTGACAACCTCGTACAGTATTCTGCTG
TTGCGAATCTGCCTCAGTGCGACTTGTCGCTTTCCATTTAAACTCGTTAATGCCCCCGCAATTCCTTTTTTCCTCGCTGCCGCTGGCATCGTCACTTCCCGCTGGT
GTCGCGAGCACCGCTACGCGCTTCTCACATTGGTGAGCCTTTGGAACGTGGCCTATCTCACCGACTTCTTGTACACAAGCGTTTCCGATGTCTGCTCGTCTCTG
GAAATTTCTTGCTTCCGGGTGGAGGCGTGCAAAAGGAAAGACGGCGTTAGTGGTGGAAAGAGTGCGAACTCGGGGGCTGGCGAGAGTGCGCCTAAAGAG
CTCAAGCGTCGGGGCAAGGCCGCAATGATGCAAAAGGAAGCCAACACTGAAGACGAGAATATCCCCGATGTGGCTGTCTCTTCACGTGAAAGCAGACGGCG
CGGGGCTTAG 
 
>TgEPT2 
ATGATGGTCGGTGGCGTTTTCGGGTGTTTCATCACTCGACAGGGTCTGGAGGAGCTCCGGCGCTACGAGTACCGCGGGGGCGGCAGCACTCCCATTGATCG
GTTGATGAATCCTTGGTGGGATTACGTCGCGGGCAAACTTCCTCTTTGGCTCAGTCCGAACCTCCTGACCGTCTTCGGCTTCGGCTGCACTCTCTTGTGCATGC
TGCTGGTCATGAGCTGGATGCCCCACTTGAGAGAGGCCGCGCCCCGCTGGGTGTACTTCGCCATGTGCCTCCTTCTCTTCGTCTACCAAACTCTGGACGCTGTT
GACGGGAAGCAAGCGCGAAGAACAAATTCGTCGACGCCTCTGGGGCAATTGTTTGACCACGGTTGCGACTCGTTCAGCACAGTATTCGCTGTCTTCATCAAC
GCCGCGACCGCGCGCATGGGCGTCTGCATGTTTTCCTACGTCCTCTTGGCCATTCTGCAAATGCAAATGTTCATCTATTCGTGGTGGGAGATCCACTTCCACGTT
TATCGCTGTCACACAGGCGTCACCGGCGTCACGGAGGGCCAGCTTGTCACGATGGGTGTGAATCTGCTCGGAGCTATTTTCGGTCCTGACATTTTTCTCCTCAC
CTTCGGCCAGTGCCTCGCCCTCACTTATAGCCCAGCCGCTGCTTTCTTCCCCGACTGTCTGTTGAACACTCCGATGCAGTACATCATATCCTTCCCCTTCTACCTT
CTTTTAACCTACATGCTGGTGTCCGACATCTTCAATGGGTGCCGACTCGTCAACGACAAAGCGCTTGCCATTCCGCAACTGATTGGCTGCTTTTCGCACGTACTC
TTCCAGTTCGCTTTCTTCTGCTCGGGCCTCATGCAGACCCACCCTGCGGTGTGCTACTCCCTCATCATCATTAATTCGTCAATCGTCGTCCTGCGCATGAATATTG
CAGCGACGTGCAGGCTGCGCTTCTACCCCGTTCAGTGGCCGGCGCTGCCGTTCTACGCGACGAGTCTCTACTTCTACTTGGCATGTCCGAATCCGTCTTCTCCG
CTTGCGGCGGTTCTCTCCTCGCCGCTCTCTGAAGCGCAGCAGGCGTACCAGCAGAAGCATGTGATTCCCTGGGTGTTGACTGCCGTAAGTCTCTGGAGTGTCT
TCTACCTGTACGACTTCCTGCTCAGCACCATCACAGCGATATGCAGTCACCTCGACATCACATGTTTCTGTGTGAACGCGAAGGAAGAGAAAGGGAAGGGAA
GAGGCCGAGGACCCTCCGCAGGGTCGCCGAAGCTCGAGGGACTGCAAGGAGACAGTCCAGTCGCGGCGCGGGGGGGCACGAGCCCTATGCAGACGAGG
CGCCGAGCACAGGCCGCTGTGAATGCTCAAGAGCTTAATGCTCTCAAAAAGAGCTCCTAA 
 
 
IX. APPENDIX 
112 
 
Appendix 2 
(A) Protein sequence of TgPSD1pv with predicted signal peptide highlighted in blue, PSD domain 
(PF02666) in orange and proteolytic cleavage motif in red colour: 
 
 
 
 
 
 
 
 
 
 
 
IX. APPENDIX 
113 
 
(B) Protein alignment of coccidian PSD orthologs from T. gondii (TgPSD1pv), Hammondia hammondi 
(HhPSDb) and Eimeria falciformis (EfPSD2b). Areas of low protein conservation are shown in blue, 
whereas conserved aminoacids appear in lighter colour. 
 
 
 
IX. APPENDIX 
114 
 
Appendix 3 
Processing of TgPSD1pv compared to yeast ScPSD2 as shown by C-terminal HA-tagging and Western 
blot using anti-HA antibody. PSD enzymes are known to be processed into α- and β- subunits at a 
conserved XGST cleavage-motif. SP = Signal peptide, EMS = Endomembrane sorting sequence 
 
 
IX. APPENDIX 
115 
 
Appendix 4 
Analysis of the phospholipid composition of the TgPSD1pv overexpression strain via 1D-TLC, and lipid 
phosphorous assay. 
 
 
IX. APPENDIX 
116 
 
Appendix 5 
(A) pTKO-TgPSD1mt-5’UTR-DHFR-TS-TgPSD1mt-3’UTR 
Plasmid used to generate the TgPSD1mt conditional knockout in the Δku80-TaTi strain: 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGT
CGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGC
AAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGG
CGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCC
GTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAA
AAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAG
GATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAA
TGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCT
CCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGC
TCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCC
GATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACT
GGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTT
AAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGAT
CTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATAC
TCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCG
CGCACATTTCCCCGAAAAGTGCCACCTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGC
GCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTT
AGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGT
CCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTG
IX. APPENDIX 
117 
 
GTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGG
GCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGAC
GTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGAT
TCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCCCACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGACTTCTTCAGCACA
TCGTGTGTTGGGAGCTTCTGGGTCCGGACAACACTCCCTGGTACTCGGCCCACGGAAGCATTGTGCAGCGTTTCTCCACTTCCCCTCATCGGTCACACGCGGT
TCATTTGAGTGCTGAGACACACTCGTCTTCTATTTGCTTCATCTTCGGTTGCGAGACCAGCTCAGGCTACTGCTGGTTTTGGCTGTGGCACGTCTCGTTGAACC
ACTTGTACCCCAGTTGTCCAATAGGGAATTCCGGACGACATCGCGCCCGGGTATTTGCTGTGGCTCGCTTTGCCAAGCTGCAGCAACCGAGCTTCGGGACTTC
TTACTTCTCCGTTGACGTGTTCCGTCATTCTTTCTGGACCAATAGCGCAAGACCTGCCGCGTCTATAAGTAGCCCTGTCCTGTGGGTGCTCTCCAACTCTGCTCTT
GTCGGAGCTTTTGACTCGGTAGAGGACAACTCACGTATCAACATCCAGTGTAATGGAAGGGAAGTTGTAGAGAAGTTGTAGACGATATCACCGGAGCAGCTA
GCTTTTGCTGCGAATGGGGACACCCAGAGTCCGTCGATTTTGGTTTCTGTGCTCTCGATCGACGTGTGGATTGTCTCCGCTCCGTGTGCCCTTTCCTCGGACCT
CTCTTCTTTAACGCCTTGAAGAACAAGGTGGTTTGCCTTTTTTTTCTCACATCCTCGCCTTTTATCATATTTTTGTGAGTTTAATTTCGTACGGCTTCTCACCGGGT
CGTGACCGTCTTATTAGCTATTCGTCGAACTTCTTTTGTCAGCTTGCGTCAGAGGTTGACGCGCTTCGTGTGACACCCTGTGGTGGGGGATGTGGTTGGCTGA
AGGAAGCCAGACGCGAGGGACGAGGCCCAGCGTTTCTGCGTGCCGTATCAGAGAGCACGCGACTCCTCCAAAACGGCCAGTTACACATCGCCTGCCACCAT
ATCACAAGGCAAAGGACATCGCGACGTTATCGTGCTTCTCTTGAGATGTTTGCACTAGTGGATCGATCCCCCGGGCTGCAGGAATTCATCCTGCAAGTGCATAG
AAGGAAAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATTCACGAGTGGATACACGCACATCTGCGT
CACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACATGAAGAGTCATCCCTTTTCTTCGATAAAGGA
CACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAGGAAAACGAGAGACGGGCAGCTTCTGTA
TTTCCGCTAGACAGCCATCTCCATCTGGATTCGTCCGTGCGGGACGTAGCCCACGACCTCAAAATCCTCGGCGGTGAAATCGTCGATTTCCTTGATGCGTTCCTT
GTTGAGGATGTTCACAATGGGGAACGGTCTCGGTTCTCTCCGCAGCTGCTCTTTTAAAGCCTCGACATGGTTCGTGTAGACATGCGTGTTCCCCATGAAGTGA
ATGAACTCCTTAGGTTTTAGGTTGCAGACGTGTGCAACCATGAGCGTCAAAAGCGAATAGGAAGCGATGTTGAAGGGGACGCCGAGGCCGACATCGCACGA
CCGCTGATACATGATGCACGACAGCTCCTTCTGGTCGTTCACGTAGAACTGGCACAACAAGTGACAAGGCGGCAGCGCCATTTCGTCCAGCGCTGCAGGATTC
CAGGCAGTCATGAGCATGCGACGATCTGTTGGATTCGTTCTCAGCATCTGGATCACATTCTTCAGCTGGTCGACGCCCTGCCCTGTGTAGTCTGTGTGCATGTCT
TTGTATGCCGCGCCGAAGTGTCTCCACTGGAAGCCGTAGCCCGGGCCGATGTCTCCGACCTCTCGGTGGGGGAGATTGCGCGAATCGAGGAACTCGCGTGTC
ACATTCTTGTCCCAGATCTTCACGCCCTTCTCAGAAAGATGGTTTGCGTTCGTGTCGCCGCGAATGAACCACAGCAACTCTTCGAGGACCCCTTTCCAGAACAC
ACGCTTTGTGGTGAGAAGTGGAAAGGCCTGATCCAGCGAGTAGCGCATAGTGCAGCCGAATTTGGAGATGACACCAACGCCCGTTCGGTCATCCATTGTCCT
TCCATTGTTAATAATGTCGGCAATGAGATCAAGGTACTGGAATTCTTCATGGCCTCTAAAGTGAACATGCGGAACGGCCCGAATCAGTTCCTTTTGCTCGCGTTT
TTTCCGGTCTTCTTCGTCCATCCACGCCAACACCGGGGCAATGGCTGCGGCCGAAGAAGGAGCCTGCAACCCGTGCACGGGAGTTGTCTCCCTCGTGGACGT
CAAGGAGCTCATTGCGTTGCTCGGTTCCGCAGTGGCTGCGTCGTCAGTCTTCCTTCTCTTCTCGAGAACCACAAAGTCGTAGGGTACCCCGTTGTCTGAGAAG
GTCTTGGAAATGAAGATGGGTCGATACGTCGCTTCATTGTCCTTCTCTCTTCCGAGCTCCGGACAAAAGGGAACGAACACAGACTCGGCAGGAGCTGCAGCC
TGCGCAGCAGTTGATTTGTTTGAAAGAATGTCATCTCCGGGGAACGCAGGGAAGAAAACGTCGCACGGAAACTCGCGGGCTACACGCGTGATGTACAGGTG
AGAGGCAACGCCCAGAGACAGCGCTGCCTCGTACAGTCCCGCTCCTCCCACGACAAAAATCTGGTCGACAGAATCCTTGTACTCTTCCTCCAGAAGGCTGAG
AGCTGCTGGGAGTGAAGCACAGACTCGGACGCGCTGCTGGCCTTCAGCTTGAGGCTTCTCCGCCGCAATGTCTTCTTCTTTGAGGGAAGAGGAAACGACGA
TGTTCAATCTGTCCACGAGGGGTCTAAACTTTCGAGGCATGCTTTCCCAGGTTTTCCGTCCCATGACAACGGCGTTGAATCTCTTGCCGACTGATGGAGAGGG
AAGTCCAGAGTCGCCCGTCTTTGCAAATTTCCTGGGAAGCCACCCGTTCAGGCGACTGGCTTCTTCGGGCGTCGTTTTTGTCACACGAGAAAAGTGTTTGAA
ATCTGTGGTCAAGTGGGGCCACGGGAGGCCGTTGTTGATGCCGATGCCCCTCTTGGGGGTCATCGCGACGACCAGACACACCGGTTTCTGCATCTTCCCAGA
CACGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCTCCGCACTGCCGTGTGGTAAAATGA
AAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCACGGAGGAGAGACGGAAAGTGCTTA
CATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAAGAATGAAGTTCCCCGATTTTCCCAAAAAT
GGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGGACGCTACTGGGACTGCGAACAGCA
GCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGTCGAAAAAGAGAATGGAACTTAATGTCCACGTAGTTCGCGCATGAAAAGCGTC
CTACCACTCAAAAAAGACAAAAACCGCACTCGCGGCGTTGAATGTGCGGGGGAACGGATGGCTCTCTTTTTTGGAAAGCGAATGCAAAAAGACAAGACGCA
GACGCATACAACGTTAGTCCCCTGGCACGAGAGATAGAGGTGCTGGGGGCCATTGCGGTGTCGTGGATTTACCAGTCATGGACGAGATCGTTCCGGAGCCTG
TCTTTCCTGAAAGTCTGAAAAAATTGCGGGAAAGTCACGCATATGGAACAGCACCGGGGCGGGACAGAGTTGTCTCGACAACGAATGACACACAGGAACTA
CGCGGGGGGTGAAAATCGAATGACATGCTAGCGTTCAACTTCTGGAAAGGTGGTGGCTTCTCGATCAGGAAACTCCGTTTTCTAGTGTTGAACAGGTGCGCT
CCGAGAAATCGCACGCGGGCTAATACGTGGTAAGACAAAAGACCAGCCTGTCGCCGGATTTAGAAGTCGTGGCACTACATACGGACCTCTGTACGAGACATG
CCGATGCCAAGGGCGTTATCTGGTGCCTGTGACCGCCAGTTTCAGACAGTACGCGTCTACTAAGTTTGAAAACGCATATGAACGCGTTTGTCGGTTACCATTCA
TTCTGCAACTGTCTCAGGCATTGCGTGAGCAAAGCGAGCGCCTCGCTGGTAGTCCCAACTGAATATTATCGAGTAAGCACACTACTCCACGGACATCCCTAGCG
CTCTTACCTGTTCGTAGGGCTAGAGAAATGATTCGGATATGGTTACACGTGACCACGCCAAAGTAGAAAGGAATTAGCATAACTCAGTCAGGCAGTCTCCCTGA
GGACACCTGCTTGATGATTTGTGAGGACGACTCACGGGATTTACAGCCTGGCGAAGCTTGCTAGCGTTAACTTTGACTGAATCGCTTTGTTGGGATGCAGACC
GCTTTGCGGTCTGCCAGAAATCGCACTGCAGCGCAGCCGCGAAATTACTTTGTGAATCATCGTATCTTGTCGCTGAGGTGCTTGCATATTTTGCCATCATCAGAT
TGTTGGCTGGTGTTCTCTCCACGAGCGAGCAAGTTTTGTGTGCTAGCCGGCCGGCTCGGAGTATGCGCAAGGGCTTCACACATGTGCCCATAGTCGCATTCGT
GTTCCTCACCTCGTGAACTGCGTTGCTCGAGTCGAGGGTTGGAGATATGCATCATTGTTGGTGCGGCAGTAGTAATCTGCTTCTGTACGTGCCAGTACGCGATT
CGTAAGAGATGAATCGCTGAGGAAAGTGATCTTGTTACCACTAAGAGGCGCGATAGATCGCAAACACGCGCGCAGTGTCTCTCCACAGCGGTCGTGCGTCGG
CTCTTCGCTAGAGAAATTACCGGTGCCAATATGTACGTGCATTTTCTTGGTAATTAGCAGTGGAAGCTAGAGCTCATACCTGCACTCATGACACGAAGCGCGCG
GAAAGTAGACTTCCGGATCGTTAAGTTCATTTGAAAGTAAGGTTCTGTCTCTACAATGAAGATTGCCTGACTGTACCAGTTCGCACAGGTCTTCACCAGTCTGA
AAATATGGAAAATACGGGTAATACCGGCTACTGGGCACCACATGGAATAACATCGCTACCTAGCGGAAGCTTCCCACATGAAAAGTCTCCTCTTAACGGCTCCT
GCAAAAGATTTCACAGGTCTTGTTGCAAGTTGACACACAGTGTCTGTCCGTACTCAAAAATACCTTGAACATACTCAAGCAACACAATATTCAGCAATCATCTG
GCAGTTTGGAAAGGGCACGATGGATGCCTCGAGATATGGGGCATTCCCTTGTTCAAAAACGCAACACCGCCACCCAGGACCAAGACAATGAAACTTGCACAC
GTAGCATCATATCTAAGCCTGAAGGGGTTTCGCTGTGGGCCCCGTACC 
5´UTR fragment of TgPSD1mt  
3´UTR-fragment of TgPSD1mt  
DHFR-TS resistance cassette coding sequence underlined  
TgPSD1mt-5´UTR-KO-F1/R1 primer (Restriction sites underlined XcmI/SpeI) 
TgPSD1mt-3´UTR-KO-F1/R1 primer (Restriction sites underlined HpaI/ApaI) 
[The vector was cloned by Maria Hellmund during her Bachelor´s thesis (152)] 
IX. APPENDIX 
118 
 
(B) pTKO-TgPSD1mt-5´UTR-HXGPRT-3´UTR 
Plasmid used to generate the TgPSD1mt direct knockout in the Δku80-hxgprt- strain: 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAAC
ATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCT
CGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAA
AAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGAT
ACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTG
TGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCA
CTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTAT
CTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGC
AGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTG
GTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTT
ACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGG
GCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCG
CAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGT
TGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTT
GTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCT
TACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
GTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGT
TGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATG
CCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCG
GATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGCGCCCTGTAGCGGCGCATTAAGC
GCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCC
GGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCA
CGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAAC
CCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACA
AAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAG
GGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACT
ATAGGGCGAATTGGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCG
TTCCCCACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGCGTCTCAGCTGCGCGAGGCACCCCTCTCATAGCGTGGTACTCGTCACGAATAC
CAATCGCTGGGGTCGCGGCGGGAGGAATATGCTGTTTGTTGACCATACGATCACGCTGAACGAAAACATGGTATGAGACGCCGTAAGCGGGCACAGGTT
GTTTGCCCTCGTCTCATTGCGGACCAATTCCCGGTCCACCGCTGCGTCTCGACTCGACGGTTGTGACCACCCCACTTCGCATTGGGCAGTCGGTAAAGCCAC
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AACATTACTTTGCAATTTTATCGGTTGAAACTGCCGAGCGAGCTTGCGTTTTTGGGTGCTATCTTCTCCCACCTTTTATCAGTTAAGTTGTACAGTGAGTGTC
AGCTTGTTTCGACACGTCTGTATAGACGCAACTCGGTTTGCTTGTGTTGGTTGGTGGCTGGCCAAATCAAAGGCTATTCATTTTTCACTTGCTGTGTTCTTTG
AAGAAATCAAGCAAGATGCATAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGT
CAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTAC
TTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAGCGGCACGACTTCTTCAAGAGCGCCATGCCTGAGGGATACGTGCAGGAGAGGA
CCATCTTCTTCAAGGACGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAGGGAGACACCCTCGTCAACAGGATCGAGCTTAAGGGAATCGATTT
CAAGGAGGACGGAAACATCCTCGGCCACAAGTTGGAATACAACTACAACTCCCACAACGTATACATCATGGCCGACAAGCAAAAGAACGGCATCAAAGCC
AACTTCAAGACCCGCCACAACATCGAAGACGGCGGCGTGCAACTCGCTGATCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGAC
AACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACAT
GGCATGGATGAACTATACAAATAATTAATTAAGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGT
GAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAAGGACACT
GCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAGTTGGTTGT
ATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACGAATTAT
TGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCCACCGCGGTGGCGGCCGCACTGCAGGGTACCTCTGAAACCGG
TTACAGACCAGCCATGGGAGAGTCATCGCACGGCATTTGCACCAGCGTCTACTTCACACATCTGTAGTGTGAAACCTTCCCCGAAACTCTGCAAAGAAAACT
GTCCCTCACCAGCTCGCACAGACAACACAGGAATACATACCCTCCACACAAGTCAGCGCCACACGCCACACCTGTCAGCTTCCGCGGTTCACCGTGAATACC
CACGAAAAAGAAACCGGGGTTACACATTGCTTCACGTCTTTTCCCAACGGATGTCTGACGATGAAATATCTCCTAATGTCCTTCGCTGCCAGCGTCTCCTCC
AAACTTCGAGGCATTCTCATTCGGCTTGTTGTTAAAGAAGCTCAGGTGCTTGAACTTGATCATCCCGTACATGTTGGCAAAAACAGGGATTCCAATGATGCC
CAAAGGAACCCATGGCGGCACGAATTGCCTGACTTCGTGAAGTACGAAACGCAAACCAGTTGGTCCTGCCATCGTTAGAGGCAGAAAAGGACGTAATCAG
AAAAACGCAGAACGCCCACCGACGACCACAGCCCTGTGACCGATACTGTCCAGAAGAGACTGGGCAATTTCATACGACAGCTGCACACAAACGAAGCAGT
TTACTCGAACCCGAGCTTCGTGCACTTATGGAAAGTTGTCGAACATTATTATGGAATAGCGAACACCGTCCCAAACAGAGTTTGTTCCAGTTTTTCCTGGCA
GCGCGGCTGGTCGGGAAAACAGTCGCCGCATGCCTGCATTTTTCGGTTATAAGCCGCTACCATGCCAAGCCGCATTGCCGGTAGTCACCAGTTCACGCTTA
CAGAGTTGCCTGGGTCACCAAGAGCTCTATTTACGTTCGCTACTCCTTTGTGATAATGAACTATTTTCTTCCACTTTGCTCCTCTAAGTGCTTTGATATTTTCA
ATTCCTGAGAAGGAGCCAAGTTCTATGTTTTTTTCCAACTGGAACATCCAGGTTACTCGCTCTGTTGCACAACCGACGGGAGCTTTGTCTCCCAGGCAGCCA
ATTTATCCCAACTGGCTCCTCGGTTCTCCCACAAAAACGCATCAACTGGAAGGAAGTTCGAAATGGTTTGAAAAATCAGCTTGACAGATAAAACCACCTTTG
ATTTTAAACCTCTGTTTCCCCTGAGACAACCTGTTTCGCCGGGACGTGGACTGTGTTGCAGGCTCCGTTGAGGCGCGAGCAGGGACTAAGTGGCCTTGTTT
TGTCGTTTTGGATCTCTTCGAGACGGGAGAGGTCTCTCTTCAGCCCTACGCGTTTTCCTGAGAAGAAGTTTTTGCGTGGACTTTTGCTTTGTTCTGCTGGGG
GGGGTCGACCAGGCCGTGATTGCGTCCTGTGTGAGGAACTGTTCAAGCATCGGTAGAGGGTGGCCGTCTCTCGGCTTACCCCGGGTGCATTTTATCTCGTC
CGGAGCGTTCTAGAACGGAGCTCTTTCCGGAAGTACTGCTTTGTATGTGGTGATACAGGGACTGACTTCTTCAGCACATCGTGTGTTGGGAGCTTCTGGGT
CCGGACAACACTCCCTGGTACTCGGCCCACGGAAGCATTGTGCAGCGTTTCTCCACTTCCCCTCATCGGTCACACGCGGTTCATTTGAGTGCTGAGACACAC
TCGTCTTCTATTTGCTTCATCTTCGGTTGCGAGACCAGCTCAGGCTACTGCTGGTTTTGGCTGTGGCACGTCTCGTTGAACCACTTGTACCCCAGTTGTCCAA
TAGGGAATTCCGGACGACATCGCGCCCGGGTATTTGCTGTGGCTCGCTTTGCCAAGCTGCAGCAACCGAGCTTCGGGACTTCTTACTTCTCCGTTGACGTGT
TCCGTCATTCTTTCTGGACCAATAGCGCAAGACCTGCCGCGTCTATAAGTAGCCCTGTCCTGTGGGTGCTCTCCAACTCTGCTCTTGTCGGAGCTTTTGACTC
GGTAGAGGACAACTCACGTATCAACATCCAGTGTAATGGAAGGGAAGTTGTAGAGAAGTTGTAGACGATATCACCGGAGCAGCTAGCTTTTGCTGCGAAT
GGGGACACCCAGAGTCCGTCGATTTTGGTTTCTGTGCTCTCGATCGACGTGTGGATTGTCTCCGCTCCGTGTGCCCTTTCCTCGGACCTCTCTTCTTTAACGC
CTTGAAGAACAAGGTGGTTTGCCTTTTTTTTCTCACATCCTCGCCTTTTATCATATTTTTGTGAGTTTAATTTCGTACGGCTTCTCACCGGGTCGTGACCGTCTT
ATTAGCTATTCGTCGAACTTCTTTTGTCAGCTTGCGTCAGAGGTTGACGCGCTTCGTGTGACACCCTGTGGTGGGGGATGTGGTTGGCTGAAGGAAGCCAG
ACGCGAGGGACGAGGCCCAGCGTTTCTGCGTGCCGTATCAGAGAGCACGCGACTCCTCCAAAACGGCCAGTTACACATCGCCTGCCACCATATCACAAGG
CAAAGGACATCGCGACGTTATCGTGCTTCTCTTGAGATGTTTGCATGCGCAGTTACTTGCGGTTTTCGGATCGCCATCGTCAACGACCAACACGTCCCCGTA
AACGCGTGATTTGTAGTAGCGCACATTTCATTTGCAGCCGCATGTCGCCAGCCGCGACGGCGCAGTCGCCTTTTGGCATCTCCCTCCACTCTTTGTCTTTCCG
TTTGCTGCTGATATTCCGCGGTTCCATCGTAGCCATGTCGCGTCGTTTTGTATACAAGCTTGATCAGGCAGTAACAGCCGCACTCGGGCCAAATGGCCGCTA
CATCGCGATGGTTGGCATGACCGCGTCAGCAGTCCTCCTCACTTTCCATTACAAGTTCCGGGAGGTCATTGCGGCGACAGACAATGTTGCAGAGATACAGA
GCCCCTCCAAGGTAGGACACGATAAGGTCATTGCACAAAAAATGCGATTAGCTCAAGCGACTTCGTCTACGTTTTTCTGCTGGCCTCCCTTCGATGCACATG
AACAACTGTTTCTCTAGTTATGGCTTCCAGAGCTCGAGGATATCTACCCGTACGACGTCCCGGACTACGCGTAGGAATTCATAACTTCGTATAGCATACATT
ATACGAAGTTATGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGGGGAGGT
GGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAAGGACACTGCTTCAATGTTAAGAACCTGT
TTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAGTTGGTTGTATGTGACGCTCCCAGATGTCA
TATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACGAATTATTGACATGATACAAGGACGCA
GAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCACTAGTGGATCCCCCTCCACCGCGGTGTCACTGTAGCCTGCCAGAACACTTGTCAACCGACTGT
GTCCACATTTTTATGCGCACTGACTGGCATGAATGGCCAGAGGCAGGCATCAGCAAGTCACGTAGGCCAACGCGTGCGCAGAAACGCTCAAGGCTCGATT
GTGGGTGGGGGTTGGTAGCATTTTATCGACCTAAACAAGGTTTACACTTAGGTGGTGCGGTTTTACTGATCTGGACGGATTCAGCGGTCGCAGATTATCGA
TCTGCAAATGGTGTACACTTAGGTGTCGCGGCTTATTTAGTTAAGGGAGCTTCGTGGTCGGAGCCTAACAAGTCAACAGAGACGTATCGCCAATCGTTCGC
GGTGAAGAGTCGAAACTGACAGCACATCGTAGGGAAACTGAGAGGGTGCTCCTTTCTCTCCGTCGTTTGCGCTGCACCATCCTGCAAGTGCATAGAAGGA
AAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATTCACGAGTGGATACACGCACATCTGCGTCACC
CGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACATGAAGAGTCATCCCTTTTCTTCGATAAAGGACA
CAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAGGAAAACGAGAGACGGGCAGCTTCTGTA
GGGCTATGCAGGGTTTACTTCTCGAACTTTTTGCGAGCGGCGTCGCTCAGGACGGCGACGTGGTCGAAGTCGCGGAACATCTCGTTGAAGTCGTAGCAGC
AACCAACGATCCAGACGTCTTCAATGCTGAAGCCGACGAAGTCGCCCTTCAAGCTGTTGGAGCGATCTGTGCGCTTCTCGACGAGGGTGGCGATTCTCATC
GACTTGGGACCGACGGCTTTCAGGCGCTCACCGAACTCGGTGAGGGTGAAACCGGTGTCGACGATGTCCTCAACAATCAGAACGTGCTTGTCGCGAAAGA
TTGACAAGTCGTCGCTCAAGACGGTGAGCTGGCCTGTGCTGTTGTCGTTCTGGTAGGACTTCAGGCGGACATAGTGCTCGAAGAAGGGGGGCACGCTGG
ACTCACGACCACTGTACTTCTGTATGGTGGCAAGGTAGTCGATCAGAAGGTTGAAGAAGCCGCGAGAGCCTTTCAGGATGCAAATGATGTGCAACTCCTC
GCCGAAGTAAGTTCTGTGGATGTCATACGCCAACTTCTCAACTCTGTCCTTGACCAATCCACCAGGGAGGAGGATTTTGTCAATGTAGGGCTTGCAGTGGG
GGGGCACAAGAAAGTCATCAGCGTTGTAGAAGGTGTTGTCGGGGATATACATGGGCTCAATACGGCCCTTGCCCTTGCCGTAGTCTTCAATGGGTTTGGA
CGCCATTTTGGATCTGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCTCCGCACTGCCG
TGTGGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCACGGAGGAGA
GACGGAAAGTGCTTACATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAAGAATGAAGTTCC
CCGATTTTCCCAAAAATGGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGGACGCTAC
TGGGACTGCGAACAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGATCATAACTTCGTATAGCATACATTATACGAAGTT
ATAAGCTTGCTAGCGTTAACTCATGCACATGGTTGCTGTGGCTGCGTACAATGTCGGCAACATCCGAATCGACAAAGAACCAGTAAGTTCGAGCTGTGTAC
GGCGAACTGTGGCGTAGGCGTGCACATTTCGAGGGACAAGAACAAATCGATGTGGGGCACCAAGTTCTGACACTTTTAAAGGCACTCGCCCGAGTAGTAG
AAGTCCATTATTTCTATACCGTTCCTGAGACAATCCCCAAGGCAGTACAGATGTAATTACACTATAGAACCCAGTTGCCTGGGTGGCAAGAAACCATTCGGT
IX. APPENDIX 
120 
 
TTCCTTGGTGTCATAACCGATTCACTCTCCAGCGGGATATCGCACGTTGATGATTACAGCTCGTGATGCAAGAACGATTGCATGTTCGTCATTTTTTCTTCAG
AGTTTGCGGACTAACGAACTAAGGGTCGTGCTCCGACACCTTGGAGGCGATGTGGAAACCAGAACCTACTCCCGTAAGCACCCTGAATTCGGGGAATGCT
GGCAGGGAGTTGCCACTCACTTAGCGTGTCTGTGAAGCTCTGCGAGAGGCGTGTATCTGTGGTCAGTAGGTTTCTTTCATGTGTGGTGAGTCACTTGATGT
CTTCTTGCTCTTTGTCAGGCCAGCCCTTCGAGTACTCTGTGGGCCAGCATGTAGGCGAGTTCCGCCTGGGTAGCACAATCGTCCTTATTTTTGAAGCACCTC
ACAACTTCACATGGGATATGGTAAGAAAGAGATAGAAGCAGTCAGAGGGCAATGTAGCGTGACCTTTAGATTCTGTCCGGTGCAGCGAGTAATTGGGTGT
GTTCGCCGTCGATCAGGGGGTGTGCAAAGTTCCTGAGACTGCAGTCATTGCTTCCGGGGTGGGATGCTTCTCGTGTCGGGTTGCTACCTTTTTCAAACTGT
GCATGAAAGGATGAGGCAAAGGTGGATTATCTTTTCTGCCCGAAAGGAGAGGCGTTTCCCCCGTCGAACACAGACCAGACCGGCCAAGAAAGACTCCAGC
AGCGGAACGCTCGGTGCTTTTCTTCATGCAACAAGAAGTGGGGCGGCGAGTACTACGTAACACACTGGTTGCGAGGGTGTCGTTTGATCTACGGGGCTAG
AATGCTGTGCATACATGTGTGCTTCTGACTTCGTGTTTTCGCAGAAACCAGGACAAGAAGTCCGTGTGGGTCAGAGGCTTGGCGGCGTCGGCCCTATTCGG
CGTGCCCAAACGGAAGATGAACGCCTGTTTGCATTTTACTGATTTGACTGAATCGCTTTGTTGGGATGCAGACCGCTTTGCGGTCTGCCAGAAATCGCACTG
CAGCGCAGCCGCGAAATTACTTTGTGAATCATCGTATCTTGTCGCTGAGGTGCTTGCATATTTTGCCATCATCAGATTGTTGGCTGGTGTTCTCTCCACGAGC
GAGCAAGTTTTGTGTGCTAGCCGGCCGGCTCGGAGTATGCGCAAGGGCTTCACACATGTGCCCATAGTCGCATTCGTGTTCCTCACCTCGTGAACTGCGTT
GCTCGAGTCGAGGGTTGGAGATATGCATCATTGTTGGTGCGGCAGTAGTAATCTGCTTCTGTACGTGCCAGTACGCGATTCGTAAGAGATGAATCGCTGA
GGAAAGTGATCTTGTTACCACTAAGAGGCGCGATAGATCGCAAACACGCGCGCAGTGTCTCTCCACAGCGGTCGTGCGTCGGCTCTTCGCTAGAGAAATT
ACCGGTGCCAATATGTACGTGCATTTTCTTGGTAATTAGCAGTGGAAGCTAGAGCTCATACCTGCACTCATGACACGAAGCGCGCGGAAAGTAGACTTCCG
GATCGTTAAGTTCATTTGAAAGTAAGGTTCTGTCTCTACAATGAAGATTGCCTGACTGTACCAGTTCGCACAGGTCTTCACCAGTCTGAAAATATGGAAAAT
ACGGGTAATACCGGCTACTGGGCACCACATGGAATAACATCGCTACCTAGCGGAAGCTTCCCACATGAAAAGTCTCCTCTTAACGGCTCCTGCAAAAGATT
TCACAGGTCTTGTTGCAAGTTGACACACAGTGTCTGTCCGTACTCAAAAATACCTTGAACATACTCAAGCAACACAATATTCAGCAATCATCTGGCAGTTTG
GAAAGGGCACGATGGATGCCTCGAGATATGGGGCATTCCCTTGTTCAAAAACGCAACACCGCCACCCAGGACCAAGACAATGAAACTTGCACACGTAGCA
TCATATCTAAGCCTGAAGGGGTTTCGCTGTCTCCCAAAGGAGACAACATTGCCAGACAGTGAATACTCCCTCTCTTCGTGATTCCTGCTTTTATTCTGTACGG
AACTCACGCCAGTCTTCTTTGTCTTCTACTTCCACCGCTGCAAACTACAACTGTTCCCCATCTGGAGATGCACGCCTCTCAAAAACTATCTGACTGGAAACGC
ATGAATATCGACATTCAGGAGAAAAACACTGATATACACTAAGAGCTGCCCAACTGCACACGAAACTGGCACTCATCAAACGTAAGCTGTTTGCACAACAT
ACTGCCGTCGGTCGTGCAGGACGACTTAAAATGACGAGAACGGCAGCACATTTCACTTCGTCAGTTTTCGCGCTGGCATCATTCGAGGGTTCTTTCGCATG
AACAGTTTTGGCCATGCCCGAACCTGGTCTTTCACTCGCCACCAGTTTTATGCTAAAAATACAGCTTTTCTATCTGTCCGCGCCACGTGCCTATCGAGTTTTAC
AGGACAAGTACGTAGTCATAAACTCTTCTAAAATACGTTCCATCACGATGTGTTCGCTTCTTCAGTTGGCTTCGTCACTTCACTGGCTGTCTGTTTCGCTGCTT
CTTCGACTGCCTGTTTCGCTGCTTCTTCGACTGTCTGTTTCGACGCTTCTTCGACTGTCTGTTTCGACGCTTCTTCGACTGTCTGCTTCGCTGCGTCTTCTGCTG
CTGGTTTTGCCGCTTCGTCGACCATTGGGGGCCCCGTACC 
 
GFP sequence 
5´UTR fragment of TgPSD1mt  
3´UTR-fragment of TgPSD1mt  
TgPSD1mt-5UTR-KO-F2/R2 primer (Restriction sites underlined KpnI/XhoI) 
TgPSD1mt-3UTR-KO-F2/R2 primer (Restriction sites underlined HpaI/ApaI) 
HXGPRT-resistance cassette – HXGPRT coding sequence underlined 
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Appendix 6 
pTKO-TgPSD1pv-5´TGD-HXGPRT-3´TGD plasmid used for TgPSD1pv targeted gene disruption in the RH 
hxgprt- strain: 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGT
CGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGC
AAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGG
CGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCC
GTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAA
AAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAG
GATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAA
TGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCT
CCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGC
TCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCC
GATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACT
GGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTT
AAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGAT
CTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATAC
TCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCG
CGCACATTTCCCCGAAAAGTGCCACCTGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGC
GCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTT
AGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGT
CCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTG
GTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGG
GCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGAC
GTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGAT
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TCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCCCACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGCGTCTCAGCTGCGC
GAGGCACCCCTCTCATAGCGTGGTACTCGTCACGAATACCAATCGCTGGGGTCGCGGCGGGAGGAATATGCTGTTTGTTGACCATACGATCACGCTGAACGAA
AACATGGTATGAGACGCCGTAAGCGGGCACAGGTTGTTTGCCCTCGTCTCATTGCGGACCAATTCCCGGTCCACCGCTGCGTCTCGACTCGACGGTTGTGACC
ACCCCACTTCGCATTGGGCAGTCGGTAAAGCCACAACATTACTTTGCAATTTTATCGGTTGAAACTGCCGAGCGAGCTTGCGTTTTTGGGTGCTATCTTCTCCC
ACCTTTTATCAGTTAAGTTGTACAGTGAGTGTCAGCTTGTTTCGACACGTCTGTATAGACGCAACTCGGTTTGCTTGTGTTGGTTGGTGGCTGGCCAAATCAAA
GGCTATTCATTTTTCACTTGCTGTGTTCTTTGAAGAAATCAAGCAAGATGCATAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATG
GTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCT
GTTCCATGGCCAACACTTGTCACTACTTTCTCTTATGGTGTTCAATGCTTTTCAAGATACCCAGATCATATGAAGCGGCACGACTTCTTCAAGAGCGCCATGCCT
GAGGGATACGTGCAGGAGAGGACCATCTTCTTCAAGGACGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAGGGAGACACCCTCGTCAACAGGA
TCGAGCTTAAGGGAATCGATTTCAAGGAGGACGGAAACATCCTCGGCCACAAGTTGGAATACAACTACAACTCCCACAACGTATACATCATGGCCGACAAGCA
AAAGAACGGCATCAAAGCCAACTTCAAGACCCGCCACAACATCGAAGACGGCGGCGTGCAACTCGCTGATCATTATCAACAAAATACTCCAATTGGCGATGG
CCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTTTGTAACAG
CTGCTGGGATTACACATGGCATGGATGAACTATACAAATAATTAATTAAGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTAC
AAAGCCGATCAGTGAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCG
GAAGGACACTGCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAG
TTGGTTGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACG
AATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCCACCGCGGTGGCGGCCGCtaggtgtcttgccactatgtggtcacttc
gtcgtacacgcaactggcctgcacagacacgtatgagcactatcgttttcggtaacgataatgtgtcactcttgtgggacaaaagagaaactgccccgcatatcgcgacacagaaaaaacattcaaaccatc
gctcgactgtggaagttcaacggccgcaacgcagcatttattgctcgctattttgcgttgtctctttcagCTCGAGGCAATCGAAGATGCAGGCGgtgagaactgacacaggtggggaagccgcga
ctttctgctgctgaaagtatacgagaatgctgctccggagagactgaaacatacagacgggttccatgcgccgacagcgtttgagcgattagggggggtaacacatctttacactcgtacgtgtgtcacagtt
gcatgaaggttaatcatgacatgcacacacaagagacactctgcacagggttgcatgaatttccagttccttttctctataagagaggggcccacggaccaatccagctgtgtcaaagggttataatgaggct
atgctttctgtttcttttgtcaatgcactcgtttccactgtcacttccagAATATCGCAGCGGCATCCTTTCCAGTATTGCCGCCAACACACGGATCATAGGGAAAATGGCTGGCTG
GCTGGCTTCCCGATCTTTTTCGAGAAGGTTCATTAGAACACTGATTAGGCTAAATAATATTGgtaagagataaggggatgggaaaaacgtacgcggaacataaggcttctgtacc
aatcgaccgacatgtatacgttcccaaatgtgtagacacatggataggtacgtgcctgcatatttacatgcatcaatcctcatggagaaacgcatcttccgttgatgtgtacgtactcaactctcgtatatgtaca
tccaaacaagcaactctgcccacgtacaggggtagctatgactgtgaacgcccacatgcatccatggctggtataaatatatatatatatacatatttaaacgggactctgcacgtttttacggtgatctttctg
cacgtgtgtgcgtgaaaggactcgactgtgtcggaagaatccccgttcttcatatccgtattcgtatatgcagtccggcttcttttcctatattcctgcctgtacacacgcccgtttcattggtggatatacagcatt
tcacgctgacgtacgctcgcgggagaagtgtatggaggaggtacatagtgggacatacccatgtttcctctgtacctttttcagATCTGGAAGAGGCCTTCAGCATGAGTGACAAGGACAGA
CGCCACTCTGCAGCAGATTTTCGGAGCGTGCAAGAGTTCTTCACCCGACCTATCAACTACCACGTCTATCGCGACATGGACCCTCGAGCATCCATTATGGCTCC
GGCGGATTCTCTAATTCAAAATATTTACACGATTCGACCTGATTTTAAAGGCGAGATTTCTCATCCAATCATTCCTCAGgtgtggacacgtcaatggggaacaccttcaagg
agactgttgacacccgtctcaaactacctcacgaggaacctaccagggtcgcagtcttagcgtcgactgtaccagtgccagtctaagtgtgatggatccgtgctgcgtccaagtcgtgtgatgtgttacgttata
cgccgaaaaatgttgacaagaaatcctctcactcttgtttcacccgtcacgcgggcagttttttttctcattacgcgtgctttgacgtacgagacattcgcgggtcttggagcttgttggtgccagtagcgcagcc
acggtacggcatatcgaggtttttctcggcgctctcgggaagcacacgcagaatcattgtttgaaattctccaagaaaaacatcatcttcgagtcttcgttcgactgttatcacttgcacgcgattattcgagcgt
gaagttgtctcctcagtgtgatgcgtatcgagggggtcgacgtcacatagtgcatttagtttctgtcgtgtgcgtatgtaaaagaaagctcagagtgaaggcccttaggttatcgccggacaccttctttgtttcta
ttctccagGTGAAATCGACGTCGTTCAATCTGCGGGAGTTTCTCTATGGAGCACGACAAGTGCCTCCTCTCCAGCTTCAGTCGCCTTCAAACCGCCTCTTCGTTAG
CATTTTGTATCTTGCCCCGAGTGACTACCACCGAGTTCATTCTCCGGCAGACTGGAGAGTCACATCACAGACCTATATCCCGGGGTGCACTCCCTCGgtacgtcgtg
cgcggttgccaaagcggtactcactagggatcaatcctcccatgcctgggactttggtttttatgccttcaacgttgaattgcacgtacctgtgcgcgcacctgcgcctccgtgctcctctccgttggctttaaacc
gcgtacgtacccatggtgtctccctgtcctcgctgacgagctaggcgtgtagagacaactcgaatggtgtgcatgcgtctccaccttacacggccacctgcaggttcaactagcaccagcctttatcagttcgtg
ttcaggtttctgtggatagatgtgcctctatgcgaGAATTCATAACTTCGTATAGCATACATTATACGAAGTTATGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCT
GAAGGGAGAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCG
TGTATCAGTTGTGCGCGGAAGGACACTGCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGC
CCAATGCCGGACGTCAGTTGGTTGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCT
TATGACAGTGGCAGACGAATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCACTAGTGGATCCCCCTCCACCGC
GGTGTCACTGTAGCCTGCCAGAACACTTGTCAACCGACTGTGTCCACATTTTTATGCGCACTGACTGGCATGAATGGCCAGAGGCAGGCATCAGCAAGTCACG
TAGGCCAACGCGTGCGCAGAAACGCTCAAGGCTCGATTGTGGGTGGGGGTTGGTAGCATTTTATCGACCTAAACAAGGTTTACACTTAGGTGGTGCGGTTTT
ACTGATCTGGACGGATTCAGCGGTCGCAGATTATCGATCTGCAAATGGTGTACACTTAGGTGTCGCGGCTTATTTAGTTAAGGGAGCTTCGTGGTCGGAGCCTA
ACAAGTCAACAGAGACGTATCGCCAATCGTTCGCGGTGAAGAGTCGAAACTGACAGCACATCGTAGGGAAACTGAGAGGGTGCTCCTTTCTCTCCGTCGTTT
GCGCTGCACCATCCTGCAAGTGCATAGAAGGAAAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATT
CACGAGTGGATACACGCACATCTGCGTCACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACATGA
AGAGTCATCCCTTTTCTTCGATAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAG
GAAAACGAGAGACGGGCAGCTTCTGTAGGGCTATGCAGGGTTTACTTCTCGAACTTTTTGCGAGCGGCGTCGCTCAGGACGGCGACGTGGTCGAAGTCGCG
GAACATCTCGTTGAAGTCGTAGCAGCAACCAACGATCCAGACGTCTTCAATGCTGAAGCCGACGAAGTCGCCCTTCAAGCTGTTGGAGCGATCTGTGCGCTTC
TCGACGAGGGTGGCGATTCTCATCGACTTGGGACCGACGGCTTTCAGGCGCTCACCGAACTCGGTGAGGGTGAAACCGGTGTCGACGATGTCCTCAACAATC
AGAACGTGCTTGTCGCGAAAGATTGACAAGTCGTCGCTCAAGACGGTGAGCTGGCCTGTGCTGTTGTCGTTCTGGTAGGACTTCAGGCGGACATAGTGCTCG
AAGAAGGGGGGCACGCTGGACTCACGACCACTGTACTTCTGTATGGTGGCAAGGTAGTCGATCAGAAGGTTGAAGAAGCCGCGAGAGCCTTTCAGGATGCA
AATGATGTGCAACTCCTCGCCGAAGTAAGTTCTGTGGATGTCATACGCCAACTTCTCAACTCTGTCCTTGACCAATCCACCAGGGAGGAGGATTTTGTCAATGT
AGGGCTTGCAGTGGGGGGGCACAAGAAAGTCATCAGCGTTGTAGAAGGTGTTGTCGGGGATATACATGGGCTCAATACGGCCCTTGCCCTTGCCGTAGTCTT
CAATGGGTTTGGACGCCATTTTGGATCTGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCT
CCGCACTGCCGTGTGGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCAC
GGAGGAGAGACGGAAAGTGCTTACATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAAGAAT
GAAGTTCCCCGATTTTCCCAAAAATGGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGG
ACGCTACTGGGACTGCGAACAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGATCATAACTTCGTATAGCATACATTATACGA
AGTTATAAGCTTggtgggcatacaccaatgccgctgccggtgggagatgaactgtgcttctctctccccttgtactcccgcgttttcagGTGAGCCGCAGAAATCTGGAGGCGGGCGATTT
GCTTCACCGATACGAGCGCACGGCGCTCATTGGACACTGGGATCCAGAGAAAAATGGTCAGCAATTGTTTTTCTCCGTGACCATGGTGGCAGCGATGTTCGTC
GGAGGCTTGCGTCTCTCTTGGGAGGAAGAGCCCCTCGGTGCGAGCATGAGATTGGGCCGCTGCACGAGATACACCGAGTCCTACGAGAAGCAAGTCGACGT
GGAATTGTGTGCGAGCCAGGAAATCGGAGCATTTCGCTTTGGAAGTACAGTCGTCATGgtaagcactgcttgggacaaacaagaaacgggctgtatcgttctctacccgagatca
accgcactttgtctttcctgtctcttgcacagctacccttttgtgcagattcctcaaagttgcgttcacttgagattcggctaaccggaggcccatgattttgcgtagcagtcagtgcattgacatcaaacaactgt
gtgccttttctagctttgtgatgcaaggcgaaatgccaccacgcacagcaaggcctatgcgttctctcagcagtgccggcgtttcatcccagtgtcacgctgtggtaaactggggaaagacgtccaaagtcacg
tggtttcgccgctctgagggtcgtcacaagattttattgaagcgacagcataacacattattataaccgcgagtcgatgatgtttattgcgatctatgaagagaatccgggcctgtgcatgtgcacctaatcacct
cccggtcccacttcgcagcggactcgattttacggacacgcgctcttcatagcagcgcctgtaccaaagcagccaaagcgcaagtttcctgcttccgtgcgtcattttttactccgctccacaaacaatggtgtg
aatttctacttgggcacgtgtattcgtttatttgcatgtcttttgtctgcgtctatactggtttgtcgttttgtgcatatagacgacccgatcctaagtattccgtacacatttttgtgggttcagcaactgctattcagc
tttttgtgtgacactttgcacgtctcataaacgctgtgtgagtttgtgtgtgtgtgatcctttgcagATCTTCGAGGCACCTGAAGACTTCGATATGACTTCTGTCGGCCAGTGCTCCCACG
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TTGCGGCAGGCCAACCAGCAGGCTATCTGGGACAAGGCCGCGAAAGGCCTCTTCAAGAGAGATGCAACGCATTTCGTGGAAACTTTGAATCACCTTTCCACT
TTTGGAAGCACCTCCAGAAAACATCCAGTGTTGATGACATTTTGAAACAAAACACGCTCGCTCCTCGCGCTTGGCGTCAGGAGCCTGGGCGTGTGTGGGCCG
AAGTTCTCCGCGCCACAGAACGTGGACTTCTCTATGGCTTCGCTCTTTCACACTACCTCTTGAAACGATGGGCTACGgtgagtagacggctcaaaacagctaacccagcac
agacgtaaaggcgaccataaggaaatgtttgagagcgtgcgtgcatacgcgttcatacacgaatcttcatctgcgacgtttcacagaaaggcaacaaaaagtgataatgtcttggtttccgtatatgcctagg
gcgccttcgtatgcgtaagaggatacgtatatatgttgagtattattcgacacaccacacgcgtactcactcatgtacctgcatcgactgtcgatttcactgtctacctcccgaagtatcaacacagctacctgtc
tcaatcgatttctgcgcatggagagacagtttgtgaattaaccggtgttctgtcctaccggctgctgctttatagGAAAATGGTAATCTTGGGGAGCTTGTGCTGGGCCAGCCGGAAGTTC
TACGGCAAAACATCAACGGTAGCGACTCCGTCATCCGTGAGGGCTTTCGATGCTTTGCGGgtaagccggactttgatggccgaaccaaaaagtggggacaggtacctggatgtt
atcaacggacgcctgcttggtcctgtcagtgaaatgcgtgttgtcctcgtgtctcgtttggtaatggcatcctgacgccatggaaactccttcgttgaccagcagttgtgaagtgtgatggcgtggtcagtggctc
cagggcagctgcggaataagagaatttctcatcgtgtgtccttgctgcttcctgtatttgttttctttcgcagCAAAAGACAAGAAGCAGATCAGACTGCAGATGTCGGGACGGCAGAGC
CAAGTTTCTCTCACTGCTACGGTAACCCCAGATGAACAATTTCTTTTCCAGCATCCCTTTTATGGATGCGTTGGAGACGAGAAATTGGGCAAACTTGTCCGGGG
CATCGATGCGACGTGGATCCTTCTACCTGgtaagtgcggtgaccggatcatcgaataagcagaagggcttcgagcggagcctggagggggaccagcgaaacgaatcctcatcgagtcaagac
ccacattctcgtccagaagacattttggtatccatcgacaagtaaacataaaggagtgtgtagcaccgctgagctcaggggtctaactccgcgtgtgagtcacaccaaactcgactgcactactccaattcgtg
attcgaaggggcatctgttagcattcgctccgccacacacagttgctggtttcttccgtactgcctttctacaatacatctttcgaaggaacccttccacaggatctggacaccagacgacgacctaGTTAAC
GGGCCCCGTACC 
 
GFP sequence 
5´TGD fragment of TgPSD1pv (Introns in lower case) 
3´TGD-fragment of TgPSD1pv (Introns shown in lower case) 
TgPSD1pv-5´TGD-F1/R2 primer (Restriction sites underlined NotI/EcoRI) 
TgPSD1pv-3´TGD-F1/R1 primer (Restriction sites underlined HindIII/HpaI) 
HXGPRT-resistance cassette – HXGPRT coding sequence underlined 
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Appendix 7 
(A) Lipid analysis of T. gondii tachyzoites after extracellular labelling with NBD-phospholipids by one-
dimensional thin layer chromatography. (B) Influence of the PSD inhibitor hydroxylamine on NBD-
phospholipid turnover. 
[S. Marquardt, (202)] 
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